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Abstract 
Asymmetric allylation of aldehydes with stoichiometric allylmetal reagents has evolved 
into an efficient and well established methodology for the synthesis of enantiomerically 
enriched homoallylic alcohols. The use of enantioenriched secondary allylboronates gives rise 
to a mixture of E/Z homoallylic alcohols with the opposite configuration at the stereogenic 
centre (reaction 1). The first part of this thesis presents a novel and conceptually different 
solution to attain high stereoselectivity in the allylation of aldehydes with secondary 
allylboronates. The method revolves around an efficient kinetic resolution of chiral racemic 
allylboronates (reaction 2). Catalysis by a chiral Brønsted acid ensures a face- and Z-selective 
allylation of aldehydes. This asymmetric allylation has proved successful over a wide range of 
aldehydes with different electronic and steric properties. The methodology provides a shortcut 
to enantio- and diastereomerically enriched homoallylic alcohols finding a wide use in 
pharmaceutical and fine chemicals development. 
 
The second part of the present thesis describes the asymmetric total synthesis of two 
bioactive metabolites of the Pseudopterogorgiane elisabethae family, ()-elisabethadione and 
()-erogorgiane. Three key reactions steps to introduce the stereogenic centres in the natural 
product scaffold include asymmetric allylation, oxy-Cope rearrangement and cationic 
cyclisation. 
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(HR)MS (High Resolution) Mass Spectrometry 
(prep-)HPLC (preparative) High Performace Liquid Chromatrography 
°C degrees Celsius 
18-C-6 18-Crown-6 
9-BBN 9-Borabicyclo[3.3.1]-nonane 
Å Angstroms 
Ac Acetate 
AcOH/HOAc Acetic acid 
AIBN Azobis(isobutyronitrile) 
AOC Anionic Oxy-Cope 
B2(pin)2 Bis(pinacolato) diboron 
BAIB Bis(acetoxyl)iodobenzene 
BH3•DMS borane dimethylsulfide 
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
BINAPO 2-diphenylphosphino-2'-diphenylphosphinyl-1,1'-binaphthalene 
BINOL 1,1'-Bi-2-naphthol 
Bn Benzyl 
Boc tert-butoxycarbonyl 
Bpin boron pinacolato ester 
brsm based on recovered starting material 
Bz Benzoate 
BzOH benzoic acid 
c Concentration 
CAN cerium amonium nitrate  
cat. Catalyst 
CbCl N,N-diisopropylcarbamoyl chloride 
conv Conversion 
CuTC Copper(I)-thiophene-2-carboxylate 
d doublet  
d.r. diastereomeric ratio 
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DCM Dichloromethane 
DFT Density functional theory 
DIBAL-H diisobutylaluminium hydride 
DIPEA diisopropylethylamine 
DIPT diisopropyl tartrate 
DMAP (4-dimethylamino)pyridine 
DME Dimethoxyethane 
DMF Dimethylformamide 
DMP Dess-Martin periodinane 
EA ethyl acetate 
ee enantiomeric excess 
ent enantiomer  
Epin tetraethylethylenegycol 
eq. Equivalents 
ESI electrospray ionization 
Et Ethyl 
HB Hünig Base 
HCl hydrochloric acid 
HMPA hexamethylphosphoramide 
iPr Isopropyl 
K Kelvin 
kcal kilocalories 
LAH lithium aluminium hydride 
LDA lithium diisopropylamide 
LHMDS lithium bis(trimethylsilyl)amide 
LP light petroleum  
mCPBA m-chloroperbenzoic acid 
MeCN acetonitrile 
min minute 
M molar 
MS Molecular sieves 
MsOH methanesulfonic acid 
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MVK methylvinyl ketone 
NBS N-bromosuccinimide  
NLE non-linear effects 
nm nanometres 
NMR Nuclear Magnetic Ressonance 
nPr propyl 
ox. oxidation 
PCC Pyridinium chlorochromate  
PE pseudoephedrine 
PG protecting group  
Piv pivaloyl 
PMA phosphomolybdic acid 
PPA polyphosphoric acid 
ppm part per million  
Py pyridine 
q quartet  
quint. quintet 
r.t. room temperature 
rac racemic 
s singlet 
sec secondary  
sept. septuplet  
sex. sextet  
SN2 bimolecular nucleophilic substitution 
SPINOL 1,1'-spirobiindane-7,7'-diol 
t triplet 
T/temp. temperature 
t-AmOH tertiary butyl carbinol (2,2-dimethylpropan-1-ol) 
TBAF tetra-n-butylammonium fluoride 
TBAI tetra-n-butylammonium iodide 
TBS tert-butyldimethylsilyl 
tert tertiary 
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Tf trifluoromethylsulfonyl 
TFA trifluoroacetic acid  
TFAA trifluoroacetic anhydride 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMEDA tetramethylethylenediamine 
TMS trimethylsilyl 
Tol toluene 
TPPA triphenyl phosphoramide 
TS transition state 
TsOH p-toluenesulfonic acid 
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1. Introduction 
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Chirality is a phenomenon characteristic to all living organisms. As a consequence, 
different behaviour of enantiomers in the chiral environment of the human body may have 
contrasting biological effects. Therefore, in the last two decades pharmaceutical and 
agrochemical industries underwent a so-called chiral switch, whereby all the new molecular 
entities have to be tested as single enantiomers, which, in turn, placed a demand for the 
efficient methods for their production. In the modern organic methodology, asymmetric 
catalysis remains the preferred way of introducing new stereogenic centres into the molecule. 
However, there are many instances where asymmetric methodology is either inadequate or the 
methods are not practical, therefore alternative techniques based on resolution of racemic 
mixtures, including chemocatalytic kinetic resolution and related enzymatic methods still hold 
their value. Furthermore, resolution protocols are becoming an invaluable tool for upgrading 
enantiopurity of compounds obtained in asymmetric catalytic processes by removing the 
undesired minor enantiomer. To address the rising demand for an efficient chiral technology, 
the development of new single-step reactions where a new C-C bond and a new stereogenic 
centre is formed with high stereoselectivity is of vital importance for the achievements of the 
challenges that we, as a scientific community, face regarding enantioselective synthesis of 
novel and complex molecules. 
1.1. Addition of allylmetal reagents to carbonyl compounds. 
Amid the possible methods to construct a new covalent bond, one of the most popular 
is the creation of a new C-C bond via the addition of organometallic reagents to carbonyl 
compounds or related imines leading to alcohols or amines, respectively. This transformation 
has been widely studied due to its important practical outcome; the reaction often generates a 
new stereogenic centre in the molecule. Particularly interesting is the addition of carbon 
nucleophiles to non-symmetrical ketones or ketimines since it leads to a new quaternary 
stereogenic centre, which is a challenging moiety to synthesise. One of the most important 
classes of these transformations is the addition of allylmetal reagents (Scheme 1). 
14 
 
 
Scheme 1 
The interest in the resulting homoallylic systems stems from the possibility of further 
functionalisation of the molecule. The asymmetric version of these transformations is 
remarkably valuable since it produces chiral homoallylic alcohols or amines, which are 
important building blocks in organic synthesis, particularly in the total synthesis of natural and 
bioactive compounds. 
From the structural point of view, all the allylmetal reagents share some common 
features. They all contain at least one transferable allylic group and a variable number of alkyl 
(R) or heteroatom-containing (L) groups on the metal to complete the valence shell. 
Nevertheless, the allylmetal reagents differ from each other by the mechanism of allyl transfer 
and, hence, the stereochemical outcome. 
In the early 80s, Denmark proposed a classification system for allylating reagents 
depending on the stereochemistry of the final homoallylic compound.
1
 Allylboron and 
allyltrihalosilane reagents are classified as Type I (Scheme 2, M = B, Si). The relative 
stereochemistry of the final homoallylic compound depends on the geometry of the allylmetal 
reagent used, i.e. E-allylmetal reagents give raise to anti homoallylic products, while Z-
allylmetal reagents afford the respective syn product. Such a good transfer of stereochemical 
information is due to the highly organised transition state. There is a strong experimental and 
theoretical evidence that the reaction occurs though a Zimmerman-Traxler chair-like transition 
state with an internal activation of carbonyl oxygen by the metalloid atom. In contrast, allyl 
trialkylsilanes and stannanes are classified as Type II reagents (Scheme 2, M= Si, Sn). 
Regardless of the stereochemistry of the starting allylmetal system, these reagents produce 
predominantly syn homoallylic products. Such stereoselectivity is caused by the open transition 
state mechanism where the carbonyl oxygen is activated externally.  Allyltrialkyltin reagents 
can also proceed through a six-membered transition state with internal activation; however, 
high temperatures are required in order to achieve the desired product.
2
 There is a third type, 
which can be exemplified by allylchromium reagents. They provide the same diastereomeric 
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outcome of the final homoallylic product regardless of the geometrical selectivity of the 
original allylmetal system (Scheme 2, Type III). The convergent diastereoselectivity is 
explained by a rapid isomerization between Z and E isomer through secondary allylic 
organometallic species prior to the carbonyl addition. Provided that a more stable E isomer 
predominates over Z, the formation of anti homoallylic product points to a cyclic six-
membered transition state similar to Type I reagents.   
 
Scheme 2 
The research projects presented in this thesis involve allylboron and allyltrichlorosilane 
reagents. Therefore, due to the broadness of the field of asymmetric allylation of carbonyl 
compounds, the literature review will be focused only on Type I allylmetal reagents. 
1.1.1. Allyltrichlorosilanes as allylating reagents. 
 Aldehydes as electrophiles. 
Pioneering the field in the late 1980s, Sakurai reported a highly diastereoselective 
allylation of aldehydes with allyltrifluorosilanes in the presence of stoichiometric amounts of 
16 
 
CsF.
3
 A few years later, Kobayashi showed that allyl- and crotyltrichlorosilanes successfully 
reacted with aldehydes using DMF as a solvent.
4
 Since then, allyltrichlorosilanes became one 
of the most common reagents for the allylation of carbonyl compounds. Enantioselective 
versions of these reactions have been widely studied by a number of research groups using 
chiral Lewis-basic promoters such as chiral phosphoramides and phosphonamides, chiral 
phosphine oxides, chiral sulfoxides, and chiral N-oxides. 
Denmark and co-workers extensively studied phosphoramides as Lewis base promoters 
for the allylation of aldehydes. First, they established that the use of achiral Lewis bases such 
as DMF, MPA or TPPA in substoichiometric amounts promoted the allylation of aromatic 
aldehydes with allyltrichlorosilane.
5
 Further investigations led to the development of a series of 
chiral mono and diphosphoramides (Scheme 3).
6,7
 
 
Scheme 3 
They also reported excellent stereoselectivity in the crotylation of benzaldehyde. As 
shown in Scheme 3, geometrically enriched E or Z crotylsilane, gave rise to anti or syn 
homoallylic alcohols, respectively.. The high level of stereospecificity clearly suggests the 
17 
 
formation of a siliconate complex and the reaction proceeding via a chair-like transition state. 
The nature of the transition state and the origins of the excellent stereoselectivity were analysed 
in detail by Denmark et. al.
6
 Two reaction pathways were suggested, one involving a 
pentacoordinated Si (trigonal bipyramidal) with a single phosphoramide bound to the silicon; 
and the second involving a hexacoordinated Si atom (octahedral) having two phosphoramides 
completing the silicon valence shell (Figure 1). 
 
Figure 1 
Kinetic data together with NLE probe led to the conclusion that more than one chiral 
phosphoramide molecule is present in the stereochemistry determining step. Kinetic studies 
revealed the reaction order of 1.77 in the chiral promoter, which could be due to the two 
competing pathways involving one or two phosphoramides running concurrently.
6
 The fact that 
the two competing mechanisms were in operation would explain the observed modest-to-good 
enantioselectivities since the pentacoordinate TS A would be less enantioselective due to the 
reduced influence of a single chiral promoter 
Following Denmark’s attempt at using phosphoramides as Lewis base promoters for 
allylation reactions, Yasumasa Hamada reported the synthesis of a novel chiral phosphonamide 
and its application to Lewis base-catalysed asymmetric allylation of aldehydes.
8
 It was found 
that TBAI accelerated the reaction. The presence of ammonium salts in solution favoured the 
dissociation of a chloride, which is advantageous for the reactivity.
9
 However, the reaction 
occurred in modest yields and enantioselectivities. They also reported on the addition of E and 
Z-crotyltrichlorosilane with benzaldehyde achieving excellent diastereoselectivity (Scheme 4). 
18 
 
 
Scheme 4 
The first enantioselective allylation of aromatic aldehydes with allyltrichlorosilanes 
catalysed by chiral phosphine oxide was reported by Nakajima.
10
 BINAPO 1, which can be 
readily obtained from the known chiral diphosphine BINAP, was employed as a catalyst. The 
results obtained with BINAPO were modest in terms of enantioselectivities and were 
dependent on the substitution pattern of the aromatic aldehyde. The excellent stereoselectivity 
achieved in the crotylation experiments supported the proposed Zimmermann-Traxler chair-
like transition state (Scheme 5). 
 
Scheme 5 
Methallylation of various aldehydes using 1 was more successful (Scheme 6).
11
 A 
decrease of enantioselectivity was observed when electron-rich or sterically hindered aldehydes 
were employed.  
19 
 
 
Scheme 6 
 Malkov and Kocovsky reported on the efficiency of 1 for the unreactive -
halosubstituted allyltrichlorosilanes.
12
 The nucleophilicity of the -carbon in the allylating 
reagents 2 and 3 is decreased due to the electron-withdrawing effect of the bromine substituent. 
Therefore, an increased reactivity on the chiral catalyst is needed to allow for the synthesis of 
halohydrins 4 (Scheme 8). Other mono and diphosphine oxides shown in Scheme 7 were tested 
in the reaction but gave lower chemical yield and enantioselectivities. 
 
Scheme 7 
Benaglia and co-workers
13
 developed a highly reactive chiral phosphine oxide based on 
electron-rich heteroaromatic rings such as 3-thienyl (5, Scheme 8). With this novel scaffold, 
both chemical yield and enantioselectivity in the addition of allyltrichlorosilane to different 
aromatic aldehydes were improved significantly. Notably, the 3-thiophenyl scaffold exhibited 
higher reactivity. Chiral phosphine oxide 5 also produced excellent stereoselectivity in the 
20 
 
crotylation experiments supporting formation of a chair-like six-membered transition state in 
the course of the reaction. 
 
Scheme 8  
Several research groups investigated the use of chiral sulfoxides as chiral promoters in 
the allylation of aldehydes with allyltrichlorosilanes (Scheme 9).
14–19
  
 
Scheme 9 
 In general, this type of Lewis base commonly required stoichiometric loading to 
promote the reaction.  They exhibited moderate to good yields and enantioselectivities. The use 
of tetrabutylammonium salts seemed to improve slightly the enantioselectivity, whereas the use 
of stoichiometric loading enhanced the chemical yield.
19
 However, these chiral promoters are 
21 
 
rarely recovered because sulfoxides can be reduced or decomposed during the reaction.
15
 This 
family of chiral Lewis bases showed excellent diastereoselectivity when geometrically 
enriched homologues of E-crotyltrichlorosilane 6-8 were employed to afford the respective  
anti homoallylic alcohol 10-12, supporting a closed chair-like transition state (Scheme 10). 
 
Scheme 10 
A positive NLE observed in the asymmetric allylation of aldehydes using chiral 
sulfoxide 9 as a promoter is in agreement with a chair-like transition state involving 
coordination of two molecules of sulfoxide to the silicon atom and, consequently, the 
formation of a hexacoordinate Si intermediate in the stereoselectivity determining step (TS D, 
Scheme 10).
19
 
Another large family of chiral Lewis base promoters widely employed for the Sakurai-
Hosomi-type reaction are the mono and bis-pyridine N-oxides. There are a vast number of 
examples reporting on the capability of such chiral Lewis bases as catalysts for the asymmetric 
addition of allyltrichlorosilane to aldehydes. N-Oxides are not only the most reactive Lewis 
bases due to their electronic nature but also are usually able to induce good to excellent 
enantioselectivity. Since Nakajima
20
 reported that axially chiral bypyridine N,N’-bisoxides are 
effective for such a transformation, different architectures have been synthesised and assessed 
on the addition of allyltrichlorosilanes to aldehydes. Scheme 11 presents the most efficient N-
22 
 
oxide catalysts introduced by Nakajima,
20,21
 Hayashi,
22
 Malkov,
23–25
 Kotora
26,27
 and 
Benaglia.
28,29
 
 
Scheme 11 
DIPEA was used as scavenger of adventitious HCl trace that could block the catalyst by 
protonation. In some cases, TBAI was additionally used to enhance the rate of the reaction, 
possibly by stabilising the ion-paired hexacoordinate reactive complexes. The commonly used 
solvents were DCM, MeCN and THF and temperatures could vary from room temperature 
down to 78 C. Crotylation experiments were also carried out to confirm the high 
diastereoselectivity of the reaction, occurring through a closed, chair-like transition state 
(Scheme 12).
23
 
23 
 
 
Scheme 12 
Up to this point, the major challenge in the use of allyltrichlorosilanes was the lack of 
suitable methods for the allylation of aliphatic aldehydes which in contrast with the aromatic 
aldehydes mostly formed -chloro silyl ether 13, thus preventing allylation (Scheme 13). 
 
Scheme 13 
The equilibrium between the aliphatic aldehyde and silyl ether 13 is shifted to the right 
and appears to be slow at low temperatures leading to very low conversions, whereas at higher 
temperatures enantioselectivity in the formation of 14 dropped dramatically.
23
 This problem 
was resolved with the introduction of novel amides derived from cinchona alkaloids, as 
reported by Zhao and co-workers.
30
 They designed a highly efficient catalyst 15 for the 
allylation of aliphatic aldehydes. This novel cinchona derivative acts as bidentate Lewis base 
catalyst with the chelation taking place via the amide group and the quinuclidine nitrogen. The 
resulting homoallylic alcohols were obtained in high enantioselectivities. Also, excellent 
diastereomeric ratios were achieved using geometrically enriched E or Z-crotyltrichlorosilanes 
(Scheme 14). 
24 
 
 
Scheme 14 
The practical importance of the novel catalytic system resides in 1) the possibility to 
obtain high enantioselectivity at ambient temperature; 2) the ability of scaling up the reaction 
with recovery of the catalyst in almost quantitative yields while preserving the high level of 
stereoselectivity. Screening of the electronic properties of the aryl group of the amide moiety 
revealed that it acts as a Lewis base rather than an H-bond donor. Replacement of the strongly 
donating dimethylamino substituent for the highly withdrawing nitro group resulted in a low 
conversion (35% ) compared to that of the dimethylamino analogue (88%), although the level 
of enantioselectivity was comparable (81% ee and 96% ee, respectively). Zhao et al. also 
performed kinetic studies showing first-order dependence in the catalyst supporting its 
bidentate character; a possible transition state E was suggested (Figure 2). 
 
Figure 2 
25 
 
 Imines and imine derivatives as electrophiles. 
Apart from the enantiopure homoallylic alcohols, enantiopure homoallylic amines 
represent another class of useful building blocks, particularly for the synthesis of nitrogen-
containing biologically active compounds. There are several reports on the allylation of imines 
and hydrazones with allyltrichlorosilanes that mainly focused on the use of chiral sulfoxides as 
the activators.
31–34
 The main drawback of these chiral promoters is the need for stoichiometric 
or even higher loadings to achieve practical results. 2-Methyl-2-butene is commonly used as a 
proton scavenger. Crotylation experiments showed high levels of diastereoselectivity 
indicating closed transition state (Scheme 15).  Closely related, enantioenriched mono- and bis-
sulfinamides, also proved successful in the asymmetric allylation of hydrazones producing 
good to excellent yields and enantioselectivities (Scheme 15).
35,36
 
 
Scheme 15 
Chiral phosphine oxides, such as (S)-BINAPO 1, also showed ability to promote the 
asymmetric allylation and crotylation of -hydrazono esters, achieving excellent enantio- and 
diastereoselectivites (Scheme 16).
37
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Scheme 16 
Highly enantiopure homoallylic amines were also obtained by the asymmetric 
allylation of N-aryl aldimines promoted by chiral formamides derived from D- and L-proline 
(Scheme 17).
38
 It is worth noting that high loading of chiral promoter was needed to achieve 
excellent levels of stereoselectivity.  
 
Scheme 17 
 Allylsilanes with Chiral Auxilliary 
In the previous sections, the addition of achiral allyltricholosilanes to carbonyl 
compounds was promoted by chiral Lewis bases. However, there is also a methodology 
developed principally by Leighton and co-workers
39
 where the reaction is taking place between 
carbonyl compounds or derivatives and allylsilanes bearing a chiral auxiliary that lead to 
homoallylic alcohols or amines in excellent yields (up to 96%) and stereoselectivities (up to 
99% ee and 99:1 dr) in the absence of catalysts. This novel family of allylsilane reagents 16 
features a constrained five-membered ring which increases the Lewis acidity of the silicon 
centre, making it more active. These chiral reagents are easily prepared from the corresponding 
allyltrichlorosilanes and various 1,2-diols, 1,2-amino alcohols or 1,2-diamines (Scheme 18).  
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Scheme 18 
Leighton’s group fine-tuned these chiral reagents to accommodate a wide range of 
carbonyl compounds. The addition to aldehydes was rather straightforward and did not require 
much tuning. However, it was found that electron-withdrawing groups in their chiral scaffold 
further increased Lewis acidity of the silicon centre, thus improving the efficiency of the 
reaction.
40
 In the case of aldimines (ketimines) and hydrazones, for the allylation to proceed the 
substrate should contain a nucleophilic atom in the proximity of the heterocarbonyl group 
capable of chelating the Si atom (TS F and H, Figure 3) creating a tight chiral environment 
thus improving the selectivity.
41–43
 Allylation of ketones required both the activated auxiliary 
and a chelating group near the carbonyl to achieve excellent yields and stereoselectivities (TS 
G, Figure 3).
44
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Figure 3 
1.1.2. Allylboron reagents 
Allylboron reagents present advantages over the allyltrichlorosilane analogues. They 
are stable to chromatography, easier to handle and not moisture sensitive. However as for their 
analogues, they can be manipulated at room temperature and stored at 20 C under inert 
atmosphere for extended periods of time. Since Mikhailov and Bubnov, back in 1964, first 
discovered the formation of homoallylic alcohol in the reaction of triallylborane with 
aldehydes, use of allylboron reagents for the synthesis of homoallylic alcohols has evolved into 
a major synthetic methodology. Dialkyl allylboranes are still used as allylation reagents, 
however allylboronic esters became the most commonly used reagents. Their reactivity can be 
tuned by varying both the boronate residues and the nature of the α and/or γ substituent in the 
allyl group. The stereoselectivity of the final product can therefore be controlled as the reaction 
proceeds through a highly organised six-membered chair-like transition state.  
1.1.2.1. External chiral induction. 
This section will describe methodologies where the chirality is introduced by an 
external chiral catalyst. Lewis and Brønsted acid catalysis as well as metal based catalysis 
using allylboronic acid esters as substrates will be discussed.  
Lewis and Brønsted acid catalysed asymmetric allylation 
Despite a widespread utility of Lewis acid catalysis, its application in the addition of 
allylboronates to carbonyl compounds is fairly recent. Hall and co-workers employed Lewis 
acid catalysis in an attempt to overcome the sluggish reaction between electron-deficient, 
highly substituted allylboronates and aldehydes in the synthesis of α-butyrolactones (Scheme 
19).
45
 They also developed Brønsted acid catalysis to tackle allylation of electron-rich 
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aldehydes to furnish α-butyrolactones (Scheme 19).46 Miyaura and co-workers reported on the 
Lewis acid catalysed allylation and crotylation of aldehydes with excellent yields but moderate 
to low diastereoselectivities.
47
  
 
Scheme 19 
Asymmetric allylation of aldehydes using simple allylboronate derived from pinacol 
was also developed by Hall and co-workers.
48–50
 The catalysts made of C2-symmetrical chiral 
diols and SnCl4 led to a high level of asymmetric induction (Scheme 20). A wide range of 
chiral diol scaffolds shown in Scheme 20 were tested, all of them delivering an excellent level 
of enantioselectivity. 
30 
 
 
Scheme 20 
In this catalytic system, coordination of SnCl4 to the oxygens of the chiral diol 
generates a rigid, highly dissymmetrical complex 17, which restricts the directional orientation 
of the hydroxylic protons and enhances their Brønsted acidity. The crucial importance of the 
free hydroxyl groups in such a complex was demonstrated by the use of methoxy protected diol 
in the presence of SnCl4 under the same reaction conditions. The reaction proceeded in less 
than 10% conversion producing a racemic mixture of the homoallylic alcohol. Molecular 
sieves and Na2CO3 were added as scavengers of traces of moisture and HCl during the 
complex formation. Slower reaction rates were observed when the hydroxylic protons were 
sterically hindered by the bulky neighbouring ortho-substituents, e.g. t-butyl or trimethylsilyl 
group. In general, alkyl nonpolar substituents worked best. Crotylation experiments proved the 
excellent diastereoselectivity of the reaction characteristic to the Type I allylmetal reagents, 
thus anti homoallylic alcohol was obtained from E crotylboronate while syn alcohol resulted 
from the Z isomer. In both cases good to excellent diastereoselectivities were attained, however 
the syn homoallylic alcohols were produced in lower yield (Scheme 21).
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Scheme 21 
Antilla and co-workers expanded the use of chiral phosphoric acids to the asymmetric 
allylation of aldehydes. The well-known binaphthyl-derived phosphoric acid (R)-TRIP (18) 
was employed as Brønsted acid catalyst yielding the corresponding homoallylic alcohols in 
excellent yields and enantioselectivities. High enantio and diastereoselectivities were also 
achieved in the crotylation studies (Scheme 22).
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Scheme 22 
Hu and co-workers reported on the development of novel spirocyclic C2-symmetric 
chiral Brønsted acid catalysts (19, SPINOL) and its application in the asymmetric allylation of 
aldehydes.
53
 High yields and enantioselectivities were achieved for a wide range of aromatic 
and aliphatic aldehydes, including -unsaturated and propargylic aldehydes. High 
diastereoselectivity was also achieved in the crotylation of benzaldehyde (Scheme 23). 
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Scheme 23 
Quaternary chiral homoallylic alcohols are valuable building blocks for natural 
products synthesis. They can be obtained by allylation of ketones; however, this process has 
been less investigated due to the lower reactivity of ketones. To fill this gap, Schaus and co-
workers developed the first enantioselective allylation of ketones promoted by BINOL 
derivatives to afford chiral tertiary homoallylic alcohols.
54,55
 After screening a wide range of 
chiral diols, 3,3’-dibromo-BINOL 20 emerged as the best catalyst delivering high yield and 
stereoselectivities (Scheme 24). 
 
Scheme 24 
 
1
H NMR and kinetic studies identified the mechanism that involves transesterification 
of one of the isopropoxy group by the chiral diol and hydrogen bonding  to the second alkoxyl 
group as depicted in Figure 4.  
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Figure 4 
Methallylation of ketones to afford -substituted tertiary homoallylic alcohols was also 
studied under conditions of chiral Brønsted acid catalysis. However, in this case, a stronger 
Brønsted acid 21 was needed to achieve the target compounds in good to excellent 
enantioselectivities and high yields.
56
 This novel approach was used in the large scale synthesis 
of enantiopure biologically active compounds. The enantiopurity of the final product was 
upgraded by recrystallisation from hexanes (Scheme 25).  
 
Scheme 25 
Metal catalysed asymmetric allylations 
The stereoselective addition of allylboron reagents to carbonyl compounds and their 
imine derivatives has also been studied in the presence of metal salts and chiral ligands. 
Shibasaki and co-workers developed the first catalytic enantioselective methodology using 
ketones and ketimines (Scheme 26).
57–59
 Highly enantio- and diastereoselective allylations 
were achieved using Cu-phosphine chiral complexes.  
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Scheme 26 
 The reaction mechanism involves a B-to-Cu transmetalation forming the active 
allylcopper reagent 24, which is accelerated by the co-catalyst (La(OiPr)3 for ketones or LiOiPr 
for ketimines). Addition to the corresponding carbonyl compound occurs through a 
Zimmerman-Traxler chairlike transition state and further dissociation/protonation releases the 
homoallylic target product (Scheme 27). 
 
Scheme 27 
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Kobayashi reported greener methods employing In
60,61
 and Zn
62,63
 to catalyse 
asymmetric addition of allylboronates to ketones and ketimines. In-catalysed reactions were 
carried out in the presence of catalytic amounts of chiral ligands providing good to excellent 
enantioselectivities (Scheme 28) 
 
Scheme 28 
Zn mediated additions also proved high yielding and proceded highly stereoselectivity. 
Catalytic amounts of ZnF2 in the presence of chiral heterocyclic ligands afforded the target 
homoallylic product in excellent selectivity. Addition of -methylallylboronate to -
hydrazonoesters and aldehydes also proved highly diastereoselective giving the anti and syn 
isomers, respectively (Scheme 29). 
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Scheme 29 
1.1.2.2. Allyllboron reagents with chiral group on boron. 
Since Hoffmann reported the first asymmetric addition of allylboron reagents to 
carbonyl compounds using camphor-derived auxiliaries, the contribution to the field has been 
growing over the years. The most important contribution to the field came from the group of 
Corey,
64
 Roush,
65
 Brown,
66
 Masamune
67,68
 and Soderquist
69,70
 separately. More recent is the 
contribution of Aggarwal, which will also be mentioned. 
Allylboranes chiral auxiliares 
Allyldialkylboranes are known to be significantly more reactive than their boronic ester 
counterparts. Moreover, the lack of a heteroatom spacer allows the chirality to be closer to the 
boron centre, which generally enhances the selectivity. Since the late 80s, several research 
groups carried out detailed investigation into the asymmetric allylation of carbonyl compounds 
using enantiopure allylboranes. Brown developed B-allyl and B-crotyl 
diisopinecampheylboranes 25, which upon addition to aldehydes yielded the corresponding 
homoallylic alcohol in excellent yields, enantio- and diastereoselectivities.
71
 Masamune and 
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co-workers introduced chiral monosubstituted allylborolanes 26 and disubstituted 
crotylborolanes 27, which on the addition to aldehydes showed excellent transfer of 
stereochemical information.
67,68
 Soderquist and co-workers expanded the field to 10-TMS-9-
borabicyclo[3.3.2]decanes (10-TMS-9-BBD, 28) as allylating reagents,
70,72
 which also afforded 
the target homoallylic alcohols in high yields, enantio- and diastereoselectivities (Scheme 30). 
 
Scheme 30 
Soderquist took a step further to develop a modified 10-Ph-9-BBD 29, which served as 
a more reactive allylating reagent for methyl ketones, in contrast to its counterpart 10-TMS-9-
BBD.
69
 10-Trimethylsilyl derivative was too bulky to accommodate groups bigger than 
hydrogen, while 10-phenyl presented less steric hindrance and hence was capable of hosting 
bulkier groups (Scheme 31). 
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Scheme 31 
Despite the fact that a chiral auxiliary is employed, the methodologies developed by 
Masamune and Soderquist allowed recovery of the chiral moiety. Refluxing the boron 
intermediate in MeCN in the presence of enantiopure pseudoephedrine resulted in the 
transterification yielding the corresponding homoallylic alcohol 30 and borane complex 31 as a 
crystalline solid (Scheme 32), which can be recycled. 
 
Scheme 32 
Valuable building blocks, such as 1,2- and 1,3-diols, were synthesised by Brown
66
 and 
Soderquist,
73
 respectively, using allyl vinyl diboron reagents. A single asymmetric allylation 
followed by oxidative workup afforded 1,2-diols, while a sequential double allylboration of 
ketones and aldehydes gave rise to 1,3-diols. In both cases, the products were obtained in 
moderate to good yields and excellent enantioselectivities (Scheme 33). 
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Scheme 33 
Jäkle and co-workers reported the use of ferrocene-based planar chiral bimetallic 
complexes as allylation reagents. This novel reagent gave no significant asymmetric induction 
in the allylation of aldehydes. At the same time, when ketones were used as substrates, the 
respective tertiary homoallylic alcohols were obtained in up to 80% ee in DCM within 30 
minutes at room temperature (Scheme 34).
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Scheme 34 
NMR spectroscopic analysis of the intermediate obtained upon reaction of the chiral 
ferrocene derivative 32 with acetophenone showed an 
11
B NMR signal shift to 48.9 ppm 
(initially being 71 ppm) while the 
119
Sn NMR signal remained at -14.4 ppm (initially being -
14.3 ppm). These studies confirmed the allyl transfer occurred from the boron rather than the 
tin centre. 
Allylboronate chiral auxiliaries 
Since the late 70s, when they were pioneered by Hoffman, chiral allyl boronic esters 
and amides have been widely studied by different research groups. Several architectures were 
explored as chiral auxiliaries, such as camphor derivatives 33 and 34
75–77
 and bis-sulfonamides 
35 (Scheme 35).
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Scheme 35 
Extensive investigations have been carried out by Roush
78,79
 using chiral esters and 
amide analogues. After initial studies on the addition of achiral allylboronates to chiral 
aldehydes revealing substrate control of the stereoselectivity, the group then studied the 
allylation of achiral and chiral aldehydes using chiral auxiliaries on the dioxaborolanes (36-40), 
as illustrated in Scheme 36.
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Scheme 36 
The high level of stereoselectivity was attributed to the repulsive electronic interactions 
between the lone pairs of the aldehydic oxygen and the neighbouring ester oxygen within the 
associative six-membered transition state (Figure 5a). Hence by changing the enantiomer of the 
chiral auxiliary, the stereochemistry of the final homoallylic alcohol was inverted. Further 
studies to probe this hypothesis led to the development of a conformationally more rigid cyclic 
N,N’-dibenzyl-N,N’-ethylenetartramide allylboronate derivative 41, which improved 
stereoselectivity up to 99.7:0.3 e.r. and 98:2 d.r. in the reactions with chiral aldehydes (Figure 
5b).
81
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Figure 5 
This methodology that has been known since the late 80s, recently was adapted to 
continuous flow systems. Ley and co-workers
82
 described the addition of chiral crotylboronates 
to both achiral and chiral aldehydes using their developed flow technology. The reactions 
produced high levels of stereoselectivity, up to 20:1 d.r. and 16:1 d.r. for achiral and chiral 
aldehydes respectively.  
After Kaufmann reported the first example of chiral boron BINOL scaffolds for a wide 
range of asymmetric allyl transfer reactions.
83
 Chong introduced a more reactive BINOL 
derivative for the asymmetric allylation methodology.
84
 A highly electrophilic BINOL 
derivative bearing electron-withdrawing CF3 groups proved more reactive towards carbonyl 
compounds. The allylation of both aldehydes and ketones led to the corresponding secondary 
and tertiary homoallylic alcohols in high yields and excellent enantiomeric ratios (Scheme 37). 
 
Scheme 37 
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Further studies on the asymmetric allylation of carbonyl compounds and their 
derivatives were reported by Szabó and co-workers.
85
 They developed a one-pot allylic 
substitution of allyl acetates 42 catalyzed by Pd(0) using diboron compounds derived from 
chiral diols followed by in situ allylation of aldehydes or sulfonylimines (Scheme 38). In this 
one-pot synthesis of chiral homoallylic alcohols and amines, the allylation proceeded through 
the well-established six-membered transition state yielding high level of diastereoselectivity (> 
99% d.r.) in most examples. However, only moderate enantioselectivities (up to 53% ee) were 
achieved for the homoallylic products.  
 
Scheme 38 
In a special area of asymmetric allylation of aldehydes using chiral secondary 
allylboronates extensive work was carried out by Pietruszka and co-workers.
86
 Due to the close 
chair like transition state mechanism, secondary allylboronates 43 give raise to E or Z linear 
homoallylic alcohols 44-45. Furthermore, the use of enantiopure -substituted allylboron 
reagents yields a mixture of geometrical isomers with opposite stereochemistry at the new 
chiral centre (Scheme 39). 
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Scheme 39 
The control of the geometrical selectivity can be achieved by tuning the electronic and 
steric properties of the allylating reagent. Pietruszka’s group focused on the synthesis of Z-
homoallylic alcohols by increasing the bulk of the chiral boronic ester moiety and modifying 
the electronic properties of the -substituent. Thus, by using enantiopure secondary 
allylboronates 46 with bulky diol moieties the corresponding homoallylic alcohols were 
obtained in good to excellent yields and high level of stereoselectivity (Scheme 40). This 
methodology was employed in the synthesis of different analogues of the dihydro--pyrone 
class of natural products.
87
 
 
Scheme 40 
Recently, Pietruszka and co-workers used the same boronate fragment in the synthesis 
of E-homoallylic alcohols. A range of highly substituted E-homoallylic alcohols were obtained 
in high enantio- and diastereoselectivities (Scheme 41).
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Scheme 41 
The apparent inversion in the geometrical selectivity results from the steric interactions 
in the six-membered chair-like transition state (Figure 6). The transition state leading to Z 
isomer presents A
1,3
 interactions between the substituents in the  and -positions (TSZ). The 
TS leading to E isomer (TSE) is free from destabilising A
1,3
 interactions but presented 
disfavoured interactions between the amide and the chiral diol moiety, however, the 
pseudoequatorial position of the former minimised the interactions with the aldehydic side 
chain, thus overall favouring this reaction pathway (Figure 6). 
 
Figure 6  
Lewis base catalysed asymmetric allylation 
Aggarwal recently reported the use of Lewis bases to promote the asymmetric allylation 
of aldehydes via the in situ generated borinic esters, which have an intermediate reactivity 
between borolanes and dioxaborolanes.
89
 They investigated the allylation reaction using chiral 
-substituted crotyl and methallyl boronic esters resulting in the corresponding homoallylic 
alcohols with excellent stereoselectivity (Scheme 42). 
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Scheme 42 
When the chiral -substituted allylboron reagents 47-49 were reacted at room 
temperature with aldehydes without further activation, Z-isomers were formed. However, in the 
presence of a Lewis base, a borate complex is formed in the equilibrium with a ring opened 
form (Scheme 41), which subsequently is trapped with trifluoroacetic anhydride (TFAA) 
stabilising the borinic intermediate at lower temperatures. This prevents 1,3-borotropic shift to 
occur, allowing for the allylation reaction to proceed through the well-known chair-like 
transition state with an excellent E selectivity.   
 
Scheme 43 
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1.2. Addition of allylic halides 
The catalytic asymmetric addition of allyl fragments to different types of carbonyl 
compounds proved to be a powerful methodology for to achieve enantiomerically enriched 
homoallylic alcohols or amines. The previous sections have been focused on the 
organometallic reagents. However, there are also catalytic asymmetric allylation procedures 
employing allyl halides as precursors to the organometallic reagents. In the next section, these 
strategies will be discussed briefly.    
1.2.1. Indium mediated allylations 
Despite the fact that indium (In) has been known since the 19
th
 century, it was not until 
the early 90s when it was introduced to organic synthesis to mediate organic reactions. In-
promoted reactions became attractive due to low air- and moisture sensitivity of the 
organoindium intermediates, their significantly lower toxicity and higher tolerance to a wide 
range of functional groups. For the formation of a new C-C bond via transfer of an allyl 
fragment to carbonyl or heterocarbonyl compounds, allylindium reagents can successfully 
compete with their Si, B and Sn analogues. In the case of the base-sensitive imine derivatives, 
allylindium reagents are promising as they have low basicity. 
Several asymmetric procedures were reported in the literature where allylindium 
reagents were used either with the substrates decorated with chiral auxiliaries,
90
 or in 
combination with stoichiometric chiral promoters.
91,92
   
There are also a few examples of asymmetric addition of allyl halides mediated by In 
under Barbier-type conditions in the presence of catalytic quantities of chiral controllers. Cook 
and co-workers
93
 developed the first catalytic asymmetric addition of allylindium reagents to 
hydrazones employing 3,3’-disubstituted BINOL derivatives 50. They found that acidity of the 
hydroxyl protons has a strong effect on the overall outcome of the reaction. The second 
generation of structurally similar chiral BINOL derivatives 51 with a strong electron-
withdrawing substituent in the 3,3’-positions gave the products in better isolated yield and 
higher enantioselectivity (Scheme 44).
94
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Scheme 44 
Jacobsen and co-workers exploited the potential of chiral ureas and thioureas as 
promoter for the catalytic asymmetric allylation of acylhydrazones. They developed a new 
sulfinamide-urea catalyst 52 that afforded the target chiral homoallylic hydrazines in good to 
excellent yields and enantioselectivities (Scheme 38). This new chiral promoter also worked 
well in the crotylation of the imine derivatives with both E and Z crotyl bromide, however, 
poor diastereoselectivity was observed.
95
 A similar level of selectivity was achieved when 
cinchona alkaloid derivatives 53 and 54 were used as chiral promoters.
96
 It was assumed that 
low basicity of the allylindium reagents permitted the use of protonated chiral amines as chiral 
promoters providing high to excellent yields and enantioselecivities (Scheme 45).  
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Scheme 45 
1.2.2. Chromium mediated allylations 
The reaction of organochromium compounds was pioneered by Nozaki and Hiyama in 
the late 70s using stoichiometric amounts of Cr (III) and LiAlH4 as reducing agent. The 
subsequent addition to carbonyl compounds led to homoallylic alcohols in good to excellent 
yield.
97
 Kishi and co-workers found that Ni salts had a catalytic effect on the formation of the 
C-Cr bond, improving the efficiency of such transformations.
98
 However it was not till the 
mid-90s when the use of catalytic amounts of Cr source was realised by Fürstner and co-
workers (Scheme 46).
99
 They introduced two reagents in the reaction system: nontoxic, 
commercially available manganese powder as stoichiometric reducing agent to recycle Cr(II) 
species and  TMSCl assisting in the dissociation of Cr-O bond. The new improved reaction 
conditions had beneficial effect on the scope, chemo- and diastereoselectivity in the addition of 
allylchromium species to carbonyl compounds. 
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Scheme 46 
Although Kishi introduced a chiral bipyridine derivative as ligand for the allylation of 
carbonyl compounds mediated by Cr, the procedure required stoichiometric amounts of metal 
source.
100
 Cozzi and co-workers developed chiral ligands. Enantiopure salen-type of ligands 
promoted the Barbier-type reaction with good enantioselectivities but moderate yields.
101
 Since 
then, a wide range of chiral ligands has been explored and tested in the addition of allylic, 
methallylic and crotyl halide mediated by Cr. Figure 7 presents a selection of ligands reported 
to date capable of performing the addition in a good level of enantio- and/or 
diastereoselectivity. The yield and selectivities correspond to the target secondary or tertiary 
homoallylic alcohol.
102–105
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Figure 7 
It is clear that many types of chiral architectures have been developed. It is worth 
mentioning bis-oxazoline ligands 56. Both the isolated yield and the absolute configuration of 
the final homoallylic alcohol depended on the presence or absence of substituents in the 
oxazoline ring.
106–108
 Kishi and co-workers also developed the sulfonamide-base scaffold 
which induced high levels of enantioselecectivity. With their first generation of chiral 
sulfonamides 55, they introduced the use of a second metallic species which enhanced the rate 
of formation of the chromium-bromide complex.
109
 The second generation of sulfonamides 57 
presented the advantage of being easily recovered. Their crystallinity makes them rather 
convenient for large scale processes.
110
 
As seen in this chapter, allylation of carbonyl compounds has been a well-known 
methodology to achieve chiral homoallylic alcohols, amines and their derivatives for more than 
two decades. Due to the excellent control of the stereoselectivity, the product of the -
allylation, resulting in branched products, has a defined stereochemistry, E-allylreagents give 
exclusively anti homoallylic adducts and Z-allylreagents give syn homoallylic adducts, 
52 
 
whereas -allylation, resulting in linear products, does not happen. Excellent stereoselectivities 
are achieved using chiral auxiliaries or chiral catalytic systems as well as excellent yields for 
the target molecule. However, to achieve -products, i.e. linear homoallylic adducts, secondary 
allylboron reagents are required. When enantiopure secondary allyl reagents are used, a 
mixture of E:Z homoallylic adducts are obtained, each of which has opposite absolute 
configuration. 
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2. KINETIC RESOLUTION 
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2.1. Aims and objectives 
The aim of the present project is to establish a new and efficient methodology for 
kinetic resolution of chiral racemic α-substituted allylboronates (±)-69 in the addition to 
aldehydes employing chiral Brønsted acid catalysis (Scheme 47). 
 
Scheme 47 
To achieve these aims, two converging objectives were set up 1) to develop a practical 
method for the synthesis of secondary allylboronates; 2) to develop chiral Brønsted acids 
capable of an efficient kinetic resolution of α-substituted allylboronates (±)-69. 
As the intended outcome of this project, it is hoped to develop a practical catalytic 
strategy allowing for the synthesis of highly enantio- and geometrically enriched homoallylic 
alcohols representing valuable building blocks for use in pharmaceutical and fine chemicals 
development.    
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2.2. Results and discussion  
2.2.1 Brief overview of kinetic resolution methodologies. 
In modern synthesis, asymmetric catalysis remains the preferred method of introducing 
new stereogenic centres into the molecule and is the most widely used among total synthesis 
strategies. However, there are many instances where asymmetric methodology is either 
inadequate or the methods are not practical; therefore alternative techniques based on 
resolution of racemic mixtures still hold their value. In fact, resolution methods together with 
chiral pool processes take almost a 50% share of the industrial chiral technology. Desirable 
characteristics of all catalytic asymmetric reactions, such as high yield, short reaction times, 
scalability, low catalyst loading, inexpensive catalyst, minimal generation of waste, 
reproducibility, broad substrate scope and functional group compatibility are also important 
considerations in kinetic resolution 
Kinetic resolution methods are used to resolve a racemic mixture of two enantiomers 
(R,S) aided by a chiral reagent or by the combination of an achiral reagent and a chiral catalyst 
in substoichiometric loading. The latter methods represent an advantage since they do not need 
stoichiometrical chiral reagents, hence being more economical. There are different methods to 
carry out kinetic resolution. In a classical kinetic resolution (CKR) one enantiomer of a 
racemic mixture is derivatised much faster than another, so ideally at 50% conversion, both the 
product and the starting substrate could be obtained in enantiomerically pure form. However, 
this is not always the case, and special care has to be taken in order to stop the reaction at the 
appropriate conversion values, so that the product or the substrate can be obtained in 
satisfactory enantiomeric excess (ee). In this case, while the more reactive enantiomer is being 
converted into the final product, the enantiopurity of the less reactive enantiomer increases 
(Scheme 48). 
 
Scheme 48 
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A slightly different method is the parallel kinetic resolution (PKR) where both 
enantiomers react independently with similar reaction rate affording enantiomers of different 
final products (Scheme 49). Due to both enantiomers following different reaction pathways, the 
ee values are independent of each other, therefore both of them can be optimised separately.
111
 
 
Scheme 49 
A drawback of the strategies so far described is the low yield achieved for the target 
molecule. Since the reaction starts from a racemic mixture, the yield will not be higher than 
50% based on the racemic mixture. To overcome this issue, many elegant processes have been 
designed that can transform both enantiomers of a racemic starting mixture into a single 
enantiopure product. Dynamic kinetic resolution (DKR), dynamic kinetic asymmetric 
transformation (DYKAT) or enantioconvergent processes (ECP) serve as the examples. The 
DKR couples a kinetic resolution with a rapid in situ racemization of the chiral substrate 
through an achiral intermediate or transition state. As the faster reacting enantiomer of the 
substrate is converted into the product in a stereoselective manner, the less reactive enantiomer 
is converted into the more reactive one through the racemization process (Scheme 50).
112
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Scheme 50 
In DYKAT strategies, both enantiomers of the mixture form a single intermediate losing 
the stereogenic centre, which then undergoes desymmetrization or epimerization in the course 
of the final product formation (Scheme 51).  
 
Scheme 51 
 In the ECP, each enantiomer of the racemic mixture is converted into the same 
enantiomer of the product through different pathways (Scheme 52).
113
 One pathway involves 
retention of the configuration of the stereogenic centre while the other involves inversion. 
 
Scheme 52 
Overall, the efficiency of a kinetic resolution is given by the relative rates of reaction of 
the substrate enantiomers (SR and SS) with the chiral catalyst (CatR) to generate the products 
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(PR and PS). Another descriptive parameter of the efficiency is the selectivity factor, s, which is 
related to the G‡, the free energy difference between the selectivity-determining 
diastereomeric transition states. These two parameters are used interchangeably (Figure 8). 
 
Figure 8 
2.2.2 Brief overview of the synthesis of chiral -substituted allylboronates 
Organoboron compounds have attracted considerable attention in organic synthesis 
because C-B bonds can be converted into C-O, C-N, or C-C bonds in a stereospecific manner. 
Moreover, the presence of the allylic moiety makes -substituted allylboron reagents appealing 
for total synthesis strategies. Chiral allylboron compounds are very versatile reagents for the 
synthesis of allylic alcohols, amines or new C-C bond formation. It can be achieved either via 
direct reaction of the C-B bond or by allyl transfer to carbonyl compounds. In fact, allylboronic 
ester derivatives are the most versatile and commonly used reagents for the allylation due to 
their relative stability to air and moisture, low toxicity and relatively low cost. 
Methodologies for the synthesis of chiral -substituted allylboronate reagents include 
both metal-free and metal-catalysed processes. It expands from the use of stoichiometric chiral 
auxiliary reagents to the application of catalytic methods including asymmetric hetero [4+2] 
cycloaddition mediated by Cr (III) catalyst;
114
 1,4-silaboration;
115
 enantioselective Pd-catalysed 
diboration of allenes developed by Morken
116
 and asymmetric allylic substitution of 3-
chloropropenboronates using Grignard reagent.
117,118
 Nucleophilic substitution of allylic 
carbonates with diboron compounds also played an important role as it provides an access to 
functionalised enantioenriched allylboronic esters. Owing to the similarities of the final 
products in all the methodologies listed above, this brief overview will be focused mainly on 
59 
 
Cu(I) catalysed SN2
’
 reactions developed by groups of Ito,
119,120
  Hoveyda,
121
 McQuade
122
 and 
also Hall
117
 independently. The use of metal-free chemistry developed by Pietruszka and 
Aggarwal towards the synthesis of chiral -substituted allylboronate reagents will be explored 
separately. 
2.2.2.1 Metal catalysed synthesis of chiral -substituted allylboronates 
The -selective and stereospecific nucleophilic substitution of allyl carbonates was 
reported by Ito and co-workers using a catalytic system Cu(I)/achiral phosphine-type ligand 
(Xantphos) to afford the corresponding allylboronates in excellent yield and regioselectivity.
119
 
A few years later, the same group developed an enantioselective version of the reaction 
producing chiral -substituted allylboronate reagents (Scheme 53).120 They employed R,R-
QuinoxP* ligand 58  to induce chirality into the final product. The corresponding 
allylboronates were obtained in good yields and excellent enantioselectivities. 
Scheme 53 
Using this catalytic procedure, they also developed desymmetrisation of meso 
carbonates 59 to synthesise chiral -substituted allylboronates 60.123 Although isolation of the 
corresponding chiral allylboronates proved difficult, the high stereoselectivity of the formation 
of the allylboron compounds was proven by one-pot allylation of various aromatic aldehydes to 
afford the corresponding homoallylic alcohols 61 with a high enantio- and diastereoselectivity 
(Scheme 54). 
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Scheme 54 
The main drawback of the Ito’s protocol for the synthesis of enantiopure acyclic -
substituted allylboronates was the dependency on the substrate structure; the reaction 
proceeded with a high level of selectivity only with Z-carbonates, whereas the use of E-isomers 
resulted in a drop in enantioselectivity from 94% to 44%, even though the yield improved 
(from 77% to 94%). In a further development, Hoveyda and co-workers broadened the scope of 
this reaction by using complexes of Cu(II) with bidentate N-heterocyclic carbene (NHC) as 
catalysts.
124
 The allylboron compounds were not isolated but oxidised in situ to afford the 
corresponding secondary allylic alcohols in a stereospecific manner in excellent yields and 
enantiopurity (Scheme 55). 
 
Scheme 55 
With a slight modification to the bidentate NHC ligand, the reaction could also be 
applied to the synthesis of tertiary allylic alcohols in a high enantioselectivity and excellent 
yields (Scheme 56). 
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Scheme 56 
Similar investigation was carried out by McQuade.
122
 His group described a 
stereoconvergent process using a complex of Cu(I) with six-membered NHC ligand as catalyst 
for the nucleophilic substitution of allylic aryl ethers 62 (Scheme 57). Advantages of this 
methodology included lower loadings of B2pin2 (1.1 eq.) and catalyst (1 mol %) still providing 
high yield. Again, the excellent enantioselectivity of the reaction was established by oxidising 
the resulting boronates to the corresponding allylic alcohols. 
 
Scheme 57 
In line with allylic substitution catalysed by Cu(I) chiral complexes, Hall reported the 
alkylation of 3-chloropropenylboronates affording chiral -substituted allylboronates.117 Due 
to the instability of this family of organoboron compounds on silica gel, the enantioselectivity 
of the allylboronate was determined, in this case, on the isocyanate derivative 63. Screening of 
chiral phosphoramidate ligands and different boronic acid groups was carried out to optimise 
the reaction conditions (Scheme 58).  
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Scheme 58 
Subsequently, they developed a one-pot procedure for the stereoselective allylation of 
aldehydes based on the synthesis of chiral -substituted allylboronate presented above. The 
excellent chirality transfer in the allylation reaction produced the target homoallylic alcohols in 
excellent overall selectivity (Scheme 59).  
 
Scheme 59 
2.2.2.2 Metal free synthesis of -substituted chiral allylboronates 
The use of chiral secondary allylboronates modified by chiral boronic esters was 
extensively studied by Pietruszka and co-workers.
86
 They focused on the synthesis of 
enantiopure Z-homoallylic alcohols which proved to be a challenge. Since the allylation with 
allylboronates proceeds through a well-defined transition state (Scheme 39), Z-selectivity 
would be enhanced by increasing the bulk of the boronic ester and/or the use of an electron-
withdrawing group. They synthesised enantiopure secondary allylboronates from readily 
available propargyl alcohols through [3,3]-sigmatropic rearrangement using a chiral boronic 
ester group (Scheme 60). 
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Scheme 60 
Another interesting approach to chiral -substituted allylboron reagents was reported 
by Aggarwal and co-workers.
125
 The target optically active boranes were obtained upon 
reacting chiral sulfur ylides with vinyl boranes at low temperature (Scheme 60). The absolute 
stereochemistry of the allylborane is determined by the sulfur ylide configuration (64, Scheme 
61). The subsequent stereospefic 1,2-migration of the vinyl group yielded the corresponding 
allylborane. The kinetic allylborane 65 can undergo a 1,3-borotropic rearrangement to its 
isomer 66. Both allylboranes proved excellent allylating reagents yielding structural isomeric 
homoallylic alcohols 67 and 68 upon addition to benzaldehyde (Scheme 61). 
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Scheme 61 
A more recent work published by Aggarwal and co-workers described the synthesis of 
highly diastereomerically enriched homoallylic alcohols where stereoselectivity was controlled 
by choosing the appropriate reaction conditions.
126
 They developed elegant strategies for the 
synthesis of -substituted allylboron reagents via lithiated carbamates focusing on minimizing 
both the A
1,3
 strains and the steric hindrance between the equatorial substituent and the boron 
moiety in the transition state. Thus, by tuning the non-vinyl substituents on the boron atom and 
the geometry of the vinyl group, a selection of homoallylic alcohols with different relative 
stereochemistry were obtained in >95:5 e.r. and >98:2 d.r. in all cases (Scheme 62).   
 
Scheme 62 
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2.2.3 Kinetic resolution of secondary allylboronates. Theoretical studies 
2.2.3.1 Theoretical modelling of the reaction 
It has been demonstrated that addition of enantiomerically enriched α-substituted 
allylboronates to achiral aldehydes proceeds with a near perfect transfer of chirality, so-called 
substrate controlled allylation. The addition produces a mixture of geometrical isomers of 
opposite stereochemistry at the carbinol centre (Scheme 39). However, if a racemic mixture of 
α-substituted allylboronate is used instead four stereoisomeric transition states are possible, 
leading to a mixture of four stereoisomeric homoallylic alcohols (Scheme 63).  
 
Scheme 63 
In order to perform a kinetic resolution, three essential factors have to be taken into 
account: 1) the enantiofacial selectivity in the addition of the allylic group to aldehyde; 2) 
selective recognition/differentiation of the enantiomers of the allylboronate and 3) the structure 
of the boronic ester. Chiral Brønsted acid catalyst was chosen as external controller to address 
the first issue, whereas the second will rely on the pseudo axial/equatorial preference of the α-
alkyl group, which can be analysed in terms of steric effects. In both TS1 and TS2, 
unfavourable steric interactions are present. The non-bonding 1,2-interactions between the 
pseudo-equatorial α-alkyl and the boronic ester in TSRe1 (or TSSi1, Scheme 63) have a 
detrimental effect, whereas in TSSi2 (or TSRe2, Scheme 63) it is the unfavourable A
1,3 
strain 
between the pseudo-axial α-alkyl and the pseudo-axial olefinic hydrogen. Therefore, when 
bulky boronic esters are used, Z homoallylic alcohols are expected to modestly predominate 
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among the final reaction products. Hence, the larger the ester group, the more preference for Z-
homoallylic alcohol. 
To increase the geometrical selectivity, preference for a certain transition state can be 
enhanced by changing either the boronic ester fragment or the α-alkyl substituent. In this 
respect, the reaction was modelled using quantum chemical computations to assist and 
facilitate the bench chemistry. DFT level calculations were accomplished to elucidate the 
influence of the steric size of the cyclic boronate moiety on the E/Z ratio of the resulting 
homoallylic alcohols. The initial calculations were performed at B3LYP/6-311+g(d,p) level of 
theory. Solvation of the system was taken into account using the implicit polarisable 
continuum model using toluene as the reaction solvent; while the intrinsic reaction coordinates 
(IRC) analysis was performed to unambiguously assign the transition states of the reaction 
pathway. Theoretically predicted diastereomeric ratios were calculated from the corresponding 
relative free Gibbs energies using Arrhenius approximation, 
  
where G‡ values are expressed in kcal mol-1; R is the ideal gas constant expressed in kcal K-1 
mol
-1
 (1.98 10
-3 
 kcal K
-1
 mol
-1
),
 
T is the temperature expressed in Kelvin (298 K). First, the 
non-catalysed reaction was modelled in order to obtain optimised structures. 
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The first case study was the addition of -methyl substituted allylboronates with a 
range of different boronic esters moieties to benzaldehyde under non-catalysed conditions 
(Scheme 64). The results in Table 1 show that the bulkier the boronic ester moiety is the more 
preferred the pathway leading to the formation of Z isomer. This outcome agrees with the 
rational explanation of the increased steric interactions between the pseudo-equatorial α-alkyl 
and the boronic ester residue in TSSi1 (or TSRe1, Scheme 63). These data follow the same trend 
of the experimental results reported by Hoffmann in 1980.
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Scheme 64 
Table 1. Activation energies (ΔG) for both transition states. 
 
TS_69.1a TS_69.2a TS_69.3a TS_69.4a TS_69.5a 
GZ
a
 26.91 30.2 26.14 32.18 35.7 
GE
a
 24.17 29.56 26.29 32.89 37.41 
d.r.
b
 (Z:E) 1:88 1:3 1:1 3:1 18:1 
d.r.
c
 (Z:E) 24:76 49:51 n.r.
d 
69:31 n.r.
 d
 
a  
Values given in kcal/mol; 
b
 predicted; 
c
 values reported by Hoffmann: 
d
 not reported   
Investigation of the influence of different -substituents was carried out with boronic 
acid pinacol ester 69.4a taking into account the ease of synthesis
128
 of the respective 
allylboronates 69.4b-d (scheme 65). 
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Scheme 65 
Table 2. Activation energies (ΔG) for the isomeric transition states. 
 
TS_69.4b TS_69.4c TS_69.4d 
GZa 29.57 31.79 30.51 
GEa 30.17 32.41 32.24 
d.r.
b
 (Z:E) 3:1 3:1 19:1 
d.r.
c
 (Z:E) n.r.
d 
79:21 n.r.
 d
 
a  
Values given in kcal/mol; 
b
 predicted; 
c
 values reported by Hoffmann; 
d
 not reported   
Computational data (Table 2) revealed the same tendency as described for the boronic 
ester group: the larger the α-substituent, the higher the preference for the Z isomer. The A1,3 
strain between the pseudo-axial α-alkyl group and the pseudo-axial olefinic proton is less 
disfavoured over the 1,2-interaction between the pseudo-equatorial α-alkyl group and the 
boronic ester. This difference grows with increase in size of the -group. 
2.2.3.2 Computational insight into the reaction mechanism. 
In the Brønsted acid catalysed allylation of aldehydes with allylboronates, protonation 
can take place at either of the oxygen atoms of the boronate fragment, as well as at the 
carbonyl oxygen of the aldehyde. Theoretical studies published by Sakata and Fujimoto 
revealed that Lewis acid catalysis of the reaction occurs through coordination on the pseudo-
equatorial oxygen of the boronate (scheme 66a).
129
 On the other hand computational 
investigation on the asymmetric allylboration of aldehydes catalysed by Brønsted acids, 
recently published by Goodman and co-workers,
130
 revealed that a double activation mode is 
preferred over the classical single-point coordination (scheme 66b). They claimed the 
stabilisation will arise from the H-bonding interaction between the phosphoryl oxygen and the 
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formyl hydrogen of the aldehyde. Moreover, Houk, in collaboration with Antilla,
131
 reported 
the existence of H-bonding interactions between the phosphoryl oxygen and the ortho aromatic 
proton of the aldehyde, which also plays an important role in the reaction pathway (scheme 
66c). 
 
 
Scheme 66 
Since the present work relies on the chiral Brønsted acid catalysis, both Houk’s and 
Goodman’s findings were adopted to investigate how the additional interactions between the 
phosphoryl oxygen of the catalyst and the formyl hydrogen of the aldehyde (TS3 and TS4, 
Scheme 67) or the ortho-hydrogen of the aromatic group (TS5 and TS6, Scheme 67) will 
influence the selectivity of the kinetic resolution of racemic secondary allylboronates. DFT 
calculations of the catalytic system were carried out at a high level of theory (TPSSh/cc-pVTZ) 
using the implicit polarisable continuum model to implement solvation in toluene. In order to 
save computational time and resources, the BINOL-derived chiral phosphoric acid was initially 
mimicked as its butadiene analogue. The computations were performed on three different 
boronic ester groups, i) pinacol; ii) tetraethylethylengycol and iii) 2,2-dimethyl-1,3-propandiol 
(scheme 67), all  sec-butenyl derivatives (-methyl allylboronates). 
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Scheme 67 
Table 3 
G‡ (kcal/mol)a TS3 (Z) TS4 (E) TS5 (E) TS6 (Z) 
i 15.4 15.7 16.4 16.4 
ii 18.1 20.5 20.4 20.4 
iii 12.9 11.9 12.8 14.4 
a  
Predicted values calculated at 233 K 
The calculations summarised in Table 3 revealed a general trend: in all three boronic 
esters, the two-point activation mode described by Goodman is generally more favoured for 
both transition states, leading to Z and E-isomer compared to the Houk mode. Also, a clear 
trend emerged showing that the larger the steric bulk of the boronate, the higher the preference 
for the formation of Z-isomer (ii > i > iii), mirroring the results of the non-catalysed studies. It 
is worth noting that 2.4 kcal/mol difference between TS3-ii and TS4-ii predicted a highly 
enhanced ~100:1 Z/E ratio for the tetraethylethylenglycol (Epin) derivative, whereas 2,2-
dimethyl-1,3-propandiol (iii) should favour E-isomer. 
2.2.4 Experimental studies. 
2.2.4.1 Synthesis of -substituted allylboronic esters. 
Taking into account the outcome of the theoretical calculations performed on the 
allylboration of aldehydes, synthesis of different allylboronates was carried out.  Several 
methods were examined to find the most practical, reliable and applicable to a wide substrate 
scope. 
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The synthesis of racemic secondary allylboronate 69.4a was first tackled via a catalytic 
nucleophilic substitution of the methyl carbonate derivative of crotyl alcohol (70) using Cu-
phosphine complex and bis(pinacolato)diboron (B2pin2). The reaction was examined by 
varying both Cu sources and ligands. The Table 4 summarises the screened reaction conditions. 
Table 4 
 
Entry Cu(I) salt Ligand Solvent Additive T Conversion
a 
1 CuCl (5%) L4 (5%) THF None r.t. 0 
2 CuCl (15%) L1 (10%) THF KO
t
Bu (10%) r.t. 0 
3 CuCl (20%) L2 (5%) THF KO
t
Bu (20%) 30 C 100 
4 CuCl (10%) L3 (5%) Et2O KO
t
Bu (10%) 30 C <10 
5 CuI (20%) L5 (20%) THF KO
t
Bu (100%) r.t. 100 (6)
b 
6
c
 CuI (5%) L6 (5%) THF KO
t
Bu (20%) r.t. 30 
a 
analysed by the 1H NMR of the reaction mixture; 
 b 
isolated yield in parenthesis;
 c 
carbonate added after 1h 
stirring. 
The reaction was carried out using a 1:1 or 2:1 Cu/ligand ration (for bidentate and 
monodentate ligands, respectively). Potassium tert-butoxide emerged as an optimal additional 
base to form the Cu complex, after screening several other alkoxide additives such as sodium 
methoxide and sodium tert-butoxide. Several types of phosphine ligand were screened, mainly 
the bidentate ligands with a different tether length (entries 5 and 6). Also, a more rigid 1,2-
bis(diphenylphosphino)benzene phosphine was synthesised following the literature 
procedure
132
 and tested in the nucleophilic substitution (entry 4). 
The proposed
120
 reaction mechanism suggests that initial addition of the diboron 
reagent across the Cu-OR bond forms the intermediate B, which subsequently gives a Cu-
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alkene -complex C prior to the addition across the double bond forming -
borylalkylcopperintermediate D. This intermediate eliminates CO2, which is the major driving 
force of the reaction, releasing the target allylboronate and regenerates the starting copper 
alkoxide complex A (Scheme 68).  
 
Scheme 68 
The results shown in Table 4 indicate that despite considerable efforts, suitable reaction 
conditions could not be found to form secondary boronate (±)-69.4a in satisfactory yields. 
Although all the necessary precautions were taken while performing the above reaction, the 
lack of success could be explained by two main factors: 1) the instability of the target 
allylboronate under acidic conditions, including silica gel that was used to purify the crude 
product; and 2) adventitious traces of air and moisture in the reaction media that could inhibit 
the activity of the highly air- and moisture sensitive catalyst species. Therefore, attention 
turned to other processes. 
Following the recent report in the literature,
128
 the focus now shifted to the addition of 
boranes to the corresponding allyl bromides under Barbier type conditions. For the synthesis of 
(±)-69.4a, technical grade crotyl bromide was added to a solution of commercially available 
pinacolborane in dry THF in the presence of Mg turnings at room temperature (Scheme 69). 
After a period of two hours, the reaction gave rise to the target compound, which was distilled 
under reduced pressure and obtained as pure colorless oil. 
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Scheme 69 
Scheme 70 presents two possible routes for the reaction, both of them initiated by the 
formation of the corresponding Grignard reagent. Path A relies on the nucleophilic attack of 
the aliphatic carbanion onto the borane forming a primary “ate” complex with a subsequent 
suprafacial 1,3-borotropic rearrangement yielding the target product and HMgBr. This 
mechanism was originally proposed by Singaram and co-workers.
128
 However, in an 
alternative route, a possible coordination of Lewis acidic Mg to the Lewis basic oxygen of the 
borane can be envisioned. This might facilitate the allylic addition of the Grignard reagent to 
the boron atom through a six-membered transition state delivering the secondary “ate” 
complex. Hydride elimination affords the target allylboronate along with HMrBr (Path B).  
 
Scheme 70 
Compared to the metal-catalysed SN2’ reaction, the main advantage of this synthesis of 
allylboronates is its applicability to a wide range of allyl bromides and boranes. To obtain a set 
of -substituted allylboronates, synthesis of 1-bromohex-2-ene and tetraethylethylene glycol, 
that were not commercially available, was carried out following literature protocols. 
The bulky diol tetraethylethylene glycol 71 was synthesised by pinacol coupling of 3-
pentanone in the presence of catalytic amounts of SmI2.
133
 In the catalytic cycle (Scheme 71a), 
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the initially formed Sm(III) alkoxide A was converted by TMSCl into the silyl enol ether 
releasing SmClI2, which was reduced by Mg turnings to Sm(II). Deprotection of the silyl enol 
ether under acidic conditions yielded the corresponding diol (Scheme 71a). The longer alkyl 
chain analogue, 1-bromohex-2-ene 72, was synthesised from the corresponding alcohol by 
treatment with PBr3 in THF through a typical SN2 mechanism (Scheme 71b).
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Scheme 71 
Once all the precursors were ready, a set of 5 different allylboronates could be 
synthesised following the one-pot reaction sequence shown in Scheme 72. Treatment of the 
corresponding diol with BH3•DMS in THF delivered the target borane.
135
 The borane 73 was 
reacted with the appropriate allyl bromide under Barbier-type conditions to produce the final 
allylboronates (±)-69 in moderate to good yields.  
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Scheme 72 
2.2.4.2 Synthesis of chiral Brønsted acids BINOL-derivatives. 
In their pioneering work Terada
136
 and Akiyama,
137
 independently reported on the use 
of BINOL-derived phosphoric acids as efficient chiral Brønsted acid catalysts. Since then this 
area of organocatalysis experienced an explosive development and a vast number of 
stereoselective reactions have been carried out under chiral Brønsted acids catalysis, including 
the earlier mentioned allylboration of aldehydes by Antilla and Hu.
52,53
 Therefore for kinetic 
resolution of racemic secondary allylboronates in the allylation of carbonyl compounds, chiral 
Brønsted acid catalysis, specifically the BINOL-derived phosphoric acid (R)-TRIP, was 
chosen. Due to the high cost of the commercial reagent, the catalysts were synthesised in 
laboratory.  
The synthesis was accomplished in a 23% overall yield following the procedure 
published by List.
138
 However, a slight variation in the functionalization of the 3,3’-positions 
was needed to improve the yield in this step (Scheme 73). (R)-BINOL was protected by 
methylation upon treatment with potassium carbonate and methyl iodide in refluxing acetone 
yielding compound (R)-74 in 92% yield. Iodination in 3,3’ position yielded precursor (R)-75 
(60%), which was submitted to the Ni-catalysed Kumada coupling with (2,4,6-
triisopropylphenyl)magnesium bromide 76 leading to compound (R)-77. Cleavage of the 
protecting group using BBr3 led to compound (R)-78 which was obtained in 50% yield over 
two steps.   
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Scheme 73 
Synthesis of (R)-TRIP 79 was completed by treating diol (R)-78 with phosphoryl 
oxychloride in refluxing pyridine for 14 h followed by subsequent hydrolysis by refluxing in 
water for 3 h (Scheme 74). Two other chiral Brønsted acids were synthesised alongside (R)-
TRIP 79 to test their activity in the kinetic resolution. (R)-N-Triflyl phosphoramide 80 was 
obtained upon treatment of the phosphorylated chiral binaphthol (R)-78 with 
trifluoromethansulfonamide in CH3CN under reflux for 18 h in 70% yield after purification 
(Scheme 74).
139
 (R)-Thio-TRIP was prepared by treating (R)-78 with P4S10 in toluene under 
reflux for 24 h in 82% yield (Scheme 74).
140
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Scheme 74 
The last two chiral acids (R)-80 and (R)-81 are stronger acids compared to the oxo-
analogue (R)-79. The presence of the strongly electron-withdrawing N-
trifluoromethanesulfonyl group in (R)-80 enhances acidity of the N-H bond. In the case of the 
phosphorodithionic acid (R)-81, the higher acidity can be explained by a possible 
delocalisation of the negative charge onto the vacant d orbitals of the sulfur atom, which is not 
possible in the case of the phosphoric acid (R)-79.  
2.2.4.3 Optimisation of the reaction conditions 
Addition of allylboronate (±)-69.4a to benzaldehyde was chosen as the model reaction.  
First, optimisation of the reaction conditions for the kinetic resolution included testing the set 
of the three different Brønsted acids at 5 mol% loading, anhydrous solvents at concentration of 
0.23M and the reaction temperature. The allylboronate (±)-69.4a was used in 2.5-fold excess 
(Scheme 75). 
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Scheme 75 
Optimisation of solvent, temperature and chiral catalyst. 
The preliminary results of the first steps towards the optimised reaction conditions are 
summarised in Table 5.  
Table 5 
Entry
a 
Brønsted acid Svt. T, C 
Reaction 
time 
d.r. (83aa:84aa)
b
 ee (83aa:84aa)
c
 
1 (R)-79 Tol r.t 18 h 67:33 60:91 
2 (R)-79 Tol 30 18 h 75:25 91:97 
3 (R)-79 Tol 78 18 h 75:25 66:92 
4 (R)-79 THF 78 18 h 67:33 3:10 
5 (R)-79 DCM 78 18 h 71:29 44:71 
6
d
 (R)-79 Tol 30 72 h ND 91:97 
7 (R)-80 Tol 30 1 h 86:14 54:64 
8 (R)-81 Tol 30 18 h 67:33 0:2 
a 
full conversion based on benzaldehyde was observed in all case otherwise stated; 
b 
d.r. (%) was taken from 
1
H 
NMR of the crude reaction mixture; 
c
 ee (%) were determined by chiral HPLC; 
d
 recrystallised (R)-TRIP 
was used 
Initially the reaction was carried out at room temperature using (R)-79 in toluene as a 
solvent. The alcohols Z-83aa and E-84aa were obtained in 60% and 91% enantioselectivity, 
respectively, with diastereomeric ratio of 67:33 (entry 1), close to that predicted by calculations 
(3:1, Table 1). Seeking to boost the efficiency of the process, the next reaction was performed 
at 30 C. The reaction reached full conversion in 18 h, bringing improvement in 
enantioselectivity for the Z isomer and a slight increase in diastereoselectivity (entry 2). At 78 
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C the reaction was also completed in 18 h but, rather surprisingly, ee of the Z isomer dropped 
to the level achieved at room temperature, while the d.r. was maintained at 75:25 (entry 3). The 
influence of the solvent was studied next by increasing the polarity of the reaction media. THF 
and DCM were used at 78 C, but both provided lower enantioselectivities, especially THF 
(entries 4 and 5). These results are in agreement with the findings of Antilla,
52
 who reported a 
drop in enantioselectivity as the polarity of the solvent increased.  
Next, the inconsistencies in the stereoselectivities obtained at 30 C and 78 C were 
investigated. From the energetic point of view and according to transition state theory, the 
lower the temperature of the reaction, the slower it will proceed. Thus, running the reaction  in 
toluene at 30 C, further control experiments were carried out in order to 1) shed light on the 
apparent inconsistency and 2) exclude the possibility of any artefact being responsible for the 
high enantioselectivity and ensure the reproducibility of the reaction. Unfortunately, all the 
attempts failed to deliver consistent and reproducible results giving a wide variation in the 
enantioselectivities and the reaction times. Luckily, the geometrical selectivity was kept at the 
same level. Careful analysis of the experimental data led to the conclusion that the observed 
irreproducibility might be caused by 1) an early quench of the reaction whereby the 
uncatalysed reaction may take place during the work-up; 2) traces of HCl remaining in the (R)-
79 after the synthesis competing with the chiral catalyst. The unconsumed benzaldehyde could 
react during the work-up procedure in an uncatalysed fashion, thus lowering the 
enantioselectivity. Monitoring the reaction by TLC gives only a qualitative assessment of the 
reaction course as both reagents, aldehyde and allylboronate, can react on silica, so based on 
the TLC data, the reaction might be stopped at different conversion stages. Hydrochloric acid 
may also play a detrimental role in the catalysed reaction. It is reasonable to assume that HCl 
would accelerate the background reaction thus also decreasing the level of enantioselectivity. It 
is worth noting that in the initial optimisation trials, a non-purified batch of (R)-TRIP 79 (a pale 
brown solid) was employed. However, in the protocol by List,
138
 recrystallization of the final 
product was recommended to remove impurities that may influence the catalytic activity of 
(R)-79. In the 
1
H NMR spectrum (CDCl3) of the crude product, significant differences in the 
signals corresponding to the isopropyl CH groups were observed (Figure 9, A and B, 
respectively). 
80 
 
 
Figure 9  
Only two signals (4H and 2H) were observed for the phosphate salt (A) and three 
separate signals (2H each) for the free acid (B). Prompted by these results, recrystallisation of 
the crude chiral phosphoric acid (R)-79 from acetonitrile was carried out. The 
1
H NMR 
spectrum of the purified product exhibited a clear difference in the isopropyl CH groups signals 
compared to the non-recrystallised sample (Figure 9 B). 
The kinetic resolution of allylboronate (±)-69.4a in the reaction with benzaldehyde was 
performed with a pure batch of (R)-TRIP 79 at 30 C in toluene as a solvent. Under these 
conditions, a high enantioselectivity was reproduced for both Z and E homoallylic alcohol; 
however, 72 h were needed to complete the reaction (entry 6). 
The catalytic activity of the chiral (R)-N-triflyl phosphoramide 80 and the analogue 
phosphorodithionic acid (R)-81 were also tested in the model reaction under the same 
conditions. Chiral Brønsted acid (R)-80 reacted faster than (R)-79 but gave only modest 
enantioselectivities (entry 7), whereas in the case of dithionic acid (R)-81 both geometrical 
isomers of homoallylic alcohol were obtained as racemates. The reason for the latter 
A 
B 
81 
 
phenomenon might be due to the stronger acidity of (R)-81, so that it forms a loose ion pair 
thus preventing creation of a tight chiral environment around the transition state.  
Electing the best additive 
Preliminary results indicated that the presence of an acidic additive in the reaction 
mixture could be beneficial for the reaction rate. Hence, next efforts were focused on the 
search for an adequate additive, which would increase the reaction rate without compromising 
the overall selectivity. Various Brønsted acid additives at different catalytic loadings were 
investigated (Table 6). 
Table 6 
Entry
a 
Additive T, C Reaction time d.r. (Z:E)
b
 ee (Z:E)
c
 
1 H3PO4 (2.5 mol %) 30 18 h 67:33 85:88 
2 AcOH (2.5 mol %) 30 18 h 75:25 85:88 
3 TFA (2.5 mol %) 30 18 h 72:28 80:79 
4 AcOH (1 mol %) 30 18 h 75:25 89:91 
5 TFA (1 mol %) 30 18 h 65:35 85:87 
6 AcOH (1 mol %) 78 72 h 80:20 96:98 
a 
reactions were carried out in toluene and full conversion was observed in all case otherwise stated; 
b 
d.r. (%) was 
taken from 
1
H NMR of the crude reaction mixture; 
c
 ee (%) were determined by chiral HPLC 
The acids selected were orthophosphoric, acetic and trifluoroacetic acids, having lower, 
similar and higher dissociation constant, respectively, compared to the chiral BINOL-derived 
phosphoric acid. They were used as aliquots of a 1M stock solution in toluene. The reaction 
was initially carried out at a 2.5 mol% loading of the additive at 30 C in toluene. All three 
acids succeeded in accelerating the reaction from 72 h to 18 h while maintaining the 
geometrical selectivity within the theoretically calculated values. However, a loss in 
enantioselectivity occurred for all of them, with the sharpest fall observed for trifluoroacetic 
acid (entry 3). Both orthophosphoric acid and acetic acid gave identical enantio- and 
geometrical selectivity (entries 1 and 2), however orthophosphoric acid was ruled out of further 
investigation due to its poor solubility in toluene. Therefore, acetic acid alongside 
trifluoroacetic acid was taken for further optimisation. Lowering the catalytic loading from 2.5 
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to 1 mol% resulted in a modest increase in enantioselectivity in both cases (up to 6% ee, entries 
4 and 5); the highest overall selectivity was achieved with acetic acid (entry 4). Finally, the 
reaction was carried out with 1mol% loading of acetic acid at 78 C to yield a 4:1 mixture of 
Z:E homoallylic alcohols with greatly improved selectivity of 96 and 98% ee, respectively 
(entry 6), though the reaction required longer time for completion (72 h). The optimal reaction 
conditions included 2.5 equivalents of allylboronate (±)-69.4a, 1 equivalent of benzaldehyde at 
0.23M final concentration in toluene, 5 mol% of (R)-TRIP and 1 mol% of acetic acid.  
Tuning the allylboronate architecture 
The theoretical conclusions (see Table 3) were tested by submitting the set of different 
racemic allylboronic acid esters to the model allylation of benzaldehyde under the optimal 
reaction conditions identified in the previous section, at 42 C. This temperature represents 
the lowest temperature that could be maintained by the laboratory cryocoolers.  
Table 7 
 
Entry
a 
Allylboronate Additive T, C Reaction time d.r. (Z:E)
b
 ee (Z:E)
c
 
1 (±)-69.5a AcOH (1 mol %) 42 48 h >95:5 98 (Z) 
2 (±)-69.5a Benzoic Ac. (1 mol %) 42 18 h  >97:3 97 (Z) 
3 (±)-69.3a Benzoic Ac. (1 mol%) 42 72
d
 h 40:60 41:40 
4 (±)-69.4d Benzoic Ac. (1 mol%) 42 18 h 67:33 60:72 
5 (±)-69.5d Benzoic Ac. (1 mol%) 42 18 h 98:2 94 (Z) 
a 
reactions were carried out in toluene and full conversion was observed in all case; 
b 
d.r. (%) was taken from 
1
H 
NMR of the crude reaction mixture; 
c
 ee (%) were determined by chiral HPLC; 
d
 4.0 equivalents of (±)-69.4d were 
used. 
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In an excellent agreement with the computational data, tetraethyl analogue (±)-69.5a 
showed far superior Z-selectivity than the parent pinacolboronate (±)-69.4a (entry 1, Table 7 vs 
entry 6, Table 6). Importantly, the Z-homoallylic alcohol 83 was obtained in 98% ee. However, 
the reaction seemed to be slower, probably due to the increased steric bulk of the boronic ester 
moiety. Replacing acetic acid with benzoic acid at the same loading of 1 mol% appeared to 
circumvent the issue while improving the Z-selectivity on the target homoallylic alcohol 
(>97:3, entry 2). With the least sterically hindered boronate (±)-69.3a, the Z/E ratio of the 
products started to switch in favour of the E-isomer, as predicted computationally, and was 
accompanied by a significant drop in enantioselectivity (entry 3). Moreover, the superior 
selectivity shown by the tetraethylethyleneglycol group extends to the propyl homologue (±)-
69.5d, producing a virtually geometrically pure Z-83 with high enantioselectivity, whereas the 
parent boronate (±)-69.4d gave geometrical selectivity similar to the -Me analogue (±)-69.4a 
(cf entries 4 and 5). 
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2.2.4.4 Scope and limitations of the reaction 
After establishing the optimal conditions and fine-tuning the structure of the boronate 
unit, the scope and applicability of the reaction was investigated. Boronates (±)-69.5a and (±)-
69.5d were employed in the allylation of a range of aromatic and aliphatic aldehydes (Table 8). 
Table 8 
 
Entry
a 
(±)-69.5 82, R
2
 83 Yield d.r. (Z:E)
b 
ee (Z)
c 
1 69.5a 82a, Ph 83aa 96% >25:1 97% 
2 69.5a 82b, PhCH=CH 83ab 84% >25:1 97% 
3 69.5a 82c, PhCH2CH2 83ac
d
 81% >25:1 91% 
4 69.5a 82d, 4-MeOC6H4 83ad 70% >25:1 98% 
5 69.5a 82e, 4-FC6H4 83ae 80% >25:1 85% 
6 69.5a 82f, 4-ClC6H4 83af 81% >25:1 99% 
7 69.5a 82g, 2-naphthyl 83ag 78% >25:1 98% 
8 69.5a 82h, 2-MeC6H4 83ah 75% >25:1 91% 
9 69.5a 82i, 2-thienyl 83ai 78% >25:1 99% 
10 69.5a 82j, 4-CF3C6H4 83aj 80% >25:1 96% 
11 69.5a 82k, c-C6H11 83ak 72% >25:1 88% 
12 69.5d 82a, Ph 83da 90% >25:1 94% 
13 69.5d 82b, PhCH=CH 83db 97% >25:1 93% 
14 69.5d 82c, PhCH2CH2 83dc
d 
80% 13:1 87% 
a 
reactions were carried out in toluene and full conversion based on the aldehyde was observed in all case; 
b 
d.r. 
was taken from 
1
H NMR spectra of the crude reaction mixture; 
c
 ee were determined by chiral HPLC; 
d
 the 
product was S-configured as a result of the change in the priorities of the substituents in Cahn-Ingold-Prelog 
system.  
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The results shown in Table 8 clearly demonstrate that the kinetic resolution 
methodology can be successfully applied to a wide range of aldehydes. The target homoallylic 
alcohols were obtained in a high to excellent enantioselectivities (up to 99% ee,), regardless of 
the electronic nature of the substituents. Furthermore, the geometrical selectivity was also kept 
at a high level of >25:1, in favour of Z-isomer 83. The use of the more sterically demanding 
allylboronate (±)-69.5d yielded the corresponding homoallylic alcohol 83 with a slight drop in 
enatntioselectivity compared to its analogue 69.5a (cf entries 12 and 13 vs 1 and 2) while 
maintaining the high geometrical selectivity. A drop in d.r. was observed in the case of 3-
phenylpropionaldehyde, which showed a 13:1 Z/E ratio when a more hindered allylboronate 
69.5d was used (entry 14). 
In conclusion, a highly efficient protocol for the kinetic resolution of chiral secondary 
allylboronates has been developed in the frame of asymmetric allylation of aldehydes catalysed 
by the chiral phosphoric acid (R)-TRIP. The success of this resolution method depends on the 
contribution of the two major factors: 1) the enantiofacial selectivity in the C-C bonds 
formation and 2) kinetic preference towards the axially orientated -alkyl substituent of the 
secondary allylboronate in the transition state. Quantum chemical calculations identified the 
tetraethylethylene glycol boronate scaffold as optimal to favour Z-selective reaction pathway. 
A wide range of Z-homoallylic alcohols were obtained with high geometrical and enantiomeric 
purity.
141
 Further investigations to elucidate the mechanism of the enantio- and 
stereodifferentiation are in progess. 
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3 TOTAL SYNTHESIS 
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3.1. Introduction 
(+)-Elisabethadione 85 and (+)-erogorgiaene 86 (Figure 10) are members of the family 
of marine diterpenes isolated from the West Indian sea whip Pseudopterogorgia elizabethae. 
These marine soft corals are found in warm nutrient rich reefs and shallows of the Bahamas, 
Florida Keys and West Indian region. P. Elisabethae first came to light in 1982 when routine 
screening showed the presence of cytotoxic metabolites with antimicrobial activity. Since then 
a whole host of gorgonian corals have been sampled and extracted. The isolation of a wide 
family of metabolites has been achieved and they are collectively known as Pseudopterosins 87 
which general structure is shown in Figure 10. Pseudopterosins are a family of diterpene 
pentosides sharing a hexahydro-1H-phenalene core skeleton with more than 26 variants of the 
core structure and diversity on the level of aromatic functionalisation. 
 
Figure 10 
Recent research into the biosynthetic pathway of pseudopterosins has been conducted 
by the Kerr research group.
142
 They have shown a possible mechanism for the formation of key 
intermediates in the biosynthesis of pseudopterosins. Compound 89 has been synthesised from 
geranylgeranyl diphosphate (GGPP) 88. It is postulated that cyclisation can occur through 2 
routes. In the first (Scheme 76), allylic cation 90 derived from initial loss of the pyrophosphate 
group from GGPP 88 initiates a ring closure. Allylic carbocation 90 undergoes a ring closure to 
generate a six membered ring. A second hydride shifts affords the corresponding allylic 
carbocation 91, which facilitates the second ring closure. Finally, proton abstraction at vinyl 
methyl followed by hydrogen shift gives rise to bicyclic triene elisabethatriene 89. 
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Scheme 76 
An alternative mechanism is shown in Scheme 77, in which intermediate 90 leads to a 
ten-membered ring. Hydride migration then leads to the bicyclic ring system, which undergoes 
proton abstraction at the vinyl methyl followed by hydrogen shift to afford 89.
143
 
 
Scheme 77 
The significance of intermediate 89 comes from extensive isolation and extractions of 
the crude natural product, which was doped with radiolabeled 
3
H-GGPP and 
14
C-xylose by 
adsorbing the radiolabeled compounds onto food particles for ingestion via the filter feeding 
gorgonian.
142
 This allowed the determination of intermediates in the biosynthetic pathway and 
allows the attempt of a biomimetic synthesis in the laboratory from the commercially available 
GGPP. The next transformation from elisabethatriene 89 to erogorgiane 86 proceeded via a 
89 
 
dehydrogenation and aromatization process using selenium dioxide in the presence of 
trimethylsilyl polyphosphate (PPSE) (Scheme 78).
144
  
 
Scheme 78 
3.1.1. Synthetic methodologies towards (+)-Elisabethadione 
Despite the fact that (+)-elisabethadione 85 exhibits high levels of biological activity, 
only one total synthesis has been accomplished so far by Davies and co-workers where the 
stereocontrolled formation of the three key stereogenic centres is achieved in a single step 
through the combined C-H activation/Cope rearrangement sequence. The racemic poly 
hydroxylated compound 92 was resolved to yield the cyclopropane 93 and the desired 
intermediate 94. The latter was first hydrogenated followed by ester reduction to yield the 
alcohol 95 (Scheme 79).
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Scheme 79 
After resetting the aldehyde functionality upon oxidation with PCC, a chain extension 
was accomplished through Wittig olefination. Further deprotection of the hydroxyl 
functionalities revealed the quinone scaffold thus furnishing (+)-elisabethadione 85 (Scheme 
80). 
 
Scheme 80 
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3.1.2. Synthetic methodologies towards (+)-Erogorgiane 
Biological evaluation of (+)-erogorgiane 86 has revealed its high activity against 
Mycobacterium tuberculosis H37Rv (96% inhibition at concentration of 12.5 g/mL), an 
aetiological agent that causes tuberculosis. However, the natural sources of it are scarce, and 
that encouraged the scientific community to develop stereoselective synthetic routes towards 
this potent natural product. Even though its structure is not very complex, the major challenge 
associated with its synthesis resides in the introduction of three stereogenic centres on the 
diterpene backbone lacking functional groups, which neighbour the chirality. To date, there are 
four total syntheses and two formal syntheses of (+)-erogorgiane 86 published in the literature. 
Yadav and co-workers reported the total synthesis of (+)-erogorgiane in a 16-step 
sequence in an overall yield of 8.2% using the aldol chemistry approach.
146
 The use of Evans 
chiral auxiliary, Crimmins aldol protocol with chiral oxazolidin-2-thione and an intramolecular 
Friedel-Crafts reaction via an oxetane established the three stereocentres C1, C11 and C4 
respectively, present in the natural product (Scheme 81). 
 
Scheme 81 
The benzylic stereogenic centre C1 was established by means of alkylation using the 
Evans chiral auxiliary 99 with complete control over the diastereoselectivity (>99% dr). 
Crimmins protocol afforded the non-Evans aldol product 104 in a highly diastereoselective 
manner introducing the next stereocentre C11. After three further steps the derived oxetane 105 
was obtained, which after treatment with Lewis acid led to the intramolecular Friedel-Crafts 
92 
 
alkylation product 106 installing the third chiral centre C4. The target diterpene ()-86 was 
synthesised within three more steps. 
More recently, Aggarwal and co-workers accomplished the total synthesis of (+)-
erogorgiane in 8 steps with an overall yield of 44%.
147
 They used their own developed 
methodology of lithiation/borylation-protodeboronation as key steps to install the stereogenic 
centres C1, C4 and C11 (Scheme 82). 
 
Scheme 82 
Asymmetric reduction of p-methylacetophenone with Noyori’s catalyst and subsequent 
carbamoylation, afforded the precursor 107 for the first lithiation-borylation sequence upon 
which the chiral centre C1 was introduced using boronic acid pinacol ester 108. A second 
reduction/carbamoylation sequence allowed for the preparation of the trans carbamate 111. 
The use of the borane 112, prepared in situ, established the adequate stereochemistry at this 
centre through a second lithiation-borylation-protodeboronation affording the final natural 
product in a 73% yield and 13:1 diastereomeric mixture. The synthesis of the C4-epimer 
carbamates 111 together with the opposite enantiomer of the borane 112 allowed the 
preparation of each of the remaining diastereomers of (+)-erogorgiane. 
Hoveyda and co-workers reported the first asymmetric total synthesis of (+)-
erogorgiane.
148
 The key steps to install the stereogenic centres involved Cu-catalyzed 
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alkylation of -unsaturated ketones and Birch reduction (Li/NH3) (Scheme 83). The 
synthesis was achieved in 18 high yielding steps and high stereoselectivity.  
 
Scheme 83 
The use of the less hindered phosphine ligand 118 introduced C11 in a higher 
regioselectivity (1,4 vs 1,6 alkylation) in the conjugate addition to the unsaturated ketone 117 
(9:1 in favour of 1,4 addition vs 1.5:1 in the case of the bulkier dipeptide ligand 114).  
A shorter asymmetric total synthesis of (+)-erogorgiane was reported by Davies et al.
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By means of an elegant enantiodifferentiation in the C-H activation/Cope rearrangement 
sequence, C4 and C11 stereogenic centres were introduced in a one-pot operation (Scheme 84). 
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Scheme 84 
Due to the fact that C1 stereogenic centre is resolved in the course of the parallel kinetic 
resolution process that operates in the cascade C-H activation/Cope rearrangement, the racemic 
dihydronaphthalene (±)-121 could be used. The reaction gave a 1:1 mixture of the C-H 
activation/Cope rearrangement product 123 and the cyclopropane 124, both of 98% ee. The 
synthesis of (+)-erogorgiane was completed in four further steps involving hydrogenation of 
the two double bonds over Pd/C (10 mol%), reduction of the ester to the alcohol using LiAlH4, 
oxidation to the aldehyde with PCC and final alkenylation as reported for (+)-
elisabethadione.
145 
Yadav reported a protecting group free formal total synthesis of (+)-erogorgiane 
starting from commercially available (S)-(-)-citronellal (Scheme 85).
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Scheme 85 
 The formal total synthesis is composed of 12 steps and an overall yield of 14.2%. This 
novel sequence had the advantage of employing (S)-(-)-citronellal as the starting material that 
already contains one out of the three required chiral centres. The stereogenic centre C4 was 
introduced before C11 via intramolecular Friedel-Crafts cyclisation in the presence of Lewis 
acid and at a later stage, C11 was successfully installed using the previously reported lithiated 
Evans benzyloxazolidinone chiral auxiliary 99. 
Harmata and co-workers also developed a formal total synthesis of (+)-erogorgiane via 
benzothiazines using stoichiometric amounts of the chiral sulfonimide 131 to set the benzylic 
stereogenic centre at C1 (Scheme 86).
150
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Scheme 86 
Synthesis of compound 116 represented a formal total synthesis of (+)-erogorgiane 
since this intermediate was featured in the synthetic sequence reported by Hoveyda.
148
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3.2. Aims and objectives 
The aim of this project was to develop a practical scalable method for the asymmetric 
allylation of highly substituted cinnamaldehydes to be used in the asymmetric total synthesis of 
(–)-elisabethadione 85 and (–)-erogorgiane 86, the marine natural products of the 
pseudopterogorgia secondary metabolite family. 
The strategy for the racemic total synthesis of (±)-elisabethadione was developed in the 
Malkov group by Paul O’Hora during his PhD project (Scheme 87).151  
 
Scheme 87 
The retrosynthetic analysis is shown in Scheme 88. The advanced intermediate alcohol 
95 was featured in the synthesis of (+)-elisabethadione reported by Davies and co-workers
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and may, therefore, represent a formal total synthesis of ()-85. The synthetic strategy is built 
around the three key steps for the construction of the stereogenic centres C1, C4 and C11. It 
involves asymmetric allylation of the suitably functionalised cinammyl aldehyde 162; anionic 
oxy-Cope rearrangement (AOC) of the resulting enantiopure homoallylic alcohol 167 (C1 and 
C11) and cationic cyclisation of the trans-alkene 171 (C4).  
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Scheme 88 
The same strategy will be applied to the total synthesis of ()-erogorgiane (Scheme 89). 
A detailed investigation of the AOC would be conducted to improve the diastereoselectivity 
obtained in the previous studies. In this instance, to circumvent the problem of regioselectivity 
in the cationic cyclisation step, the ortho position to the methyl group in the aromatic ring is 
blocked by bromine, which will be removed at a later stage in the synthesis. 
 
Scheme 89 
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3.3. Results and discussion 
Despite the fact that both marine diterpenes ()-85 and ()-86 share the key reactions 
for the installation of the stereogenic centres, the precursor cinnamyl aldehydes for the 
asymmetric allylation step are different and prepared by different synthetic sequences. 
Therefore, the total synthesis of each natural product will be described separately. 
The advantage of the proposed synthetic route over those already described in the 
literature is that a single asymmetric transformation, a Lewis base catalysed allylation of a 
cinnamaldehyde, is employed to introduce chirality into the molecule, which efficiently 
controls the formation of the required stereocentres by two subsequent stereoselective 
transformations: anionic oxy-Cope rearrangement and cationic cyclisation. This synthesis does 
not use any alternative directing/controlling groups such as chiral auxiliaries. It does not 
require costly protecting groups or resolution techniques. To get a better insight into the 
stereochemistry of the oxy-Cope rearrangement and the cationic cyclisation, a brief overview 
of those transformations will be presented below. Asymmetric allylation was already been 
extensively discussed in chapter 1. 
3.3.1. Anionic oxy-Cope rearrangement 
The well-known anionic oxy-Cope (AOC) rearrangement is a [3,3]-sigmatropic 
rearrangement. It is generally accepted that it proceeds through a chair-like transition state, 
whereby the oxyanionic bond sits in the pseudoequatorial position. Theoretical and 
experimental studies on isotope effects showed the AOC is characterised by a highly 
dissociative transition state where the C3 – C4 bond is extensively dissociated with only a 
small degree of bond formation between C1 and C6 (Scheme 90).
152
 Numerous investigations 
were reported, in which chair-like transition state was found to have both pseudoequatorial and 
pseudoaxial orientations of the oxyanionic bond. Further examples have also shown that the 
pseudoaxial oxyanionic bond and boat like transition states are possible in a structurally 
enforced transition state.
153,154
 It should be noted that the structure of the molecule plays an 
important role in the rearrangements because the steric effects of substituents can severely 
retard the rate of reaction or indeed stop it altogether. 
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Scheme 90 
One of the main advantages of the AOC is its ability to translate chirality from the 
reactant to the product. Transfer of chiral information may proceed in a highly selective 
process, as Lee and co-workers
155
 showed in their route to the synthesis of (+)-
dihydromayurone. Allylic alcohol 136, with a single stereogenic centre, was converted into the 
corresponding aldehyde 137 (Scheme 91). The single stereogenic centre at the carbinol carbon 
was successfully transferred into the product in a highly stereoselective manner. The efficiency 
of the chirality transfer had its origins in the preferred pseudoequatorial position of the 
oxyanionic bond in the chair-like transition state during the rearrangement.  
 
Scheme 91 
Further research on the AOC rearrangement by Paquette and co-workers
156,157
 
demonstrated that pure E-138 and Z-139 underwent [3,3]-sigmatropic rearrangement with a 
slight preference for the pseudoequatorial orientation of the oxyanion (61% and 57%, 
respectively, Scheme 92). 
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Scheme 92 
Nakai improved the diastereoselectivity by placing an alkyl substituent in the -carbon 
to that bearing the hydroxyl group.
158
 This is shown in the examples of alcohols 140-143 
(Scheme 93). In the first two examples the pseudoaxial position of the oxyanion induces A
1,3
 
interactions disfavours reaction pathways involving 144 and 145 (reactions a and b). When 
dienol 142 is used (reaction c), the alkoxide and methyl groups adopt pseudoaxial or 
pseudoequatorial positions with no A
1,3
 interactions. The 69:31 diastereoselectivity of E/Z 
aldehydes shows the rearrangement proceeds with a slight preference through transition state 
146. The use of alcohol 143 also avoids any A
1,3
 interactions and favours the pseudoequatorial 
orientation of the oxyanion bond leading to a 90:10 diastereoselectivity through the chair-like 
transition state 147 (reaction d). 
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Scheme 93 
3.3.2. Cationic cyclisation 
The topic of cationic cyclisation in the synthesis of natural products has been little 
mentioned in the literature over the past 25 years, mainly due to the lack of control over the 
stereoselectivity during the reaction. However, Corey and co-workers in the late 90s disclosed 
the influence of the electronic properties of the arene substituents in the cationic cyclisation of 
148 and 149 catalysed by methanesulfonic acid.
159
 Working towards the total synthesis of 
pseudopterosins, they observed that TBS and Ms protecting groups on phenolic oxygen yielded 
opposite stereoselectivity in the formation of the new chiral centre during the cationic ring 
closure (Scheme 94). 
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Scheme 94 
After the initial protonation of the diene 148 (or 149), the presence of the electron 
withdrawing group MsO could favour the direct cyclisation of the allylic cation onto the arene 
ring to give 150. However, the alternative cyclisation to form a 5-membered ring followed by a 
1,2-rearrangement with ring expansion 5  6, could explain the opposite stereochemistry on 
the new chiral centre when TBSO group was used (151). They found a similar stereochemical 
dichotomy during the synthesis of the diastereoisomers of pseudopteroxazoles (Scheme 95).
160
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Scheme 95 
In this case the solvent played an important role during the mechanism. When the 
reaction was performed in acetic acid using methanesulfonic acid as catalyst, the preferred 
reaction pathway was likely to proceed via the 5-member ring closure followed by 1,2-
rearrangement with ring expansion (152  155). The higher electron donating ability of the 
carbamate NH-group compared to the carbamate oxygen combined with the solvation 
stabilisation of the transition state favoured this pathway. However, when DCM was used as 
solvent, the direct 6-membered ring closure was favoured as the reaction pathway (152  
153). 
Casey and co-workers investigated cationic cyclisation for their synthesis of tetralins.
161
 
Following literature precedent, they initiated the reaction by addition of an electrophile (I

) 
followed by electrophilic attack onto the arene. They studied the 6-exo and 6-endo modes of 
addition. The 6-exo cationic cyclisation showed limited reaction scope. However, 6-endo 
proved to proceed stereoselectively, allowing to access different stereochemistry in the tetralins 
depending on the geometry of the starting alkene, i.e. 1,4-cis tetralins were obtained from Z-
alkenes, whereas 1,4-trans tetralins were prepared from E-alkenes (Scheme 96). 
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Scheme 96 
In order to explain the diastereoselectivity, they postulated a reversible formation of the 
iodonium intermediate and a faster cyclisation occurring when the benzylic methyl occupies a 
pseudoequatorial position in the six-membered transition state (Scheme 97). 
 
Scheme 97 
From this brief overview on the key synthetic steps, it can be concluded that a E,syn 
homoallylic alcohol will be required to achieve a reliable transfer of the stereochemical 
information from the homoallylic alcohol in the AOC rearrangement (to set up C4), 
additionally, the trans alkene configuration is a prerequisite for setting up the correct 
stereochemistry at C1 in the subsequent cationic cyclisation. 
3.3.3. Total Synthesis of ()-Elisabethadione 
The asymmetric synthesis of elisabethadione started by producing the starting 
cinnamaldehyde 162 (Scheme 98). This sequence was initiated by alkylation of the 
commercially available 1,2,4-trimethoxybenzene at the C-3 position yielding compound 158 
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quantitatively. In the next step, selective halogenation at C-5 was performed using the method 
optimised by the former researcher to afford compound 159 in 89% yield.
151
 Lithium/bromine 
exchange followed by addition of DMF, after hydrolysis, provided the required aromatic 
aldehyde 160 in a 52% yield.  
 
Scheme 98 
Wittig alkenylation of aldehyde 160 with (carbethoxyethylidene)triphenylphosphorane 
in aqueous media needed to be repeated three times to achieve full conversion. Unfortunately, 
due to the purification process after each cycle, the corresponding ester 161 was obtained in a 
rather moderate yield (54%). The reduction-oxidation sequence of the -unsaturated ester 
161 furnished the respective cinnamaldehyde 162 which is required for the asymmetric 
allylation step.  
To streamline the route to aldehyde 162, a direct aldol condensation between aldehyde 
160 and propanal using sodium hydroxide as a base was also investigated. Optimisation of the 
reaction conditions are summarised in Table 9. The reaction was performed by adding a 
solution of propanal in MeOH to a solution of substituted benzaldehyde and base in MeOH.  
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Table 9. Direct aldol condensation towards 162 
 
Entry ArCHO (eq.) EtCHO (eq.) NaOH 2M (eq.) Temp.  (h) Conversion 
1 1 2 0.8
a 
r.t. 2 60% 
2 1 2 0.8
a 
r.t. 18 70% 
3 1 1 1 50 C 2 80% 
4
b 1 1 1.1 50 C 18 45% 
5 1 1.5 1.1 50 C 18 60% 
6 1 2.5 2.5 50 C 5 >90% 
a
 NaOH 1M was used; 
b
 the base was added dropwise to a solution of aldehydes in MeOH 
The reaction was initially carried out with one equivalent of the substituted 
benzaldehyde 160 and two equivalents of propanal in the presence of substoichiometric 
amounts of 1M NaOH. After the reaction was stirred at room temperature for two hours, the 
conversion of 160 to the corresponding cinnamaldehyde 162 reached 60% (entry 1). Extended 
period of time under the same reaction conditions did not deliver significant improvements 
(entry 2).  The use of an equimolar mixture of aldehydes and 2M NaOH  at 50 C, stirring for 
two hours, improved conversion to the target aldehyde to 80% (entry 3). To examine the 
influence of the order of addition, an equimolar mixture of the corresponding aldehydes was 
prepared in MeOH. A slight excess of 2M NaOH was added to the reaction mixture at room 
temperature followed by stirring at 50 C (entry 4). The low conversion obtained confirmed 
that an excess of base was needed in the reaction mixture prior to the addition of propanal to 
accelerate the reaction. In order to improve the conversion, 1.5 eq. of propanal and 1.1 eq. of 
2M NaOH were employed carrying out the reaction at 50 C. Conversion to the desired 
cinnamaldehyde 162 reached 60%, significantly lower than previously (cf entry 5 with entry 
3). Next, the amounts of both propanal and 2M NaOH were increased in order to cut the 
reaction time to 5 hours. The new conditions resulted in ca. 90% conversion of 160 to 162 
(entry 6), the isolated compound was suitable for use in the allylation protocol, as it was 
illustrated by a racemic variant of addition of Z-crotyltrichlorosilane 164 to aldehyde 162 in 
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DMF. Due to time restrictions, the aldol condensation was not optimised further. However, it is 
clear that the synthesis of the cinnamaldehyde precursor can be obtained in fewer steps using 
the direct aldol addition reaction     
Retrosynthetic analysis of 86 and 87 (Schemes 88 and 89) and the literature overview 
clearly demonstrate that to achieve efficient transfer of chirality in the AOC rearrangement and 
install correct relative stereochemistry at C1 and C4, enantioenriched syn-homoallylic alcohol 
167 is required. To meet this requirement, asymmetric 1,2-addition of Z-crotylmetal reagents to 
aldehyde 162 were attempted. It became apparent during the development of the racemic 
version of the synthesis
151
 that the reactivity of the cinnamaldehyde 162 is considerably 
reduced due to the electron-rich nature of the aromatic ring, which complicated the search for 
an efficient chiral catalyst. The main task in this project was to find a catalytic system and 
optimise the reaction conditions that would allow (a) to circumvent the poor reactivity problem 
of the aldehyde and (b) to achieve the desired level of enantioselectivity. The results of this 
investigation are presented in Table 10.  
Table 10. Asymmetric allylation of cinammyl aldehyde 162 
 
Entry  AllylM Solvent Temp.  Reaction scale Catalyst
a 
Yield ee 
1 163 Toluene 30 C 0.5 mmol (R)-TRIP 78% 90% 
2 163 Toluene 30 C 5.0 mmol (R)-TRIP 65% 40% 
3 164 EtCN 60 C 0.5 mmol Bis-N-oxide 85% 97% 
4 164 EtCN 60 C 5.0 mmol Bis-N-oxide 82% 94% 
a
 TRIP 10 mol%; N-oxide 2 mol%  
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With the experience gained in the project of the Brønsted acid catalysed addition of 
allylboronates to aldehydes (see Chapter 2), the attention was first focused on the allylation of 
162 employing commercially available Z-crotylboronic acid pinacol ester 163 using 10 mol% 
of (R)-TRIP as the catalyst. When the reaction was performed at 0.5 mmol scale, the desired 
homoallylic alcohol 167 was obtained in good yield and excellent enantioselectivity (entry 1). 
However, an attempt to carry out the reaction at a larger scale (5 mmol) under the same 
conditions led to a sluggish reaction and was accompanied by a substantial drop in 
enantioselectivity (entry 2). Taking into consideration the relatively high cost of the Z-
crotylboronate 163 (SigmaAldrich, 1 g at £96), the attention shifted to the Lewis base catalysed 
addition of allyltrichlorosilanes to aldehydes, where Malkov’s group has accumulated a 
considerable experience. In a parallel project in the group, a new bis-N-oxide 165 was 
developed, which exhibited a very high reactivity in model allylation reactions, exceeding 
reactivity of the existing Lewis bases.
24,25
 It is worth noting that the chiral catalyst 165 was 
synthesised by an oxidative coupling of the corresponding isoquinoline-N-oxide 168 yielding a 
single diastereoisomer of 165 (Scheme 99). The absolute configuration of the catalyst is not 
known but it is assumed to be as shown in Table 10 by comparison with literature results.
162
 
 
Scheme 99 
The asymmetric allylation of 162 with Z-crotyltrichlorosilane 164 catalysed by the 
chiral bis-N-oxide 165 (2 mol%) at 0.5 mmol scale afforded the enantioenriched syn-
homoallylic alcohol 167 in 85% yield and 97% ee (entry 3). Importantly, applying the same 
reaction conditions to a large scale synthesis (5 mmol) retained excellent yield and 
enantioselectivity (entry 4).   
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With the single stereoisomer of the homoallylic alcohol (–)-167 in hand, next the 
anionic oxy-Cope rearrangement was performed. Treatment of (–)-167 with KH and 18-crown-
6 in DME at 40 C for 5 h led to a full conversion producing enolate 169. After brief 
optimisation of the quenching conditions, the best results were achieved when the mixture was 
first cooled to 78 C followed by a quick addition of MeOH. In this way, aldehyde 170 was 
obtained, according to the 
1
H NMR spectrum of the crude product, as a 3:1 mixture of 
diastereoisomers at C11, an improvement over the original procedure developed by the former 
researcher. It is worth noting the excellent transfer of chirality during the AOC rearrangement 
to form the C4 stereocentre, as evidenced by the stereochemical course of the subsequent steps 
and X-ray analysis of one of the advanced intermediates (compound 97, vide infra, page 
112
151
).  The origin of the observed high stereoselectivity in the AOC rearrangement is in the 
presence of the -methyl substituent in the cinnamyl fragment in 167; of the two possible 
chair-like transition structures I and J, the TS J is clearly disfavoured due to the A
1,3
 clash 
(Scheme 100). In order to visualise how the protonation of the enolate 169 occurs, a Felkin 
Ahn model along the bond C-11/C-4 can be used (Scheme 100). The proton is more likely to 
approach the less hindered face of the enolate, namely pro-Re face. The approach from the pro-
Si face will be disfavour due to the presence of the ortho-methoxy group. 
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Scheme 100 
To minimise manipulation of the oxidation prone aldehyde and to avoid epimerisation 
of C11, crude 170 was subjected to Wittig-Horner-Emmons olefination conditions. The 
corresponding -unsaturated ethyl ester 171 was obtained in 84% yield over two steps 
(Scheme 100). 
Diastereoisomers of ethyl ester 171 were not separable by conventional column 
chromatography, therefore the synthesis continued with the mixture. The final stereogenic 
centre C1 was installed through the cationic cyclisation of 171 upon treatment with 
methanesulfonic acid to afford the hexahydro-1H-phenalene derivative 172. Importantly, the 
process proved to be highly stereoselective to form only trans cyclohexene ring (no other 
diastereoisomers were detectable by 
1
H NMR spectroscopy). Next, continuous flow 
hydrogenation of 172 using an H-Cube furnished aliphatic ethyl ester 173 followed by its full 
reduction with DIBAL-H to afford primary alcohol 95 as a 2.7:1 mixture of C-11 isomers. At 
this stage, the isomers showed slightly different Rf values on TLC but gave a clear baseline 
separation on analytical HPLC column. Therefore, separation of 500 mg of the mixture was 
successfully accomplished using preparative HPLC to afford pure trans,syn-95a and trans,anti-
95b, the latter slightly contaminated by other isomers (Scheme 101). The stereochemistry is 
defined in such a way that trans refers to the relative configuration of the methyl group at C1 
112 
 
and the alkyl chain at C4; while syn refers to the relative configuration of the hydrogen at C4 
and the methyl at C11, according to the reported example (vide supra Figure 10).   
 
Scheme 101 
After isolation of the isomerically pure primary alcohol 95a, the formal synthesis of 
elisabethadione was completed. The subsequent five steps to the actual natural product were 
accomplished following Davies’ report (Scheme 102).145  
 
Scheme 102 
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Partial oxidation of the primary alcohol ()-95a using DMP in CH2Cl2 yielded the 
corresponding aldehyde ()-174 in 74% yield. The subsequent alkenylation afforded ()-96 in 
80% yield. In an attempt of create a shortcut to the ()-elisabethadione 85, a full deprotection 
of 96 using BBr3 to the final natural product 85 was examined.
163
 However, the reaction 
yielded an intractable deep-purple oil, similar to what was experienced by other researchers 
using similar compounds.
164
 Therefore Davies’ route was continued. Partial deprotection of 96 
using lithium ethanethiolate yielded the corresponding aryl diol ()-97 in 68% yield. 
Importantly, in the racemic variant of the synthesis, compound 97, obtained as a 2:1 mixture of 
isomers, gave crystals suitable X-ray crystallography analysis,
151
 which confirmed the correct 
relative configuration of the major isomer and also showed that the two isomers differ only at 
C11. To complete the synthesis, ()-97 was oxidised to ortho-quinone ()-175 by CAN, 
followed by treatment with tosic acid in benzene to afford ()-elisabethadione 85 (20% yield 
after 5 steps), the enantiomer of the target natural product. The synthesised compound 
exhibited optical rotation []D
25
 = –267 (c = 0.16, CHCl3), opposite in sign but similar in the 
absolute value to the compound reported by Davies ([]D
25
 = +278, c = 0.58, CHCl3).
145
   
3.3.4. Total synthesis of ()-Erogorgiane  
The total synthesis of (–)-erogorgiane started with the synthesis of the corresponding 
substituted cinnamaldehyde 179. Reduction of commercial 2-bromo-3-methylbenzoic acid by 
borane dimethylsulfide complex yielded benzylic alcohol 176 in 85% yield. Subsequent 
oxidation using MnO2 produced substituted benzaldehyde 177 in 79 % yield (Scheme 103). 
 
Scheme 103 
The aldehyde 177 was subjected to a Wittig olefination upon treatment with ethyl-2-
(triphenylphosphoranylidene)propanoate in water under reflux to yield the -unsaturated 
ester 178 in 76% yield. Reduction of the ester with DIBAL-H followed by oxidation of the 
alcohol with MnO2 afforded aldehyde 179 in 82% yield over two steps (Scheme 104). 
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Scheme 104 
Analogously to the ()-elisabethadione route, synthesis of the precursor 
cinnamaldehyde 179 was also examined via the aldol condensation between benzaldehyde 177 
and propanal using NaOH as base, as summarised in Table 11.  
Table 11. Direct aldol condensation towards cinammyl aldehyde 179 
 
Entry ArCHO (eq.) EtCHO (eq.) 2M NaOH (eq.) Temp.  (h) Conversion 
1
 1 1 1
a 
r.t. 3 >99%
b
 
2 1 1 1
a 
r.t. 18 60% 
3 1 1.5 1 50 C 18 90%
c
 
4 1 1.5 1 50 C 48 86% 
a
 1M NaOH was used; 
b
 compound 179 could not be separated from byproducts; 
c
  isolated 
yield 60%  
The reaction was first attempted using an equimolar mixture of the substituted 
benzaldehyde 177, propanal and 1M NaOH following the same procedure as in the ()-
elisabethadione synthesis. After stirring for 3 hours at room temperature, a full conversion was 
reached but the target cinnamaldehyde 179 was obtained together with other aldehydic 
byproducts, which could not be separated (entry 1). Dropwise addition of base to the solution 
of both aldehydes at room temperature and extending the reaction time gave 60% conversion 
(entry 2). Following the latter procedure, the conditions were further modified by using 1.5 eq. 
of propanal and a stronger concentration of base. After stirring the reaction at 50 C for 18 
hours, the target cinnamaldehyde 179 was obtained in 90% conversion and 60% isolated yield 
(entry 3). Longer reaction time using the same reaction conditions did not bring any 
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improvement, as entry 4 shows. These results demonstrated that direct aldol condensation 
methodology can be used as a shortcut in the synthesis of the precursor cinnamaldehyde 179.  
Having learnt from the synthesis of (–)-elisabethadione, asymmetric crotylation was 
carried out using allyltrichlorosilane methodology under the conditions of Lewis base catalysis. 
Addition of cis-crotyltrichlorosilane 164 to 179 in the presence of 2 mol% of the chiral bis-N-
oxide 165 in propionitrile at 60 C yielded the corresponding syn-homoallylic alcohol 180 in 
72% yield and 98% ee (Scheme 105).  
 
Scheme 105 
Having successfully synthesised syn homoallylic alcohol 180, the oxy-Cope 
rearrangement was carried out next. Due to the chair-like pathway, the AOC would occur 
stereoselectively: the presence of the methyl group at C11 favours the TS K where the 
oxyanionic bond occupies a pseudoequatorial position and which is free from any A
1,3
 
interactions between the substituents, unlike the TS L, where there is A
1,3 
strain between the 
two methyl groups (Scheme 106). 
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Scheme 106 
The AOC controls the stereochemistry at C4. At the same time, the configuration at 
C11 is more difficult to control since it is created during the protonation of the enolate. It was 
hoped that the existing stereogenic centre at C4 and the appropriate choice of the proton source 
for quenching the reaction would favour formation of the correct diastereoisomer. Obviously, 
the desired overall stereochemistry to proceed with the total synthesis of (–)-erogorgiane 86 is 
represented by E,syn-181. 
Taking into account the lack of success in the AOC of 180 by the former researcher, 
optimization of reaction conditions was first performed using racemic syn-homoallylic alcohol 
180 (Table 12). 
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Table 12. AOC rearrangement optimization 
 
Entry 
KH 
(eq.) 
18-C-6 (eq.) T (C)/  (h) H+ source Conversion Dr 
a 
1 16 0.5 40/2 MeOH/r.t. >99% 2.6:1:1.7:1.5 
2 3 1 22/48 MeOH/r.t. 20% 1.7:1 
3 3 1 40/18 MeOH/-78 C >99% 1.2:1 
4 8
b
 1 22/18 MeOH/-78 C >99% 1.2:1 
5 16 1 22/18 182
c
/-78 C >99% 2:1 
a
 determined by 
1
H NMR of the reaction crude; 
b
 KH was use neat weighted by mass difference; 
c
 182 = 2,4,6-tri-tert-butylphenol 
The use of 16 equivalents of KH 30% in mineral oil, 0.5 equivalents of 18-Crown-6 in 
DME at 40 C gave a mixture of 4 diastereoisomers (entry 1). It was realised that the use of 18-
crown-6 helped to capture the potassium cation into the complex so the ionic pair K-alkoxide 
was fully dissociated. Hence, at least one equivalent of the crown-ether would be needed. In 
addition to this increment, the use of only three equivalents of KH 30% in mineral oil at room 
temperature gratifyingly afforded a mixture of only two diastereoisomers in 1.7:1 ratio after 
methanolic quenching at room temperature. Although the major isomer was the desired one, 
the reaction only proceeded at 20% conversion after 48 h (entry 2). Full conversion and only 
two diastereoisomers were achieved when the reaction was performed at 40 C using three 
equivalents of KH 30% in mineral oil and one equivalent of 18-Crown-6. The subsequent 
methanolic quenching at 78 C produced a 1.2:1 diastereomeric ratio (entry 3). The use of 8 
equivalents of neat KH, 1 equivalent of 18-crown-6 at room temperature was used next. 
However, after the subsequent methanolic quenching at low temperature the same 
diastereomeric ratio was achieved (entry 4). Finally, the reaction was performed at room 
temperature increasing the amount of KH to 16 equivalents affording only two 
diastereoisomers. Quenching the enolate at 78 C with bulkier 2,4,6-tert-butylphenol (182) 
gave a mixture a 2:1 d.r. (entry 5).  
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Once the reaction conditions for the AOC rearrangement were optimised, enantiopure 
syn-homoallylic alcohol ()-180 was subjected to the [3,3]-sigmatropic rearrangement 
affording aldehyde ()-181. Analogously with ()-elisabethadione, a Felkin-Ahn model can 
help visualising how the protonation of the corresponding enolate occurs (Scheme 107). The 
protonation is also likely to happen at the pro-Re face of the enolate as it provides less steric 
hindrance compared to the pro-Si face. To avoid oxidation of the aldehyde functionality and 
epimerisation at C11, the crude product was submitted straight to the Wittig-Horner-Emmons 
olefination protocol to afford the -unsaturated ethyl ester ()-183 in a two-step yield of 81% 
(Scheme 107). Mirroring the route towards (–)-85, the diastereoisomers of ethyl ester ()-183 
were not separable by column chromatography, so the total synthesis was carried out with the 
mixture. 
 
Scheme 107 
To introduce the final stereogenic centre of the natural product scaffold, cationic 
cyclisation was carried out next. Treatment of the ester 183 with methanesulfonic acid in 
CHCl3 at room temperature yielded the cyclisation product 184 after 2 days in 83% yield. It 
has to be noted that in this instance, cis-cyclohexene isomer was visible by 
1
H NMR 
spectroscopy (ca. 5-8%). Continuous flow hydrogenation of the double bond employing an H-
Cube furnished the aliphatic ester 185 and the subsequent reduction of the ethyl ester 
functionality produced primary alcohol 186 (Scheme 108).  
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Scheme 108 
At this stage, attempts to debrominate the intermediate 186 were carried out. Following 
published procedure employing a similar substrate,
165,166
 compound 186 was treated with 
LiAlH4 in the presence of dry air that was purged into the reaction vessel through a column 
filled with KOH. Several attempts were performed but without much success, as evidenced by 
the 
1
H NMR spectra of the crude reaction mixtures. A more detailed look at the 
1
H NMR 
spectrum of the primary alcohol 186, taking the chemical shift of the aromatic methyl group as 
a standard, revealed that the first flow hydrogenation protocol afforded a mixture of 
brominated alcohol 188 and the desired debrominated analogue 187 in an 85:15 ratio (Figure 
11). The presence of 187 in this mixture was confirmed by high resolution mass spectrometry 
which contained two major peacks corresponding to the brominated alcohol 186 ([M+
107
Ag]
+
 
requires 431.0134, found 431.0140) and debrominated 187 ([M+
109
Ag]
+
 requires 353.0984, 
found 353.1033). 
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Figure 11 
Encouraged by these results, the mixture of the primary alcohols was subjected to 
harsher conditions of the flow hydrogenation (20 bar, 40 C) (Scheme 108). After 4 hours, the 
debrominated primary alcohol 187 was obtained in 70% yield over three steps (with ca. 5% of 
alcohol 186 remaining in the mixture, Figure 11). The mixture of the C11 isomers was 
separated by preparative HPLC to afford both C11-epimers. Dess-Martin periodinane oxidation 
of ()-trans,syn-187a led to the aldehyde ()-trans,syn-188a in 84% yield. The final chain 
elongation through a Wittig procedure afforded the enantiomer of the natural product ()-
erogorgiane in 80% yield exhibiting optical rotation []D
25
 = –25.5 (c = 0.52, CHCl3; []D
25
 = 
23.2, c = 0.75, CHCl3;
146
 []D
25
 = 69.1, c = 0.77, DCM;147 []D
25
 = 40.6, c = 0.14, 
CHCl3
148
 []D
25
 = 21.4 (c = 0.14, CHCl3
111
). The stereochemistry is defined as shown 
previously for ()-elisabethadione (Scheme 109, also vide supra Scheme 101). 
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Scheme 109 
The asymmetric total synthesis of ()-erogorgiane was accomplished in 12 steps with 
an overall yield of 14.2% based on the commercially available 2-bromo-3-methyl 
benzaldehyde 177. Despite the fact that the synthesised isomer had optical rotation of opposite 
sign to those previously reported, ()-86a is a natural product that has been isolated from a 
brown alga (Dictyota dichotoma) collected in Troista Bay of the Peter the Great Gulf, Sea of 
Japan, also exhibiting potent biological activity.
167 
Furthermore, the ()-86b C11-epimer of (–)-erogorgiane derived from ()-trans,anti-
187b was also completed. It has the same absolute stereochemistry as the natural diterpene 
leubethanol (Figure 12) isolated from the root bark of Leucophyllum frutescens, an evergreen 
shrub in the figwort family, also known as cenizo, a medicinal plant of Mexican traditional 
medicine, which has long been used to treat lung complaints and specifically tuberculosis.168 
This hydroxylated analogue also exhibits potent biological activity against Mycobacterium 
tuberculosis H37Rv.  
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Figure 12 
The asymmetric total synthesis of ()-elisabethadione and ()-erogorgiane has been 
accomplished in 2.1% and 14.2% yield, respectively. The methodology here presented benefits 
from the use of a single asymmetric step which in turn is the key step where the 
enantioselectivity is introduced. The stereochemistry of the homoallylic alcohol controls the 
installation of the three stereogenic centres in the backbone skeleton. The biological activity of 
these natural products is currently being tested. Preliminary studies carried out at Perm State 
University (Russia) have shown ()-86b exhibits anti-inflammatory properties against 
carrageenan induced paw edema in mice with 23% at 25 g/kg (voltaren exhibits 49% at 10 
g/kg).   
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4. EXPERIMENTAL 
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General Procedures 
 NMR spectra were recorded in CDCl3, 
1
H at 400 MHz and 
13
C at 100.6 MHz with 
chloroform-d1 (δ 7.26 ppm, 
1H; δ 77.0 ppm, 13C) as internal standard unless otherwise 
indicated. Various 2D-techniques and DEPT experiments were used to establish the structures 
and to assign the signals. The IR spectra were recorded in KBr disc unless otherwise indicated. 
The mass spectra were measured on a Thermo Exactive (Orbi), where the spectra was recorded 
in a positive or negative ion mode using electrospray ionization (ESI) from methanol or 
acetonitrile in the presence of AgNO3 where specified. All reactions were performed under 
atmosphere of dry, oxygen-free nitrogen using oven-dried glassware. Yields are given for 
isolated products showing one spot on a TLC plate and no impurities detectable in the NMR 
spectrum.  
 All chromatographic manipulations used silica gel as the absorbent. Reactions were 
monitored by thin layer chromatography (TLC) on aluminium backed plates with Merck Kiesel 
60 F254 silica gel. TLCs were either visualized by UV radiation at a wavelength of 254 nm, or 
stained by exposure to an ethanolic solution of phosphomolybdic acid or potassium 
permanganate aqueous solution, following by charring where appropriate. Purification by 
column chromatography was carried out using Merck Kiesel 60 H silica adsorbent.  
All solvents and reagents for the reactions were of reagent grade and were dried and 
distilled under nitrogen immediately before use as follows: benzaldehyde from sodium 
hydroxide, toluene from calcium hydride and tetrahydrofuran was distilled under argon 
atmosphere from the sodium/benzophenone. Petroleum ether refers to the fraction boiling in 
the range 40-60 °C. 
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4.1. Synthesis of allylboronates 
4.1.1.  Synthesis of the precursors. 
(E)-but-2-en-1-yl methyl carbonate (70) 
 
A solution of crotyl alcohol (25 mmol, 2.13 mL, 1 eq.) and pyridine (110 mmol, 8.8 
mL, 4.4 eq.) in DCM was placed in a 100 mL round bottom flask. The mixture was cooled at 0 
C and methylchloroformate (55 mmol, 4.25 mL, 2.2 eq.) was added dropwise to the solution 
while stirring. The resulting white suspension was allowed to stir for further 2 h at r.t. The 
mixture was diluted in 30 mL of water and extracted with light petroleum (350 mL). The 
organic phase was washed with 35 mL of brine and dried over Na2SO4. The solvent was 
remove in vacuum and the residue was purified by column chromatography on silica eluting 
with 90:10 mixture of light petroleum:ethyl acetate to yield the title compound as a colorless 
oil (1.17 g, 60%). 
1
H NMR (400 MHz, CDCl3) δH 1.63 (dm, 3H, J = 4.8 Hz, 1-H); 3.66 (s, 3H, 
5-H); 4.44 (dt, 2H, J = 6.4, 0.8 Hz, 4-H); 5.51 (m, 1H, 3-H); 5.74 (m, 1H, 2-H). 
13
C NMR (100 
MHz, CDCl3) δC 17.6 (CH3), 54.4 (CH3), 68.4 (CH2), 124.6 (CH), 131.9 (CH), 155.6 (C). IR: 
3028, 2959, 1749, 1443, 1379, 944, 793 cm
-1
. HRMS (ESI) 153.0521 (C6H10O3Na ([M+Na]
+
) 
requieres 153.0522). 
3,4-diethylhexane-3,4-diol (71) 
 
A round bottom flask was charged with magnesium turnings (14 g, 600 mmol, 8 eq) 
and flame dried under inert atmosphere. After vigorous stirring for 1 hour, a 0.1 M solution of 
SmI2 in THF (75 mL, 7.5 mmol, 10 mol%) and TMSCl (4.7 mL, 37.5 mmol, 0.5 eq) were 
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added at room temperature. Into the mixture was added dropwise a mixture of 3-pentanone (7.6 
mL, 75 mmol, 1 eq) and TMSCl (9.5 mL, 75 mmol, 1 eq) at the rate to maintain the blue colour 
of SmI2. After the reaction was completed, HCl 1M was added (ca 25 mL) and the organic 
compounds were extracted with diethyl ether (3x 75 mL). The organic layers were combined, 
dried over MgSO4 and concentrated in vacuum The title compound was obtained as a pale 
yellow oil by flash chromatography on SiO2 (3.67 g, 56 % yield); 
1
H NMR (400 MHz, 
CDCl3):  1.93 (s, 2H, OH); 1.66-1.56 (qd, J = 15.6, 3.2 Hz, 8H, 2-H); 0.94 (t, J = 8 Hz, 12H, 
1-H); 
13
C NMR (100 MHz, CDCl3):  78.8 (C), 27.3 (CH2), 8.8 (CH3); IR:  3454, 2968, 
2882, 1462, 1383, 1265, 1125, 1039, 951, 916, 851 cm
-1
; HRMS (ESI) 197.1511 (C10H22O2Na 
[M+Na]
+
 requires 197.1512). 
(E)-1-bromohex-2-ene (72) 
 
PBr3 (16.96 mmol, 1.6 mL, 0.4 eq.) was added at 10 C to (E)-3-hex-2-en-1-ol (42.4 
mmol, 5 mL, 1 eq.) in dry diethyl ether (95 mL). The reaction mixture was allowed to stir 
overnight while warming up to room temperature. The reaction was cooled in an ice bath and 
slowly quenched with water; it was washed with NaHCO3 and extracted with DCM. The 
organic layers were combined and dried over Na2SO4. Flash column chromatography eluting 
with 100% petroleum ether afforded 5.4g of the target compound (56% yield); 
1
H NMR (400 
MHz, CDCl3):  0.90 (t, J = 7.2 Hz, 3H); 1.41 (sept, J = 7.6 Hz, 2H); 2.04 (q, J = 7.2 Hz, 2H); 
3.95 (d, J = 7.4 Hz, 2H); 5.65-5.81 (m, 2H); 
13
C NMR (100 MHz, CDCl3):  13.6 (CH3), 22.0 
(CH2), 33.7 (CH2), 34.1 (CH2), 126.5 (CH), 136.5 (CH); IR:  3032, 2960, 2930, 2873, 1660, 
1463, 1436, 1379, 1203, 963, 592 cm
-1
; MS was in agreement to the literature.
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4.1.2. General synthesis of allylboronates: 
 
A flame dried round bottom flask was charged with a solution of the corresponding diol 
(1 eq.) in a freshly distilled THF. The solution was cooled at 0 C with an ice bath and 
127 
 
BH3•DMS (0.9 eq.) was added dropwise to the mixture. After the addition was completed the 
reaction was allowed to stir at this temperature for 30 minutes and then 90 minutes at room 
temperature. The corresponding borane 73 was used in the next step without further 
purification in solution at ca 1.3M in THF. 
A flame-dried round bottom flask was charged with magnesium turnings (1.2 eq.). 
Freshly distilled THF was added to the flask followed by the previously prepared solution of 
borane with vigorous stirring (ca 0.8M in THF). The corresponding allylbromide (1 eq.) was 
added at room temperature to the solution and let stirred for 30 minutes. After this time a 
second equivalent of allylbromide was added to the reaction mixture and the solution was 
stirred for an additional 1.5 h. The reaction was quenched by dropwise addition of 0.1M HCl 
until the remaining magnesium turnings were fully consumed. The mixture was extracted with 
dichloromethane and the organic phase was dried over Na2SO4. After filtration, the solvent was 
removed under reduced pressure. The crude mixture was purified by flash chromatography 
using a gradient eluent system (100 hexane to 95/5, hexane/ethyl acetate) unless otherwise 
stated. 
(±)-2-(But-3-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (69.4a). 
 
(±)-69.4a was purified using bulb-to-bulb distillation under reduced pressure (b.p = 100 
o
C, p = 4 mbar) was obtained as a colorless oil (997 mg, 72 % yield); 
1
H NMR (400 MHz, 
CDCl3): H 1.03 (d, J = 7.2 Hz, 3H, 4-H); 1.73 (s, 12H, 5-H); 1.83 (t, J = 7.2 Hz, 1H, 3-H); 
4.89 (dt, J = 10.0, 1.6 Hz, 1H, CHa=CH); 4.94 (dt, J = 17.2, 1.6 Hz, 1H, CHb=CH) 5.87 (m, 
1H, CH=CH2); 
13
C NMR (100 MHz, CDCl3): C 14.1 (CH3), 24.6 (CH3), 24.7 (CH3), 83.2 
(C), 111.9 (CH2), 140.9 (CH); IR:  3415, 3080, 2979, 2933, 2875, 1634, 1458, 1372, 1351, 
1323, 1272, 1145, 983, 853 cm
-1
. MS was in agreement with the literature.
120 
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(±)-2-(But-3-en-2-yl)-4,4,5,5-tetraethyl-1,3,2-dioxaborolane (69.5a). 
 
(±)-69.5a was obtained as a yellowish oil (668.4 mg, 76 % yield); 
1
H NMR (400 MHz, 
CDCl3): H 0.90 (t, J = 8.0 Hz, 12H, 5-H); 1.10 (d, J = 8.0 Hz, 3H, 4-H); 1.64 (m, 8H, 6-H); 
1.91 (t, J = 8.0 Hz, 1H, 3-H); 4.89 (dt, J = 10.0, 1.6 Hz, 1H, CHa=CH); 4.95 (dt, J = 17.2, 1.6 
Hz, 1H, CHb=CH); 5.97 (ddd, J = 17.2, 10.0, 6.8 Hz, 1H, CH=CH2); 
13
C NMR (100 MHz, 
CDCl3): C 8.7 (CH3), 8.8 (CH3), 14.2 (CH3), 26.2 (CH2), 26.3 (CH2), 88.1 (C), 111.5 (CH2), 
141.4 (CH); IR:  2973, 2947, 2884, 1635, 1458, 1384, 1351, 1307, 1289, 1195, 1114, 930 
cm
-1
; HRMS (ESI) 239.2175 (C14H27BO2Na [M+Na]
+
 requires 239.2177). 
(±)-2-(Hex-1-en-3-yl)- 4,4,5,5-tetraethyl-1,3,2-dioxaborolane (69.5d). 
 
(±)-69.5d was obtained as colorless oil (2.1 g, 51 % yield); 
1
H NMR (400 MHz, 
CDCl3): H 0.89 (m, 15H, 6,7-H); 1.25-1.42 (m, 4H, 4,5-H); 1.60-1.66 (m, 8H, 8-H); 1.84 (q, J 
= 7.6 Hz, 1H, 3-H); 4.89 (ddd, J = 10.0, 2.0, 0.8 Hz, 1H, CH1a=CH); 4.95 (ddd, J = 17.2, 2, 1.2 
Hz, CH1b=CH); 5.74-5.83 (m, 1H, CH=CH); 
13
C NMR (100 MHz, CDCl3): C 8.7 (CH3), 8.8 
(CH3), 14.1 (CH3), 22.0 (CH2), 26.1 (CH2), 26.2 (CH2), 32.5 (CH2), 88.1 (C), 112.9 (CH2), 
140.2 (CH); IR:  2957, 2884, 1632, 1460, 1384, 1366, 1349, 1306, 1289, 1253, 1114, 1043, 
995, 974, 919 cm
-1
; HRMS (ESI) 372.1490 (C16H31BO2Ag [M+Ag]
+
 requires 372.1499). 
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(±)-2-(But-3-en-2-yl)-5,5-dimethyl-1,3,2-dioxaborinane (69.3a).
63
 
 
(±)-69.3a was purified using bulb-to-bulb distillation under reduced pressure (b.p = 100 
C, p = 4 mbar) was obtained as a colorless oil (1.3 g, 57% yield). 1H NMR (400 MHz, CDCl3): 
0.88 (s, 6H, 6-H); 0.99 (d, J = 7.2 Hz, 3H, 1-H); 1.72-1.77 (m, 1H, 2-H); 3.53 (s, 4H, 5-H); 4.09-
4.89 (m, 2H, 4-H); 5.86-5.94 (m, 1H, 3-H). 
(±)-2-(hex-1-en-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (69.4d). 
 
(±)-69.4d was obtained as colorless oil (1.9 g, 55% yield); 
1
H NMR (400 MHz, 
CDCl3): C 0.81 (t, J = 7.2 Hz, 3H, 6-H); 1.16 (s, 12H, 7-H); 1.23-1.34 (m, 4H, 4,5-H); 1.76 
(q, J = 7.6 Hz, 1H, 3-H); 4.84 (ddd, J = 10, 2, 0.8 Hz, 1H, CHa=CH); 4.89 (ddd, J = 17.2, 2, 1.2 
Hz, 1H, CHb=CH); 5.65-5.74 (m, 1H, CH=CH); 
13
C NMR (100 MHz, CDCl3): C 13.9 (CH3), 
21.9 (CH2), 24.4 (CH3), 24.5 (CH3), 32.3 (CH2), 82.8 (C), 113.2 (CH2), 139.5 (C) ; IR:  2978, 
2928, 2872, 1632, 1465, 1371, 1321, 1270, 1144, 969, 848 cm
-1
; HRMS (ESI) 317.0826 
(C14H27BO2Ag [M+Ag]
+
 requires 317.0837). 
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4.2. Synthesis of chiral phosphoric acids 
(R)-2,2’-dimethoxy-1,1’-binaphthyl (74). 
 
A 100 mL three-necked round bottom flask was charged with (R)-BINOL (4 g, 14 
mmol, 1 equiv.) and equipped with a magnetic stirrer bar, reflux condenser with N2 inlet and an 
addition funnel. The flask was evacuated and back filled with N2. Subsequently the vessel was 
charged with dried acetone (140 mL). Upon complete solution of the prior compound, K2CO3 
(6.37 g, 46.2 mmol, 3.3 equiv.) was added followed by methyl iodide (3.5 mL, 56 mmol, 4 
equiv.). The resulting mixture was heated to reflux for 24 h. The volatiles were removed under 
vacuum. The resulting mixture was redissolved in water (100 mL) and it was allowed to stir for 
2 h. The resulting solid was collected in a funnel and dried under vacuum furnishing 4.09 g of 
the title compound 74 (92 %) as dim yellow solid. m.p.: 200-210 C; 1H NMR (400 MHz, 
CDCl3) δH 3.68 (s, 6H), 7.03 (d, J = 8 Hz, 2H), 7.13 (m, 2H), 7.23 (m, 2H), 7.37 (d, J = 9.2 Hz, 
2H), 7.78 (d, J = 8 Hz, 2H), 7.89 (d, J = 9.2 Hz, 2H). 
13
C NMR (100 MHz, CDCl3) δC 56.9 
(CH3), 114.3 (CH), 119.6 (C), 123.5 (CH), 125.3 (CH), 126.3 (CH), 127.9 (CH), 129.2 (C), 
129.4 (CH), 134.0 (C), 154.9 (C). IR:  3047, 3022, 2955, 2837, 1618, 1590, 1505, 1461, 
1354, 1264, 1250, 1091, 1065, 811, 747 cm
-1
. HRMS (ESI) was in agreement with the 
literature.
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(R)-3,3’-diiodo-2,2’-dimethoxy-1,1’-binaphthyl (75). 
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A 250 three-necked round bottom flask was equipped with a magnetic stirrer bar, an 
addition funnel, an N2 inlet and a glass stopper. The vessel was evacuated and backfilled with 
N2 and charged with (R)-2,2’-dimethoxy-1,1’-binaphthyl (4.09 g, 13 mmol, 1 equiv.) in 100 
mL of freshly distilled Et2O. Freshly distilled TMEDA (6.2 mL, 41.68 mmol, 3.2 equiv.) was 
added followed by n-BuLi 2M in hexanes (23.4 mL, 46.8 mmol, 3.6 equiv.) dropwise via 
syringe at r.t. The mixture was allowed to stir for 4 h. I2 (13.2 g, 52 mmol, 4 equiv.) in 100 mL 
of dry Et2O was added dropwise via addition funnel at 78 C. The resulting yellow-brownish 
reaction mixture was stirred overnight while being allowed to reach room temperature.  The 
reaction was quenched with 150 mL saturated solution of Na2SO3 and stir for 1 h. The reaction 
mixture was extracted with Et2O (3 x 150 mL). The organic layers were combined, washed 
with brine (150 mL) and dried over Na2SO4. The solvents were removed in vacuum and the 
crude mixture was subjected to column chromatography (hexanes/ethyl acetate, 95:5) yielding 
(R)-75 as pale yellow solid (4.42 g, 60%). m.p.: 160-170 C. 1H NMR (400 MHz, CDCl3) δH 
3.34 (s, 6H), 6.99 (d, J = 8.5 Hz, 2H), 7.19 (t, J = 7.2 Hz, 2H), 7.33 (t, J = 7.2 Hz, 2H), 7.72 (d, 
J = 8 Hz, 2H), 8.46 (s, 2H). 
13
C NMR (100 MHz, CDCl3) δC 61.1 (CH3), 92.3 (C), 125.4 (C), 
125.7 (CH), 125.8 (CH), 126.9 (CH), 127.1 (CH), 132.2 (C), 133.8 (C), 139.9 (CH), 154.5 (C). 
IR:cm-1. 
HRMS (ESI) was in agreement with the literature.
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(2,4,6-triisopropylphenyl)magnesium bromide (76). 
 
A 100-mL round bottom flask fitted with magnetic stirrer bar, a condenser and charged 
with Mg turnings (3.1 g, 128 mmol, 2 equiv., activated with 0.1 mL of 1,2-dibromoethane) was 
flamed dried under vacuum and was evacuated and filled with N2 (three circles). The Mg was 
covered with anhydrous Et2O (70 ml) and, subsequently, 2-bromo-1,3,5-triisopropylbenzene 
(18.12 g, 64 mmol, 1.0 equiv.) was added dropwise controlling the reflux. After the addition 
was completed, the rest of the Et2O (10 ml) was added rinsing the walls of the condenser. The 
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resulting grey solution was placed in a pre-heated sand bath to be refluxed for 24 h. The 
resulting solution was used directly in the next step. 
(1R,3R)-3,3'-bis(2,4,6-triisopropylphenyl)-[1,1'-binaphthalene]-2,2'-diol (78). 
 
An flamed-dried 100 mL round bottom flask fitted with magnetic stirrer was charged 
with (R)-3,3’-diiodo-2,2’-dimethoxy-1,1’-binaphthyl (3.52 g, 6.23 mmol 1 equiv.) and 
Ni(PPh3)2Cl2 (505 mg, 0.77 mmol, 0.12 equiv.). The flask was carefully evacuated and filled 
with N2 (three circles). Et2O (50 mL) was added followed by dropwise addition of the 
Grignard-solution 76 at room temperature. After the addition was complete, the resulting 
mixture was allowed to reflux for 6 h. The resulting brown solution was allowed to reach r.t. 
and then cooled to 0 C with an ice bath. 1M HCl solution was added dropwise until no 
vigorous reaction occurred. The resulting mixture was extracted with Et2O (3 x 50 mL), the 
combined organic layers were dried over MgSO4, filtered and the solvent was removed in 
vacuum. The resulting yellowish solid crude 77 was used in the next step without further 
purification. The crude material was evacuated and backfilled with N2 in a 250 mL round 
bottom flask fitted with a magnetic stirrer. Freshly distilled dichloromethane (25 mL) was 
added. The solution was cooled at 0 C and BBr3 (1M in DCM, 44 ml, 43.6 mmol, 7.0 equiv. 
based on (R)-3,3’-diiodo-2,2’-dimethoxy-1,1’-binaphthyl) was added dropwise. After complete 
addition, the resulting clear solution was allowed to stir for 24 h at room temperature. 
Subsequently, water (70 mL) was added to quench the reaction. The aqueous layer was 
extracted with CH2Cl2 (3 x 60 mL), the organic layers were combined, dried over MgSO4, and 
the solvents were removed in vacuum. Column chromatography (hexane/ethyl acetate 99:1) 
gave the title compound 78 as a dim yellow solid (1.62 g, 38 % over two steps). m.p.: 125-135 
C. 1H NMR (400 MHz, CDCl3) δH 2.86-3.01 (sept., 2H), 3.03-3.10 (sept., 2H), 3.12-3.17 
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(sept., 2H), 7.32 (d, J = 6 Hz, 4H), 7.47-7.53 (m, 6H), 7.95 (s, 2H), 8.03 (d, J = 8Hz, 2H); 
13
C 
NMR (100 MHz, CDCl3) δC 23.7 (CH3), 23.9 (CH3), 24.0 (CH3), 24.0 (CH3), 24.3 (CH3), 24.3 
(CH3), 30.8 (CH), 30.9 (CH), 34.3 (CH), 113.1 (C), 121.2 (CH), 121.2 (CH), 123.8 (CH), 
124.5 (CH), 126.6 (CH), 128.2 (CH), 130.7 (CH), 133.4 (C), 147.4 (C), 147.8 (C), 149.1 (C), 
150.6 (C); 
IR:
cm-1. HRMS (ESI+) was in agreement with the literature.138 
(R)-TRIP (79). 
 
Chiral diol (R)-78 (0.408 mmol, 281.7 mg, 1 eq.) was charged in a 50 mL two-necked 
round bottom flask fitted with a reflux condenser. The flask was evacuated and backfilled with 
N2. Pyridine (1 mL) was added followed by POCl3 (1.224 mmol, 0.114 mL, 3 eq.) and the 
reaction was allowed to reflux overnight. The reaction was allowed to reach room temperature, 
followed by the addition of 1.5 mL of water and the resulting mixture was heated to reflux for 
3h. After the reaction reached r.t., 5 mL of DCM were added and the resulting organic layer 
was throughly washed with 1M HCl (3x5mL) until pH < 7. The combined organic layers were 
dried under MgSO4 and volatile was removed in vacuum. (R)-TRIP (79) was obteined as a 
white-dim brownish solid after recrystalization from acetonitrile (255 mg, 83 %). M.p.: 190-
200 C. 1H NMR (400 MHz, CDCl3) δH 0.94 (d, J = 6.8 Hz, 6H), 0.98 (d, J = 6.4 Hz, 6H), 
1.05 (d, J = 6.8 Hz, 6H), 1.08 (d, J = 6.8 Hz, 6H), 1.25 (d, J = 6.8 Hz, 12H), 2.67-2.73 (m, 2H), 
2.77-2.80 (m, 2H), 2.82-2.90 (m, 2H), 5.32 (s, 1H), 6.97 (m, 4H), 7.28-7.33 (m, 4H), 7.47-7.51 
(m, 2H), 7.85 (s, 2H), 7.90 (m, 2H). 
13
C NMR (100 MHz, CDCl3) δC 23.2 (CH3), 23.4 (CH3), 
24.0 (CH3), 24.1 (CH3), 25.0 (CH3), 26.3 (CH3), 30.8 (CH), 34.2 (CH), 120.1 (CH), 121.0 
(CH), 122.4 (C), 125.1 (CH), 125.9 (CH), 127.3 (CH), 128.1 (CH), 130.7 (C), 132.2 (CH), 
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132.6 (C), 147.4 (C), 147.8 (C), 148.0 (C). IR: 
cm-1. HRMS (ESI) was in 
agreement with the literature.
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(R)-(+)-[3,3’-Bis(2,4,6-triisopropyl)phenyl-1,1’-binaphthalen-2,2’-yl)-N-triflyl 
phosphoramide (80).
139
 
 
To a solution of (R)-78 (350 mg, 0.5 mmol, 1 equiv.) in dichloromethane (3 mL), Et3N 
(0.5 mL, 3.5 mmol, 7 equiv.), POCl3 (56 µL, 0.6 mmol, 1.2 equiv.) and DMAP (122.2 mg, 1 
mmol, 2 equiv.) were added at 0 C. After the mixture was stirred for 1 hour at room 
temperature, CH3CN (3 mL) was added at room temperature followed by TfNH2 (149 mg, 1 
mmol, 1 equiv.). Then the reaction was stirred at 100 °C for 12 hours. The reaction was 
quenched with H2O (5 mL) and extracted with Et2O (2x20 mL). The organic layers were 
combined, washed with sat. aq NaHCO3 (30 mL) and 4N HCl (30 mL). The Resultant organic 
layer was dried over Na2SO4 and the solvents were removed under reduced pressure. The crude 
material was purified by column chromatography on silica gel (hexane:ethyl acetate, 75:25) 
yielding the target phosphoramide (R)-80 as a pale yellow solid (310 mg, 70%). M.p.: 215-220 
C. 1H NMR (400 MHz, CDCl3) δH 0.83(d, J = 6.8 Hz, 6H); 1.03 (t, J = 6.4Hz, 6H); 1.17 (m, 
24H); 2.56 (sept., J = 6.8 Hz, 2H); 2.75 (quint., J = 6.8 Hz, 1H); 2.77-2.88 (m, 3H); 6.93-7.03 
(m, 6H); 7.17 (m, 2H); 7.37 (quad., J = 6.4Hz, 2H); 7.77 (d, J = 14.4Hz, 2H); 7.80 (t, J = 
8.8Hz, 2H). 
13
C NMR (100 MHz, CDCl3) δC 22.6 (CH3), 23.1 (CH3), 23.3 (CH3), 23.4 (CH3), 
23.8 (CH3), 24.0 (CH3), 24.1 (CH3), 24.3 (CH3), 25.0 (CH3), 25.1 (CH3), 26.3 (CH3), 26.7 
(CH3), 30.6 (CH), 30.8 (CH), 30.9 (CH), 34.2 (CH), 34.5 (CH), 119.9 (CH), 120.3 (CH), 120.7 
(CH), 121.1 (C), 121.4 (C), 121.6 (CH), 122.3 (CH), 125.5 (CH), 126.2 (CH), 126.3 (CH), 
127.1 (CH), 127.2 (CH), 128.0 (CH), 128.3 (CH), 130.6 (C), 131.0 (C), 131.4 (C), 131.5 (C), 
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132.3 (CH), 132.5 (CH), 132.6 (C), 132.6 (C), 132.7 (C), 145.9 (C), 146.0 (C), 146.7 (C), 
146.9 (C), 147.4 (C), 148.1 (C), 148.6 (C), 
31
P NMR (162 MHz, CDCl3) P 2.3. 
19
F NMR 
(377 MHz, CDCl3) F 82.3.   IR:  3629, 3498, 2960, 2870, 1610, 1462, 1292, 1229, 1195, 
1149, 1089, 975, 894, 750 cm
-1
. HRMS (ESI): 928.3359, found 928.3334 
(C51H56O5SF3PNNa2), in agreement with literature.
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(R)-thio-TRIP (81).
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(R)-78 (150 mg, 0.22 mmol, 1 equiv.) was charged in a 25 mL round bottom flask fitted 
with a magnetic stirrer. The vessel was flushed with N2 and freshly distilled toluene (4 mL) 
was added. P4S10 (29 mg, 0.13 mmol, 0.6 equiv.) in toluene was added to the solution. The 
mixture was allowed to reflux overnight. After the reaction was cooled at room temperature, 
the solvent was removed in vacuum. The target compound was obtained as a pale brown solid, 
141.6 mg, 82% yield. M.p.: 242-245 C. 1H NMR (400 MHz, CDCl3) H 0.78 (d, J = 6.8 
Hz,3H); 1.08 (m, 6H); 1.18 (m, 6H); 1.23 (d, J = 6.8 Hz, 3H); 2.67 (quint, J = 6.8 Hz, 1H); 
2.82 (quint., J = 6.8 Hz, 1H); 3.05 (quint, J = 6.8 Hz, 1H); 6.94 (s, 1H); 7.02 (s, 1H); 7.07 (d, J 
= 8.4 Hz, 1H); 7.15 (t, J = 8.4 Hz, 1H); 7.36 (t, J = 7.6 Hz, 1H); 7.77 (s, 1H); 7.79 (d, J = 8 Hz, 
1H). 
13
C NMR (100 MHz, CDCl3) C 23.6 (CH3), 24.1 (CH3), 25.0 (CH3), 27.3 (CH), 30.8 
(CH) 34.2 (CH) 120.1 (CH), 121.6 (CH), 123.5 (C), 125.0 (CH), 125.8 (CH), 127.3 (CH), 
128.1 (CH), 130.6 (C), 132.1 (CH), 132.2 (C), 133.0 (C), 133.3 (C), 148.2 (C), 148.4 (C), 
149.0 (C). 
31
P NMR (162 MHz, CDCl3) P 126.1. IR: 
cm-1. MS 
(ESI): 829.3249, found 829.3234 (C50H56O2S2PNa2). 
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4.3 Kinetic resolution of racemic allylboronates. Allylation of 
aldehydes 
4.3.1.  General procedure for the synthesis of racemic homoallylic alcohols 83/84aa-
83/84ak and 83/84da-83/84dc 
 
A 10 mL round bottom flask was charged with allylboronate (±)-69.4a or (±)-69.4d 
(0.82 mmol, 1.2 eq.) in 1.5 mL of toluene. The corresponding aldehyde (0.68 mmol, 1 eq.) was 
added followed by trifluoroacetic acid (0.10 mmol, 7.6 L, 15 mol%). The reaction mixture 
was allowed to stir at room temperature overnight. To the reaction mixture, 2 mL of a saturated 
solution of NaHCO3 was added and stirred for further 30 minutes. The mixture was diluted 
with 10 mL of a saturated solution of NaHCO3 and extracted with dichloromethane (3x15 mL). 
The organic layers were combined and dried over Na2SO4. Solvents were removed under 
reduced pressure. The crude mixture was purified by flash column chromatography on sílica 
with a gradient eluent system (100 hexane to 95:5, hexane/ethyl acetate) afforded the 
corresponding racemic homoallylic alcohols (±)-83 and (±)-84. 
4.3.2. General procedure for the kinetic resolution of racemic allylboronates in the 
allylation of aldehydes. 
 
A reaction tube was fitted with a stirring bar. The vessel was evacuated, backfilled with 
N2 and then charged successively with a solution of (R)-TRIP (12.6 mg, 0.0168 mmol, 5 mol 
%) in 0.5 mL of dry toluene and a 0.5M stock solution of benzoic acid in toluene (6.7 L, 
0.0034 mmol, 1 mol%). The solution was cooled at 42 C. Aldehyde (0.34 mmol, 1 equiv.) 
dissolved in 0.5 mL of dry toluene was added followed by a dropwise addition of a solution of 
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allylboronate (0.84 mmol, 2.5 equiv.) in 0.5 mL of dry toluene. After the reaction was 
complete, as evidenced by TLC, a saturated solution of NaHCO3 (5 mL) was added, the 
mixture was stirred for 1 h and then the organic phase was extracted with ethyl acetate (3  15 
mL). Organic layers were combined and dried over Na2SO4. Solvent was removed in vacuum. 
Flash chromatography on sílica with a gradient eluent system (100 hexane to 95:5, 
hexane/ethyl acetate) afforded the target homoallylic alcohol.  
(R,Z)-(+)-1-Phenylpent-3-en-1-ol (83aa).
 
 
 
R-(+)-83aa Colorless oil (52 mg, 96 % yield). TLC (8.5:1.5 LP:EA, UV, PMA): 0.28; 
[]D
25
 = + 60.0 (c = 2.5, CHCl3; literature
 
 gives
169
 []D
25
 = +70.3 (c = 1.0, CHCl3, 98% ee);
 1
H 
NMR (400 MHz, CDCl3) H 1.58 (dt, J = 6.8, 0.8 Hz, 3H, 5-H); 1.97 (br s, 1H, OH); 2.43-
2.48 (m, 1H, 2-H); 2.51-2.57 (m, 1H, 2’-H); 4.67-4.71 (m, 1H, 1-H); 5.34-5.45 (m, 1H, 
CH=CH); 5.57-5.68 (m, 1H, CH=CH); 7.28-7.22 (m, 1H, 8-H); 7.37-7.30 (m, 4H, 6,7-H); 
13
C 
NMR (100 MHz, CDCl3) C 13.0 (CH3), 36.9 (CH2), 73.8 (CH-O), 125.6 (CH), 125.8 (CH), 
127.4 (CH), 127.7 (CH), 128.4 (CH), 144.1 (C); IR:  3368, 3025, 2918, 1603, 1493, 1453, 
1404, 1311, 1200, 1048, 912, 873, 758 cm
-1
; HRMS (ESI) 185.0939 (C11H14ONa [M+Na]
+
 
requires 185.0937); Chiral HPLC (Dynmax-60Å+Chiralpak IB-3 columns in series, hexane/2-
propanol = 98:2, 0.75 mL/min, UV detection at 225 nm) showed 98% ee (tR = 27.5 min 
(major), tS = 28.6 min (minor)).  
(R,1E,5Z)-()-1-phenylhepta-1,5-dien-3-ol (83ab). 
 
R-(+)-83ab was obtained as colorless oil (53 mg, 84 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.25; []D
25
 = +17.9 (c = 0.78, CHCl3, 83% ee ); 
1
H NMR (400 MHz, CDCl3):  
1.67 (dt, J = 6.8, 0.8 Hz, 3H, 7-H); 2.40-2.46 (m, 2H, 4-H); 4.32-4.37 (m, 1H, 3-H); 5.46-5.51 
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(m, 1H, CH=CH); 5.66-5.70 (m, 1H, CH=CH); 6.26 (dd, J = 16.0, 6.4 Hz, 1H, CH=CH); 6.61 
(d, J = 16.0 Hz, 1H, CH=CH); 7.24-7.30 (m, 1H, 10-H); 7.32 (t, J = 7.2 Hz, 2H, 9-H); 7.38-
7.40 (m, 2H, 8-H); 
13
C NMR (100 MHz, CDCl3):  13.1 (CH3), 35.0 (CH2), 72.3 (CH-O), 
125.2 (CH), 126.4 (CH), 127.6 (CH), 127.7 (CH), 128.5 (CH), 130.2 (CH), 131.7 (CH), 136.7 
(C); IR:  3375, 3024, 2926, 1656, 1599, 1494, 1449, 1031, 966, 916, 748 cm-1; HRMS (ESI) 
211.1093 (C13H16ONa [M+Na]
+
 requires 211.1093); chiral HPLC (ChiralPak IB-3 column, 
hexane/2-propanol = 98:2, 0.75 mL/min, UV detection at 225 nm) showed 97% ee (tR = 30.2 
min (major), tS = 62.6 min (minor)).  
(S,Z)-()-1-phenylhept-5-en-3-ol (83ac).  
 
S-(-)-83ac was obtained as colorless oil (52 mg, 81 % yield). TLC (8.5:1.5 LP:EA, UV, 
PMA): 0.25; []D
25
 =  17.7 (c = 0.61, CHCl3, 91% ee; literature gives
169,170
 []D
25
 =  21.2 (c 
= 1.0, CH2Cl2); []D
25
 =  12.2 (c = 1.0, CHCl3): 
1
H NMR (400 MHz, CDCl3):  1.75 (dt, J = 
6.8, 0.8 Hz, 3H, 7-H); 1.87-1.93 (m, 2H, 1-H); 2.34-2.39 (2, 2H, 2-H); 2.76-2.83 (m, 1H, 4-H); 
2.89-2.96 (m, 1H, 4’-H); 3.76-3.78 (m, 1H, 3-H); 5.50-5.57 (m, 1H, CH=CH); 5.73-5.81 (m, 
1H, CH=CH); 7.27-7.32 (m, 3H, 9,10-H); 7.36-7.41 (m, 2H, 8-H); 
13
C NMR (100 MHz, 
CDCl3):  13.0 (CH3), 32.1 (CH2), 35.0 (CH2), 38.4 (CH2), 70.7 (CH-O), 125.7 (CH), 125.8 
(CH), 127.5 (CH), 128.3 (CH), 128.4 (CH), 142.1 (C); IR:  3368, 3062, 3025, 2934, 2860, 
1603, 1496, 1454, 1404, 1048, 933, 862, 747 cm
-1
; chiral HPLC (ChiralPak IB-3, hexane/2-
propanol = 98:2, 0.75 mL/min, UV detection at 220 nm) showed 91% ee (tS = 18.3 min 
(major), tR = 29.4 min (minor)).  
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(R,Z)-()-1-(4-methoxyphenyl)pent-3-en-1-ol (83ad). 
 
R-(+)-83ad was obtained as colorless oil (45 mg, 70 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.28; []D
25
 = +52.2 (c = 0.72, CHCl3, 98% ee); 
1
H NMR (400 MHz, CDCl3):  
1.61 (dt, J = 6.8, 0.8 Hz, 3H, 5-H); 2.04 (br s, 1H, OH); 2.40-2.47 (m, 1H, 2-H); 2.53-2.61 (m, 
1H, 2’-H); 3.80 (s, 3H, 8-H); 4.64-4.67 (m, 1H, 1-H); 5.37-5.43 (m, 1H, CH=CH); 5.58-5.66 
(m, 1H, CH=CH); 6.88 (dt, J = 8.8, 2.8 Hz, 2H, 7-H); 7.29 (dt, J = 8.8, 2.8 Hz, 2H, 6-H); 
13
C 
NMR (100 MHz, CDCl3):  13.0 (CH3), 36.8 (CH2), 55.2 (CH3), 73.4 (CH-O), 113.7 (CH), 
125.8 (CH), 127.1 (CH), 127.4 (CH), 136.2 (C), 158.9 (C); IR:  3397, 3016, 2928, 2836, 
1612, 1512, 1460, 1247, 1174, 1036, 831 cm
-1
; HRMS (ESI) 215.1038 (C12H16O2Na [M+Na]
+
 
requires 215.1043); Chiral HPLC (ChiralPak IB-3 column, hexane/2-propanol = 98:2, 0.75 
mL/min, UV detection at 220 nm) showed 98% ee (tR = 24.4 min (major), tS = 26.9 min 
(minor)).  
(R,Z)-()-1-(4-fluorophenyl)pent-3-en-1-ol (83ae). 
 
R-(+)-83ae was obtained as colorless oil (48 mg, 80 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.28; []D
25
 = 35.2 (c = 1.34, CHCl3, 57% ee); 
1
H NMR (400 MHz, CDCl3):  
1.57 (dt, J = 6.8, 0.8 Hz, 3H, 5-H); 1.96 (d, J = 2.8 Hz, 1H, OH); 2.39-2.44 (m, 1H, 2-H); 2.49-
2.54 (m, 1H, 2’-H); 4.68 (ddd, J = 8.0, 5.2, 2.8 Hz, 1H, 1-H); 5.36-5.39 (m, 1H, CH=CH), 
5.61-5.65 (m, 1H, CH=CH); 7.00 (t, J = 8.4 Hz, 2H, 7-H), 7.31 (dd, J = 8.4, 5.2 Hz, 2H, 6-H); 
13
C NMR (100 MHz, CDCl3):  13.0 (CH3), 37.0 (CH2), 73.2 (CH-O), 115.1 (d, 
2
JC-F = 21 Hz, 
CH), 125.3 (CH), 127.4 (d, 
3
JC-F = 8 Hz, CH), 128.0 (CH), 139.7 (d, 
4
JC-F = 4 Hz, C), 162.1 (d, 
J = 244 Hz, C-F); IR:  3375, 3020, 2921, 1605, 1510, 1439, 1371, 1223, 1156, 1048, 968, 
874, 835 cm
-1
; HRMS (ESI) 163.0917 (C11H12F [M-OH]
+
 requires 163.0929); chiral HPLC 
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(two Chiralpak IB-3 columns in series, hexane/2-propanol = 98:2, 0.7 mL/min, UV detection at 
220 nm) showed 85% ee (tS = 32.8 min (minor), tR = 33.9 min (major)).  
(R,Z)- ()-1-(4-chlorophenyl)pent-3-en-1-ol (83af). 
 
R-(+)-83af was obtained as colorless oil (53 mg, 81 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.29; []D
25
 = +65.8 (c = 0.98, CHCl3, 98% ee); 
1
H NMR (400 MHz, CDCl3):  
1.59 (dt, J = 6.8, 0.8 Hz, 3H, 5-H); 2.02 (br s, 1H, OH); 2.40-2.47 (m, 1H, 2-H); 2.50-2.58 (m, 
1H, 2’-H); 4.70 (br t, J = 6.4 Hz, 1H,1-H); 5.36-5.43 (m, 1H, CH=CH); 5.62-5.69 (m, 1H, 
CH=CH); 7.29 - 7.32 (m, 4H, 6,7-H); 
13
C NMR (100 MHz, CDCl3):  13.0 (CH3), 37.0 
(CH2), 73.1 (CH-O), 125.1 (CH), 127.2 (CH) 128.1 (CH), 128.4 (CH), 133.1 (C), 142.5 (C); 
IR:  3366, 3020, 2920, 1491, 1406, 1091, 1049, 1013, 829, 784 cm-1; HRMS (ESI) 219.0547 
(C11H13ClONa [M+Na]
+
 requires 219.0567); Chiral HPLC (ChiralPak IB-3 column, hexane/2-
propanol = 98:2, 0.75 mL/min, UV detection at 220 nm) showed 98% ee (tS = 16.5 min 
(minor), tR = 17.2 min (major)). 
(R,Z)-()-1-(naphthalen-2-yl)pent-3-en-1-ol (83ag). 
 
R-(+)-83ag was obtained as colorless oil (56 mg, 78 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.28; []D
25
 = +61.6 (c = 0.73, CHCl3, 98% ee); 
1
H NMR (400 MHz, CDCl3):  
1.63 (d, J = 6.8 Hz, 3H, 5-H); 2.12 (d, J = 2.8 Hz, 1H, OH); 2.54-2.61 (m, 1H, 2-H); 2.63-2.71 
(m, 1H, 2’-H); 4.88-4.92 (m, 1H, 1-H); 5.42-5.49 (m, 1H, CH=CH); 5.62-5.70 (m, 1H, 
CH=CH); 7.46-7.52 (m, 3H, Ar-H); 7.82-7.85 (m, 4H, Ar-H); 
13
C NMR (100 MHz, CDCl3):  
13.0 (CH3), 36.8 (CH2), 73.9 (CH-O), 124.0 (CH), 124.5 (CH), 125.5 (CH), 125.7 (CH), 126.1 
(CH), 127.7 (CH), 127.8 (CH), 127.9 (CH), 128.2 (CH), 132.9 (C), 133.2 (C), 141.4 (C); IR:  
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3370, 3018, 2916, 1601, 1508, 1437, 1368, 1318, 1270, 1123, 896, 856, 819, 747 cm
-1
; HRMS 
(ESI) 235.1089 (C15H16ONa [M+Na]
+
 requires 235.1093); Chiral HPLC (Dynmax-
60Å+ChiralPak IB-3 columns in series, hexane/2-propanol = 98:2, 0.75 mL/min, UV detection 
at 220 nm) showed 98% ee (tS = 49.2 min (minor), tR = 53.2 min (major)). 
(R,Z)-()-1-(o-tolyl)pent-3-en-1-ol (83ah). 
 
R-(+)-83ah was obtained as colorless oil (44 mg, 75 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.28; []D
25
 = +80.3 (c = 1.2, CHCl3, 91% ee); 
1
H NMR (400 MHz, CDCl3):  
1.63 (dt, J = 6.8, 0.8 Hz, 3H, 5-H); 1.94 (d, J = 3.1 Hz, 1H, OH); 2.35 (s, 3H, 6-H); 2.46-2.53 
(m, 2H, 2-H); 4.96 (ddd, J = 8.0, 4.7, 3.0 Hz, 1H, 1-H); 5.47-5.50 (m, 1H, CH=CH); 5.65-5.69 
(m, 1H, CH=CH); 7.13-7.24 (m, 3H, Ar-H); 7.52 (dd, J = 7.7, 1.0 Hz, 1H, Ar-H); 
13
C NMR 
(100 MHz, CDCl3):  13.0 (CH3), 19.1 (CH3), 35.7 (CH2), 70.2 (CH-O) 125.2 (CH), 125.9 
(CH), 126.2 (CH), 127.2 (CH), 127.6 (CH), 130.3 (CH), 134.4 (CH), 142.2 (CH); IR:  3367, 
3021, 2922, 1656, 1605, 1488, 1461, 1404, 1309, 1286, 1179, 1046, 874, 757, 726, 702 cm
-1
; 
HRMS (ESI) 177.1273 (C12H17O [M+H]
+
 requires 177.1274); Chiral HPLC (Dynmax-
60Å+Chiralpak IB-3 columns in series, hexane/2-propanol = 98:2, 0.75 mL/min, UV detection 
at 220 nm) showed 91% ee (tS = 24.9 min (minor), tR = 26.2 min (major)).
(R,Z)-()-1-(thiophen-2-yl)pent-3-en-1-ol (83ai). 
 
R-(+)-83ai was obtained as colorless oil (44 mg, 78 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.26; []D
25
 = +40.3 (c = 1.3, CHCl3, 99% ee); 
1
H NMR (400 MHz, CDCl3):  
1.65 (dt, J = 6.8, 0.8 Hz, 3H, 5-H); 2.12 (d, J = 4.0 Hz, 1H, OH); 2.53-2.75 (m, 2H, 2-H); 4.96-
5.00 (m, 1H, 1-H); 5.39-5.49 (m, 1H, CH=CH); 5.61-5.73 (m, 1H, CH=CH); 6.96-7.00 (m, 2H, 
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6,7-H); 7.21-7.29 (m, 1H, 8-H); 
13
C NMR (100 MHz, CDCl3):  13.1 (CH3), 36.9 (CH2), 69.8 
(CH-O), 123.7 (CH), 124.5 (CH), 125.1 (CH), 126.6 (CH), 128.0 (CH), 148.0 (C); IR:  3374, 
3018, 2921, 1995, 1656, 1439, 1404, 1314, 1229, 1035, 851 cm
-1
; HRMS (ESI) 191.0501 
(C9H12OSNa [M+Na]
+
 requires 191.0501); Chiral HPLC (two ChiralPak IB-3 columns in 
series, hexane/2-propanol = 98:2, 0.75 mL/min, UV detection at 220 nm) showed 99% ee (tS = 
40.6 min (minor), tR = 41.7 min (major)). 
(R,Z)-()-1-(4-(trifluoromethyl)phenyl)pent-3-en-1-ol (83aj). 
 
R-(+)-83aj was obtained as colorless oil (62 mg, 80 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.29; []D
25
 = +56.7 (c = 1.0, CHCl3, 96% ee); 
1
H NMR (400 MHz, CDCl3):  
1.57 (dt, J = 6.8, 0.8 Hz, 3H, 5-H); 2.08 (d, J = 2.8 Hz, 1H, OH); 2.41-2.56 (m, 2H, 2-H); 4.74-
4.78 (m, 1H, 1-H); 5.34-5.41 (m, 1H, CH=CH); 5.62-5.68 (m, 1H, CH=CH); 7.46 (d, J = 8.0 
Hz, 2H); 7.58 (d, J = 8.0 Hz, 2H); 
13
C NMR (100 MHz, CDCl3):  12.3 (CH3), 37.0 (CH2), 
73.1 (CH-O), 125.3 (CH), 125.3 (CH), 126.1 (CH), 128.5 (CH), 147.9 (C); IR:  3367, 3022, 
2923, 1922, 1657, 1620, 1418, 1327, 1165, 1126, 1016, 875. 842, 704, 608 cm
-1
; HRMS (ESI) 
336.9953 (C12H13F3OAg [M+Ag]
+ 
requires 336.9964); Chiral HPLC (ChiralpaK IC-3 column, 
hexane/2-propanol = 98:2, 0.75 mL/min, UV detection at 220 nm) showed 96% ee (tR = 9.6 
min (major), tS = 10.6 min (minor)). 
(S,Z)-()-1-cyclohexylpent-3-en-1-ol (83ak). 
 
S-(+)-83aj was obtained as colorless oil (41 mg, 72 % yield). TLC (8.5:1.5 LP:EA, 
PMA): 0.28; []D
25
 = +11.1 (c = 0.94, CHCl3, 87% ee; literature gives []D
25
 = 2.5, c = 1.0, 
CH2Cl2 for R isomer); 
1
H NMR (400 MHz, CDCl3):  1.03-1.09 (m, 2H); 1.15-1.25 (m, 3H); 
1.36-1.37 (m, 1H); 1.63-1.65 (m, 6H), 1.74-1.77 (m, 2H); 1.84-1.89 (m, 1H); 2.21-2.24 (m, 2H, 
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2-H); 3.37 (q, J = 6.0 Hz, 1H, 1-H); 5.41-5.48 (m, 1H, CH=CH); 5.61-5.69 (m, 1H, CH=CH); 
13
C NMR (100 MHz, CDCl3):  13.0 (CH3), 26.1 (CH2), 26.3 (CH2), 26.5 (CH2), 28.1 (CH2), 
29.2 (CH2), 31.8 (CH2), 43.1 (CH), 75.5 (CH-O) 126.6 (CH) 127.3 (CH); IR:  3389, 2924, 
2852, 1449, 1038 cm
-1
; HRMS (ESI) 275.0552 (C11H20OAg [M+Ag]
+
 requires 275.0560); 
19
F 
NMR of the corresponding Mosher ester showed 87% ee (δS = 90.83 ppm and δR = 90.98 
ppm). 
(R,Z)-()-1-phenylhept-3-en-1-ol (83da). 
 
R-(+)-83da was obtained as colorless oil (51 mg, 90 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.28; []D
25
 = +40.5 (c = 0.84, CHCl3, 94% ee); 
1
H NMR (400 MHz, CDCl3):  
0.88 (t, J = 7.2 Hz, 3H, 7-H); 1.31-1.37 (m, 2H, 6-H); 1.98-2.05 (m, 3H, 5-H, OH); 2.45-2.51 
(m, 1H, 2-H); 2.53-2.61 (m, 1H, 2’-H); 4.68-4.72 (m, 1H, 1-H); 5.37-5.44 (m, 1H, CH=CH); 
5.53-5.60 (m, 1H, CH=CH); 7.28-7.30 (m, 1H, 10-H); 7.33-7.38 (m, 4H, 8,9-H); 
13
C NMR 
(100 MHz, CDCl3):  13.7 (CH3), 22.6 (CH2), 29.4 (CH2), 37.3 (CH2), 73.8 (CH-O), 124.7 
(CH), 125.8 (CH), 127.4 (CH), 128.3 (CH), 133.6 (CH) 144.0 (C); IR:  3365, 3063, 3012, 
2958, 2929, 2871, 1493, 1453, 1404, 1377, 1310, 1200, 1049, 910, 876, 758, 700 cm
-1
; HRMS 
(ESI) 297.0394 (C14H21O2Ag [M+Ag]
+
 requires 297.0403); Chiral HPLC (Chiralpak IB-3 
column, hexane/2-propanol = 98:2, 0.75 mL/min, UV detection at 220 nm) showed 94% ee (tR 
= 14.8 min (major), tS = 16.7 min (minor)).  
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(R,1E,5Z)-()-1-phenylnona-1,5-dien-3-ol (83db). 
 
R-(+)-83db was obtained as colorless oil (64 mg, 97 % yield). TLC (8.5:1.5 LP:EA, 
UV, PMA): 0.28; []D
25
 = +18.0 (c = 1.6, CHCl3, 94% ee); 
1
H NMR (400 MHz, CDCl3):  
0.83 (t, J = 7.2 Hz, 3H, 9-H); 1.32 (sex, J = 7.2 Hz, 2H, 8-H); 1.98 (q, J = 7.2 Hz, 2H, 7-H); 
2.29-2.39 (m, 2H, 4-H); 4.25 (q, J = 6.4 Hz, 1H, 3-H); 5.34-5.41 (m, 1H, CH=CH); 5.48-5.55 
(m, 1H, CH=CH); 6.18 (dd, J = 15.6, 6.4 Hz, 1H, 2-H); 6.53 (d, J = 15.6 Hz, 1H, 1-H); 7.24 (t, 
J = 7.2, 1H, 12-H); 7.32 (t, J = 7.2 Hz, 2H, 11-H); 7.39 (d, J = 7.2 Hz, 2H, 10-H); 
13
C NMR 
(100 MHz, CDCl3):  13.7 (CH3), 22.7 (CH2), 29.4 (CH2), 35.4 (CH2), 72.3 (CH-O), 125.4 
(CH),  126.4 (CH), 127.5 (CH), 128.5 (CH), 130.2 (CH), 131.7 (CH), 133.5 (CH), 136.6 (C); 
IR:  3350, 3060, 3024, 2958, 2870, 1599, 1494, 1449, 1377, 1263, 1129, 1091, 1070, 1029, 
966, 873, 748, 692 cm
-1
; HRMS (ESI) 323.0550 (C15H20OAg [M+Ag]
+
 requires 323.0560); 
Chiral HPLC (Chiralpak IB-3 column, hexane/2-propanol = 98:2, 0.75 mL/min, UV detection 
at 220 nm) showed 94% ee (tR = 24.2 min (major), tS = 45.1 min (minor)). 
(S,Z)-()-1-phenylnon-5-en-3-ol (83dc). 
 
S-(-)-83dc was obtained as colorless oil (52 mg, 80 % yield). TLC (8.5:1.5 LP:EA, UV, 
PMA): 0.28; []D
25
 = 5.8 (c = 1.1, CHCl3, 84% ee); 
1
H NMR (400 MHz, CDCl3):  0.91 (t, J 
= 7.6 Hz, 3H, 9-H); 1.39 (sex, J = 7.6, 2H, 8-H); 1.63 (s, 1H, OH); 1.77-1.83 (m, 2H, 7-H); 
2.02-2.07 (m, 2H, 1-H); 2.24-2.28 (m, 2H, 2-H); 2.65-2.73 (m, 1H, 4-H); 2.78-2.86 (m, 1H, 4’-
H); 3.62-3.68 (m, 1H, 3-H); 5.38-5.44 (m, 1H, CH=CH); 5.55-5.62 (m, 1H, CH=CH); 7.17-
7.23 (m, 3H, 11,12-H); 7.27-7.31 (m, 2H, 10-H); 
13
C NMR (100 MHz, CDCl3):  13.8 (CH3), 
22.8 (CH2), 29.4 (CH2), 32.1 (CH2), 35.4 (CH2), 38.4 (CH2), 70.7 (CH-O), 124.9 (CH), 125.7 
(CH), 128.3 (CH), 128.4 (CH), 133.5 (CH), 142.1 (C); IR:  3362, 3062, 3025, 2929, 2867, 
145 
 
1603, 1496, 1454, 1403, 1377, 1052, 927, 872, 746, 699 cm
-1
; HRMS (ESI) 325.076 
(C11H13OAg [M+Ag]
+
 requires 325.0716); Chiral HPLC (Chiralpak IB-3 column, hexane/2-
propanol = 98:2, 0.75 mL/min, UV detection at 220 nm) showed 84% ee (tR = 15.7 min 
(major), tS = 24.6 min (minor)). 
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4.4. Synthesis of bis-N-oxide 165 
()-Bis-N-oxide 165 
 
To a solution of freshly distilled diisopropylamine (84.6 L, 0.6 mmol, 1.2 eq.) in THF 
(10 mL), 1.6M nBuLi in hexanes (0.312 mL, 0.5 mmol, 1 eq.) was added dropwise under inert 
atmosphere at 0 C and the reaction was stirred for 1 hour. Isoquinoline-N-oxide 168 (200 mg, 
0.5 mmol, 1 eq.) in THF (5 mL) was added dropwise at 0 C, the solution gradually turned 
purple. The mixture was stirred for further 30 minutes after which time inert atmosphere was 
replaced by O2 atmosphere. The solution was let to stir for 3 hours while turning dark brown in 
colour. The reaction was quenched with saturated solution of NaHCO3 (20 mL) and extracted 
with DCM (335 mL). The organic layers were combined, dried over Na2SO4 and concentrated 
under reduced pressure. Purification by column chromatography on silica using gradient eluent 
up to 20:80 petroleum ether/ethyl acetate afforded in order of elution the target compound ()-
165 (63 mg, 30%, or 60% yield based on recovered starting material) and the starting 
isoquinoline–N-oxide 168 (95 mg, 47%). 1H NMR (400 MHz, CDCl3): δH 0.85 (s, 3H); 1.2 (s, 
1H); 1.34 (s, 3H); 2.32-2.38 (m, 2H); 2.62-2.67 (m, 1H); 3.08 (m, 2H); 7.33 (s, 1H); 7.89 (s, 
1H); 8.38 (s, 2H); 
13
C NMR (100 MHz, CDCl3): δC 21.2 (CH3), 25.9 (CH3), 30.5 (CH2), 32.3 
(CH2), 39.4 (C), 39.8 (CH), 44.2 (CH), 122.7 (CH), 123.2 (q, 
2
JC-F = 271 Hz, C), 126.3 (CH), 
129.7 (CH), 131.4 (q 
3
JC-F = 132 z, C), 133.6 (C), 135.2 (C), 139.3 (C), 143.2 (C), 146.3 (C);
 
19
F NMR (377 MHz, CDCl3) F 99.2; IR:  3386, 2956, 2927, 2873, 1622, 1459, 1427, 1397, 
1366, 1341, 1279, 1256, 1179, 1135, 1009, 992, 900, 880, 845, 703, 681 cm
-1
; HRMS (ESI) 
801.2342 (C40H33N2O2F12 [MH]
 
requires 801.2356). []D
25
 = 51.2 (c = 0.26, CHCl3). 
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4.5. Synthesis of (–)-Elisabethadione. 
1,2,4-Trimethoxy-3-methylbenzene (158) 
 
2.5 M n-BuLi in hexane (23 mL, 57 mmol, 1.2 eq.) was added to a solution of 1,2,4-
trimethoxybenzene (9 mL, 47.4 mmol, 1 eq.) in freshly distilled THF (35 mL) at 0 °C. The 
reaction was stirred at room temperature for 1 h before being cooled to 78 °C. Then, MeI (4 
mL, 64 mmol, 1.3 eq.) was added and the reaction stirred for a further 1 h. The reaction was 
quenched with saturated NH4Cl (15 mL) and extracted with ether (3 x 40 mL). The organic 
layers were combined, dried over Na2SO4 and concentrated in vacuo. Purification by column 
chromatography on silica (eluting with 4% ethyl acetate in petroleum ether) gave the title 
compound 158 as a yellow oil (8.5 g, 99 %); 
1
H NMR (400 MHz, CDCl3): δH 2.15 (s, 3H, 3-
H), 3.78 (s, 3H), 3.79 (s, 3H), 3.82 (s, 3H), 6.53 (d, J = 8.8 Hz, 1H, 1-H), 6.69 (d, J = 8.8 Hz, 
1H, 2-H); 
13
C NMR (100 MHz, CDCl3): δC 8.9 (CH3), 55.9 (CH3), 56.2 (CH3), 60.3 (CH3), 
105.2 (C), 109.3 (CH), 121.2 (C), 147.2 (C), 148.1 (C), 152.5 (C); IR (neat) 2938.9, 1489.0, 
1257.4, 1115.2, 717.6 cm
-1
; HRMS (ESI) 205.0833 (C10H14O3Na [M+Na]
+
 requires 
205.0835).   
1-Bromo-2,4,5-trimethoxy-3-methylbenzene (159) 
 
To a solution of 158 (8.5 g, 46.9 mmol, 1 eq.) in acetonitrile (110 mL) N-
bromosuccinimide (10.8 g, 60.8 mmol, 1.3 eq.) was added and the reaction mixture was stirred 
at room temperature for 1 h before being concentrated in vacuo. The solution was diluted with 
water (50 mL) and extracted with CH2Cl2 (3 x 75mL). The combined organic layers were, 
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dried over Na2SO4 and concentrated in vacuo. Purification by column chromatography on 
silica (eluting with 4% ethyl acetate in petroleum ether) gave the title compound 159 as a 
yellow oil (10.9 g, 89 %); 
1
H NMR (400 MHz, CDCl3): δH 2.24 (s, 3H, 2-H), 3.74 (s, 3H), 
3.77 (s, 3H), 3.81 (s, 3H), 6.92 (s, 1H, 1-H); 
13
C NMR (100 MHz, CDCl3): δC 10.1 (CH3), 56.1 
(CH3), 60.2 (CH3), 60.4 (CH3), 110.7 (C), 113.4 (CH), 127.1 (C), 147.2 (C), 149.3 (C), 149.7 
(C); IR (neat) 2936.8, 1481.3, 1237.6, 1089.2, 1007.9, 778.1 cm
-1
; HRMS (ESI) 282.9936, 
and 284.9916 (C10H13O3
79
BrNa and C10H13O3
81
BrNa [M+Na]
+
 require 282.9940 and 
285.9920).  
2,4,5-Trimethoxy-3-methylbenzaldehyde (160)  
 
2.5 M n-BuLi in hexane (25 mL, 62.8 mmol,1.5 eq.) was added to a solution of 159 (10.9 
g, 41.8 mmol, 1 eq.) in freshly distilled THF (60 mL) at 78 °C. The mixture was stirred at 78 
°C for 30 min before DMF (6.5 mL, 83.6 mmol, 2 eq.) was added. The reaction was stirred for 
a further 10 min and then warmed to 0 °C for 1 h. The reaction was diluted with water and 
extracted with ethyl acetate. The organic layers were combined, dried over Na2SO4 and 
concentrated in vacuo. Purification by column chromatography on silica (eluting with 4% ethyl 
acetate in petroleum ether) gave the title compound 160 a pale yellow solid (4.6 g, 52 %); 
1
H 
NMR (400 MHz, CDCl3): δH 2.23 (s, 3H, 3-H), 3.84 (s, 3H), 3.87 (s, 3H), 3.89 (s, 3H), 7.23 (s, 
1H, 2-H), 10.31 (s, 1H, 1-H),; 
13
C NMR (100 MHz, CDCl3): δC 8.7 (CH3), 55.4 (CH3), 59.9 
(CH3), 63.2 (CH3), 106.7 (CH), 124.2 (C), 125.7 (C), 149.3 (C), 153.5 (C), 157.0 (C), 188.6 
(C); IR (neat) 2940.2, 1682.3, 1481.9, 1389.8, 1087.8  cm
-1
; HRMS (ESI) 233.0784 
(C11H14O4Na [M+Na]
+
 requires 233.0784).  
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(E)-Methyl 2-methyl-3-(2,4,5-trimethoxy-3-methylphenyl)acrylate (161) 
 
 (Carbethoxyethylidene)triphenylphosphorane (10.3 g, 28.6 mmol, 1.5 eq.) was added 
to a solution of 160 (4.0 g, 19.1 mmol, 1 eq.) in water (17 mL) and the solution was heated to 
90 °C for 2 days. Then the reaction was cooled, poured onto saturated NaHCO3 (50 mL) and 
extracted with CH2Cl2 (3 x 100 mL). The combined organic layers were dried over Na2SO4 and 
concentrated in vacuo to give the title compound 161 as a light yellow oil (3.0 g, 54 %). 
1
H 
NMR (400 MHz, CDCl3): δH 1.29 (t, J = 7.2 Hz, 3H, 4-H), 1.98 (s, 3H, 5-H), 2.17 (s, 3H, 6-H), 
3.58 (s, 3H), 3.77 (s, 6H), 4.20 (q, J = 14.0, 7.2 Hz, 2H, 3-H), 6.64 (s, 1H, 1-H), 7.72 (s, 1H, 2-
H); 13C NMR (100 MHz, CDCl3): δC 9.4 (CH3), 14.3 (CH3), 14.3 (CH3), 56.0 (CH2), 60.3 
(CH3), 60.7 (CH3), 61.3 (CH3), 110.8, 124.3 (C), 125.7 (C), 128.5 (C), 134.8, 148.7 (C), 151.7 
(C), 168.6 (C); IR (neat) 2935.4, 1706.7, 1484.8, 1251.6, 1089.5, 754.4 cm
-1
; HRMS (ESI) 
317.1359 (C16H22O5Na [M+Na]
+
 requires 317.1356). 
(E)-2-Methyl-3-(2,4,5-trimethoxy-3-methylphenyl)acrylaldehyde (162) 
 
Reduction-oxidation protocol: 
1M DIBAL in hexane (30.6 mL, 30.6 mmol, 3 eq.) was added dropwise to a solution of 
161 (3.0 g, 10.2 mmol, 1 eq.) in freshly distilled DCM (150 mL) and 4Å molecular sieves at –
78 °C. The solution was allowed to warm to room temperature and stirred overnight. The 
reaction was carefully quenched with MeOH (10 mL), 5M HCl (15 mL) and extracted with 
DCM (2 x 100 mL). The combined organic layers were dried over Na2SO4 and concentrated in 
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vacuo to give the title compound as light yellow oil which was used in the next step without 
purification. 
MnO2 (3.1 g, 35.8 mmol) was added to a solution of the above crude product in DCM 
(250 mL) and stirred at room temperature for 24 h. The reaction was filtered through a pad of 
celite and concentrated in vacuo. Purification by column chromatography on silica (eluting 
with 10% ethyl acetate in petroleum ether) gave the title compound 162 as a dim-yellow solid 
(2.23 g, 87 % over two steps). 
Aldol condensation protocol: 
Aldehyde 160 (100 mg, 0.47 mmol, 1 eq.) was dissolved in MeOH (1 mL). A 2M 
solution of NaOH (0.47 mL, 0.94 mmol, 2 eq.) was added to the solution. Propanal (84.7 L, 
1.2 mmol, 2.5 eq.) in MeOH (1 mL) was added dropwise to the mixture at room temperature. 
The reaction was allowed to stir at 50 C for 5 h before being quenched with NH4Cl. The 
mixture was washed with NH4Cl until neutral pH and extracted with DCM (3  20 mL). The 
combined organic layers were dried over Na2SO4 and concentrated in vacuo to yield the 
corresponding cinnamaldehyde 162 (76 mg, 65% yield). Mp = 77.9-85.2 °C; 
1
H NMR (400 
MHz, CDCl3): δH 2.05 (s, 3H, 4-H), 2.22 (s, 3H, 5-H), 3.67 (s, 3H), 3.84 (s, 6H), 6.90 (s, 1H, 
1-H), 7.51 (s, 1H, 2-H), 9.60 (s, 1H, 3-H); 
13
C NMR (125 MHz, CDCl3): δC 9.4 (CH3), 11.1 
(CH3), 56.0 (CH3), 60.4 (CH3), 61.7 (CH3), 110.6 (CH), 123.5 (C), 126.0 (C), 137.8 (C), 145.1 
(CH), 148.9 (C), 149.7 (C), 152.3 (C), 195.6 (CH); IR (neat) 2934.9, 1662.0, 1614.7, 1455.6, 
1235.4, 1084.5, 999.0, 835.8 cm
-1
; HRMS (ESI) 273.1097 (C14H18O4Na [M+Na]
+ 
requires 
273.1093).  
()-(3S,4R,E)-2,4-Dimethyl-1-(2,4,5-trimethoxy-3-methylphenyl)hexa-1,5-dien-3-ol (167) 
 
A 100 mL round bottom flask fitted with a magnetic stirring bar was flame-dried under 
vacuo, evacuated and backfilled with N2. The flask was charged with dry propionitrile (25 mL) 
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and successively with a solution of bis-N-oxide 165 (80.4 mg, 0.1 mmol, 2 mol%), aldehyde 
162 (1.12 g, 4.48 mmol, 1 eq.) and  Hünig's base (1.5 mL, 8.9 mmol, 2 eq.) in 1 mL of dry 
propionitrile each. The mixture was cooled to –60 C using a cryocooler and a solution of Z-
crotyltrichlorosilane 164 (1.4 g, 7.3 mmol, 1.7 eq.) in 1 mL of dried propionitrile was added 
dropwise. The reaction mixture was stirred at this temperature for 2 days. Then, it was 
quenched with a saturated solution of NaHCO3 (10 mL), washed with 20 mL of NaHCO3 and 
extracted with DCM (3 x 60 mL). The combined organic layers were dried over Na2SO4 and 
the solvent was removed in vacuo. Flash chromatography on silica with a gradient eluent 
system (100% hexane to 95:5, hexane/ethyl acetate) afforded the target homoallylic alcohol 
()-167 as colorless oil (1.3 g, 82 % yield). 1H NMR (400 MHz, CDCl3): δH 1.12 (d, J = 6.4 
Hz, 3H, 7-H), 1.80 (s, 3H, 8-H), 2.20 (s, 3H, 9-H), 2.52 (quint, J = 7.2 Hz, 1H, 4-H), 3.61 (s, 
3H), 3.80 (s, 3H), 3.81 (s, 3H), 4.03 (d, J = 6.8 Hz, 1H, 3-H), 5.03 (dm, J = 10.4 Hz, 2H, 6-cis-
H), 5.10 (dt, J = 17.2, 1.6 Hz, 1H, 6-trans-H), 5.81 (m, 1H, 5-H), 6.53 (s, 1H, 1-H), 6.62 (s, 1H, 
2-H); 
13
C NMR (100 MHz, CDCl3): δC 9.3 (CH3), 13.9 (CH3), 15.0 (CH3), 41.5 (CH), 56.0 
(CH3), 60.1 (CH3), 60.7 (CH3), 81.0 (CH), 111.2 (CH), 114.4 (CH2), 122.5 (CH), 125.3 (C), 
125.9 (C), 139.1 (C), 140.9 (CH), 146.8 (C), 148.5 (C), 150.7 (C); IR (neat) 3447.4, 2959.5, 
1484.9, 1228.2, 1088.8, 1011.8 cm
-1
; HRMS (ESI) 329.1723 (C18H26O4Na [M+Na]
+
 requires 
329.1715). Chiral HPLC (Chiralpak IA-3, hexane/2-propanol = 95:5, 1 mL/min, UV detection 
at 225 nm) showed 94% ee (tR = 12.28 min (minor), tS = 18.14 min (major)). []D
25
 = 108.17 
(c = 0.83, CHCl3, 84% ee). 
(2R,3R,E)-2-Methyl-3-(2,4,5-trimethoxy-3-methylphenyl)hept-5-enal (170) 
 
A 30 % suspension of KH in mineral oil (1.9 g, 48.4 mmol, 15 eq.) was washed with 
anhydrous DME (3 x 5 mL). Anhydrous DME (10 mL) was added to the KH. Alcohol ()-167 
(990 mg, 3.23 mmol, 1 eq.) and 18-crown-6 (853 mg, 3.23 mmol, 1 eq.) were successively 
added to the solution, which was then heated for 5 h at 40 °C. The solution was cooled to 78 
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°C and quenched with MeOH (4 mL). The mixture was poured into a saturated solution of 
NH4Cl (20 mL) and extracted with DCM (3 x 50 mL). The combined organic layers were dried 
over Na2SO4 and concentrated in vacuo. Compound 170 (d.r. 3:1 at C-11) was obtained as 
yellow oil and was used immediately in the next step. Major isomer (taken as a mixture): 
1
H 
NMR (400 MHz, CDCl3): δH 1.08 (d, J = 7.2Hz, 3H, 5-H); 1.56 (d, J = 7.6Hz, 3H, 1-H); 2.02 
(s, 3H, 6-H); 2.34-2.37 (m, 3H, 3,11-H); 3.41-3.48 (m, 1H, 4-H); 3.67 (s, 3H); 3.78 (s, 3H); 
3.80 (s, 3H); 5.21-5.29 (m, 1H, 2-H); 5.39-5.48 (m, 1H, 1-H); 6.52 (s, 1H, 7-H); 9.56 (d, J = 
2Hz, 1H, 4-H). Minor isomer (taken as a mixture): 
1
H NMR (400 MHz, CDCl3): δH 0.85 (d, J 
= 6.8Hz, 3H, 5-H); 1.57 (d, J = 5.2Hz, 3H, 1-H); 2.02 (s, 3H, 6-H); 2.53-2.61 (m, 3H, 3,11-H); 
3.41-3.48 (m, 1H, 4-H); 3.67 (s, 3H); 3.79 (s, 3H); 3.81 (s, 3H); 5.21-5.29 (m, 1H, 2-H); 5.39-
5.48 (m, 1H, 1-H); 6.47 (s, 1H, 7-H); 9.87 (d, J = 3.2Hz, 1H, 4-H). 
(2E,4S,5R,7E)-Ethyl 4-methyl-5-(2,4,5-trimethoxy-3-methylphenyl)nona-2,7-dienoate (171) 
 
LiCl (260 mg, 6 mmol, 1.2 eq.) was weighted in a 50 mL flame-dried round bottom 
flask. The flask was evacuated and backfilled with N2. Dry CH3CN (15 mL) was added 
followed by a solution of Hünig's base (1.1 mL, 6 mmol, 1.2 eq.) and triethyl 
phosphonoacetate (1.2 mL, 6 mmol, 1.2 eq.) in 2 mL of dry CH3CN each. After stirring the 
mixture for 5 min, the crude product from the previous step (170, ~3.23 mmol, 1 eq.) in 2 mL 
of anhydrous CH3CN was added dropwise. The reaction mixture was stirred overnight. Then, 
the mixture was quenched with a saturated solution of NH4Cl (20 mL) and extracted with 
DCM (3 x 50 mL). The combined organic phases were dried over Na2SO4 and the solvent 
removed under reduced pressure. The crude mixture was purified by flash column 
chromatography on silica eluting with a gradient system (100% petroleum ether up to 5:1 
petroleum ether and ethyl acetate) to yield the target compound 171 (a 3:1 mixture of isomers 
at C11) as a colorless oil (812 mg, 84% yield over two steps). Major isomer (taken as a 
mixture): 
1
H NMR (400 MHz, CDCl3): H 0.98 (d, J = 6.8Hz, 3H, 8-H); 1.25 (t, J = 6.8Hz, 3H, 
7-H); 1.57 (dd, J = 6.4, 1.2Hz, 3H, 1-H); 2.20 (s, 3H, 9-H); 2.30-2.43 (m, 2H, 3-H); 2.60-2.65 
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(m, 1H, 11-H); 3.14-3.19 (m, 1H, 4-H); 3.61 (s, 3H); 3.78 (s, 3H); 3.79 (s, 3H); 4.15 (qd, J = 
6.8, 2 Hz, 2H, 6-H); 5.24-5.35 (m, 1H, 2-H); 5.39-5.46 (m, 1H, 1-H); 5.70 (dd, J = 15.6, 1.2 
Hz, 1H, 5-H); 6.42 (s, 1H, 10-H); 6.91 (dd, J = 16, 7.6 Hz, 1H, 4-H). 
13
C NMR (100 MHz, 
CDCl3): C 9.8 (CH3), 14.2 (CH3), 16.6 (CH3), 17.9 (CH3), 35.4 (CH2), 40.5 (CH), 42.4 (CH), 
55.8 (CH3), 60.1 (CH3), 60.2 (CH2), 60.9 (CH3), 109.1 (CH), 120.6 (CH), 124.9 (C), 126.9 
(CH), 129.2 (CH), 129.7 (C), 146.0 (C), 148.7 (C), 151.0 (C), 152.7 (CH), 166.7 (C). IR (neat) 
2935.8, 1722.6, 1487.4, 1236.1, 1087.2 cm
-1
. Minor isomer (taken as a mixture): 
1
H NMR 
(400 MHz, CDCl3): H 0.86 (d, J = 6.4 Hz, 3H, 8-H); 1.30 (t, J = 7.2 Hz, 3H, 7-H); 1.52 (dd, J 
= 6, 1.2 Hz, 3H, 1-H); 2.21 (s, 3H, 9-H); 2.30-2.43 (m, 2H, 3,11-H); 2.96-3.02 (m, 1H, 4-H); 
3.61 (s, 3H); 3.79 (s, 3H); 3.81 (s, 3H); 4.20 (q, J = 7.2 Hz, 2H, 6-H); 5.12-5.20 (m, 1H, 2-H); 
5.24-5.35 (m, 1H, 1-H); 5.83 (d, J = 16 Hz, 1H, 5-H); 6.47 (s, 1H, 10-H); 6.96 (m, 1H, 4-H). 
13
C NMR (100 MHz, CDCl3): C 9.9 (CH3), 14.3 (CH3), 16.6 (CH3), 17.8 (CH3), 36.6 (CH2), 
40.5 (CH), 42.8 (CH), 56.0 (CH3), 60.1 (CH3), 60.2 (CH2), 60.9 (CH3), 108.1 (CH), 121.0 
(CH), 124.9 (C), 126.6 (CH), 129.1 (CH), 130.8 (C), 146.0 (C), 149.2 (C), 151.2 (C), 153.5 
(CH), 166.7 (C). IR (neat) 2935.8, 1722.6, 1487.4, 1236.1, 1087.2 cm
-1
. 
(S,E)-Ethyl-4-((1R,4S)-5,6,8-trimethoxy-4,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-
yl)pent-2-enoate (172) 
 
Methanesulphonic acid (0.42 mL, 6.48 mmol, 3 eq.) was added to a solution of 171 
(812 mg, 2.16 mmol, 1 eq.) in CHCl3 (15 mL) and the reaction stirred at 40 °C for 7 hours. The 
reaction was quenched with saturated NaHCO3 (5 mL) and extracted with CH2Cl2 (3 x 20 mL).  
The combined organic layers were dried over Na2SO4 and concentrated in vacuo. Filtration of 
the crude reaction mixture through a pad of silica gel gave the title compound 172 (ca. 2.7:1 
mixture of isomers at C11 epimer) as a light yellow oil (683.2 mg, 84 % yield). The compound 
was used in the next step without further purification. Major isomer (taken as a mixture): 
1
H 
NMR (400 MHz, CDCl3): H 0.92 (d, J = 6.8 Hz, 3H, 8-H); 1.12 (d, J = 6.8 Hz, 3H, 1-H); 1.27 
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(t, J = 7.2 Hz, 3H, 7-H); 1.46-1.56 (m, 2H, 2/3-H); 1.69-1.82 (m, 2H, 2/3-H); 2.14 (s, 3H, 9-H); 
2.92-2.96 (m, 1H, 11-H); 3.02 (tbr, J = 4.8 Hz, 1H, 4-H); 3.11-3.17 (m, 1H, 1-H); 3.65 (s, 3H); 
3.78 (s, 3H); 3.84 (s, 3H); 4.15 (q, J = 7.2 Hz, 2H, 6-H); 5.63 (dd, J = 15.6, 1.2 Hz, 1H, 5-H); 
7.07 (dd, J = 15.6, 6.8 Hz, 1H, 4-H). Minor isomer (taken as a mixture): 
1
H NMR (400 MHz, 
CDCl3): H 0.88 (d, J = 6.8 Hz, 3H, 8-H); 1.11 (d, J = 6.4 Hz, 3H, 1-H); 1.23 (t, J = 7.2 Hz, 
3H, 7-H); 1.46-1.56 (m, 2H, 2/3-H); 1.69-1.82 (m, 2H, 2/3-H); 2.17 (s, 3H, 9-H); 2.83-2.85 (m, 
1H, 11-H); 2.92-2.96 (m, 1H, 4-H); 3.11-3.17 (m, 1H, 1-H); 3.66 (s, 3H); 3.80 (s, 3H); 3.82 (s, 
3H); 4.11-4.15 (m, 2H, 6-H); 5.54 (dd, J = 16, 1.6 Hz, 1H, 5-H); 6.84 (dd, J = 15.6, 7.2 Hz, 
1H, 4-H). 
(S)-Ethyl-4-((1R,4S)-5,6,8-trimethoxy-4,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-
yl)pentanoate (173) 
 
A solution of 172 (683.2 mg, 1.81 mmol, 1 eq.) in MeOH (15 mL) was circulated for 3 
hours through an H-Cube (set at 2.0 mL/min, Full hydrogen mode, r.t.) equipped with a 
cartridge containing catalyst Pd/C 10%.  The resulting solution was concentrated in vacuo to 
give product 173 as a colourless oil (622.3 mg, 91 %), which was used in the next step without 
further purification.  
(S)-4-((1R,4S)-5,6,8-trimethoxy-4,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)pentan-1-ol 
(95) 
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DIBAL, 1M in hexanes (3.2 mL, 3.2 mmol, 2 eq.), was added to a solution of 173 
(622.5 mg, 1.6 mmol, 1 eq.) in anhydrous CH2Cl2 (5 mL) at 78 °C. The resulting solution was 
allowed to warm to room temperature and stirred overnight. The reaction mixture was 
quenched with MeOH (5 mL), 5M HCl (5 mL) and extracted with CH2Cl2 (3x15 mL). The 
organic layers were combined, dried over Na2SO4 and concentrated in vacuo. Purification by 
column chromatography on silica eluting with 7:3 petroleum ether/ethyl acetate gave the title 
compound 95 as colourless oil in a 2.7:1 mixture of diastereoisomers (500 mg, 93%). The 
diastereoisomers were separated by preparative HPLC (Dynmax-60Å, hexane/2-propanol = 
98:2, 5 mL/min, UV detection at 220 nm). Trans,syn-95a: 
1
H NMR (400 MHz, CDCl3): δH 
0.73 (d, J = 7.2 Hz, 3H, 7-H) , 1.13 (d, J = 7.2 Hz, 3H, 1-H), 1.31-1.38 (m, 2H), 1.44-1.47 (m, 
1H, 2-H), 1.51-1.68 (m, 3H), 1.78-1.80 (m, 2H, 3-H), 1.91-2.03 (m, 2H, 2,11-H), 2.17 (s, 3H, 
8-H), 2.83-2.86 (m, 1H, 4-H), 3.15 (quint, J = 6.8 Hz, 1H, 1-H), 3.63 (m, 5H, 6,CH3O-H), 3.80 
(s, 3H), 3.84 (s, 3H); 
13
C NMR (125 MHz, CDCl3): δC 9.4 (CH3), 18.1 (CH3), 18.6 (CH2), 23.2 
(CH3), 26.4, 27.0, 30.6, 31.2 (CH2), 35.4 (CH), 37.4 (CH), 59.9 (CH3), 60.2 (CH3), 60.5 (CH3), 
63.4 (CH2), 76.7, 122.2 (C), 128.6 (C), 134.8 (C), 147.1 (C), 152.8 (C),; IR (neat) 3370.9, 
2930.5, 1457.9, 1403.5, 1069.0 cm
-1
; HRMS (ESI) 359.2189 (C20H32O4 [M+Na]
+
 requires 
359.2193). []D
25
 = –7.05 (c = 2, CHCl3; []D
25
 = 6.4 (c = 1.4, CHCl3)145). Trans,anti-95b: 
1
H NMR (400 MHz, CDCl3): δH 0.78 (d, J = 6.8 Hz, 3H, 7-H), 1.14 (d, J = 6.8 Hz, 3H, 1-H), 
1.31-1.38 (m, 3H), 1.44-1.60 (m, 3H), 1.75-1.94 (m, 4H), 2.10 (s, 3H, 8-H), 2.76-2.80 (m, 1H, 
4-H), 3.12 (quint, J = 6.8 Hz, 1H, 1-H), 3.50-3.54 (m, 2H, 6-H), 3.62 (s, 3H), 3.79 (s, 3H),3.82 
(s, 3H); 
13
C NMR (125 MHz, CDCl3): δC 9.5 (CH3), 18.5 (CH3), 20.2 (CH2), 23.1 (CH3), 26.4 
(CH2), 27.2 (CH), 31.1 (CH2), 31.3 (CH2), 37.2 (CH), 37.9 (CH2), 59.9 (CH3), 60.1 (CH3), 60.5 
(CH3), 63.3 (CH2), 122.1 (C), 128.4 (C), 134.5 (C), 147.2 (C), 149.5 (C), 153.0 (C); IR (neat) 
3370.9, 2930.5, 1457.9, 1403.5, 1069.0 cm
-1
. HRMS (ESI) 359.2189 (C20H32O4 [M+Na]
+
 
requires 359.2193). 
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()-4-((1R,4S)-5,6,8-trimethoxy-1,4,7-trimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)pentane 
(174) 
 
Dess-Martin periodinane (396 mg, 0.935 mmol, 1.5 eq.) was weighted in a 25 mL 
flame-dried round bottom flask. The vessel was evacuated and backfilled with N2 before being 
charged with alcohol trans,syn-95 (205.3 mg, 0.61 mmol, 1 eq.) in 6 mL of DCM. The reaction 
was allowed to stir at room temperature for 2 hours. The crude mixture was filtrated through a 
pad of silica and the crude trans,syn-174 was subjected to the next step without further 
purification (151.1 mg, 74% yield). 
()-(1R,4S)-5,6,8-trimethoxy-1,4,7-trimethyl-1-(6-methylhept-5-en-2-yl)-1,2,3,4-
tetrahydronaphthalene (96a) 
 
n-BuLi, 2M solution in hexane (2.00 mL, 4.0 mmol), was added dropwise to a solution 
of isopropyltriphenylphosphonium iodide (1.85 g, 4.3 mmol) in anhydrous THF (15 mL) at 0 
°C under N2. The mixture was stirred for 1 hour before trans,syn-174 (1.3 mmol) in THF (15 
mL) was added. The solution was allowed to stir at the same temperature for 30 minutes before 
warming to room temperature and heating at reflux for a further 2 hrs. After cooling, the 
reaction mixture was quenched with saturated NH4Cl (10 mL) and extracted with ether (3x50 
mL). The organic layer was washed with brine (20 mL), dried (MgSO4) and concentrated in 
vacuo. Purification by column chromatography on silica gel (eluting with 2 % ethyl acetate in 
petroleum ether) gave the title compound as a colourless oil ()-96 (72 mg, 60 % yield over to 
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steps); 
1
H NMR (400 MHz, CDCl3): δH 0.72 (d, J = 7.2 Hz, 3H, 4-H); 1.15 (d, J = 6.8 Hz, 3H, 
1-H); 1.26-1.35 (m, 2H); 1.45 (dm, J = 13.2 Hz, 1H); 1.60 (s, 3H, 8/9-H); 1.69 (s, 3H, 8/9-H); 
1.78-1.81 (m, 2H); 1.94-2.08 (m, 4H); 2.18 (s, 3H, 10-H); 2.88 (m, 1H, 1/4-H); 3.16 (quint, J = 
6 Hz, 1H, 1/4-H); 3.65 (s, 3H); 3.81 (s, 3H); 3.85 (s, 3H); 5.14 (tt, J = 6.8, 1.6 Hz, 1H, 7-H); 
13
C NMR (125 MHz, CDCl3): δC 9.4 (CH3), 17.6 (CH3), 18.2 (CH3), 18.5 (CH2), 23.1 (CH3), 
25.7 (CH3), 26.4 (CH2), 26.6 (CH2), 27.0 (CH), 35.6 (CH), 35.7 (CH2), 37.5 (CH), 59.8 (CH3), 
60.1 (CH3), 60.4 (CH3), 122.2 (C), 125.2 (CH), 128.6 (C), 136.8 (C), 134.8 (C), 146.9 (C), 
149.4 (C),152.9 (C); IR (neat) 2930.5, 2867.6, 1460.7, 1406.4, 1074.7 cm
-1
; HRMS (ESI) 
383.2549 (C23H36O3 [M+Na]
+ 
requires 383.2557). []D
25
 = 9.65 (c = 0.58, CHCl3; []D
25
 = 
6.4 (c = 1.0, CHCl3)145) 
()-(5R,8S)-4-methoxy-3,8-dimethyl-5-((S)-6-methylhept-5-en-2-yl)-5,6,7,8-
tetrahydronaphthalene-1,2-diol (97) 
 
To a solution of ethanethiol (2.2 mL, 29.4 mmol, 145 eq.) in anhydrous hexane (15 mL) 
at 0 °C under N2 was added n-BuLi 2M in hexane (4.6 mL, 7.3 mmol, 36 eq.) and the reaction 
stirred at room temperature for 30 minutes. The mixture was concentrated in vacuo to give a 
white powder. The white powder and ()-tran,syn-96 (72 mg, 0.2 mmol, 1 eq.) were dissolved 
in anhydrous DMF (13 mL) and the reaction was refluxed for 3 hrs. After cooling the reaction 
was acidified with 5 % HCl and extracted with ether (3x20 mL). The organic layer were 
combined, dried over Na2SO4 and concentrated in vacuo. The crude mixture was filtrated 
through a short pad of silica and used in the next step without further purification. 
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()-(5S,8R)-4-methoxy-3,8-dimethyl-5-((R)-6-methylhept-5-en-2-yl)-5,6,7,8-
tetrahydronaphthalene-1,2-dione (175) 
 
A solution of cerium ammonium nitrate (237 mg, 0.43 mmol, 3 eq.) in water (5 mL) 
was added to a solution of diol ()-trans,syn-97 (48 mg, 0.14 mmol, 1 eq.) in MeCN (5 mL) at 
0 °C. The reaction was stirred for 20 minutes before water (10 mL) was added. The mixture 
was extracted with DCM (3x20 mL). The organic layers were combined, dried over Na2SO4 
and concentrated in vacuo. Purification by column chromatography on silica gel (eluting with 
10 % ethyl acetate/petroleum ether) gave the title compound as an orange-red oil ()-trans,syn-
175 (33 mg, 50% yield over two steps). 
1
H NMR (400 MHz, CDCl3): δH 0.84 (d, J = 7.2 Hz, 
3H, 4-H); 1.07 (d, J = 7.2 Hz, 3H, 1-H); 1.22-1.43 (m, 6H); 1.61 (s, 3H); 1.67-1.81 (m, 5H); 
1.96 (s, 3H, 10-H); 1.96-2.04 (m, 1H); 2.64 (m, 1H, 1/4-H); 2.88 (quint, J = 6.4 Hz, 1H, 1/4-
H); 3.91 (s, 3H, OCH3); 5.10 (t, J = 7.6 Hz, 1H, 7-H); 
13
C NMR (100 MHz, CDCl3): δC 9.7 
(CH3), 17.4 (CH3), 17.7 (CH3), 18.5 (CH2), 21.3 (CH3), 25.7 (CH3), 25.8 (CH2), 26.2 (CH2), 
26.3 (CH), 35.6 (CH2), 36.4 (CH), 37.2 (CH), 61.2 (CH3), 119.6 (C), 124.4 (CH), 131.6 (C), 
140.3 (C), 150.6 (C), 167.7 (C), 179.4 (C), 181.1 (C); IR (neat) 2963.1, 1656.8, 1454.1, 
1575.3, 1377.4, 1235.7 cm
-1
; HRMS (ESI) 353.2087 (C21H30O3 [M+Na]
+ 
requires 353.1714). 
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(–)-(5R,8S)-2-hydroxy-3,8-dimethyl-5-(6-methylhept-5-en-2-yl)-5,6,7,8-
tetrahydronaphthalene-1,4-dione. (–)-Elisabethadione (85) 
 
4-Methylbenzenesulphonic acid (38 mg, 0.2 mmol, 2 eq.) was added to a solution of 
()-trans,syn-175 (33 mg, 0.1 mmol, 1 eq.) in anhydrous benzene (8 mL) at rt. The reaction 
was stirred for 2 hours before being diluted with ether (20 mL). The solution was washed with 
water (15 mL) and extracted with ether (320 mL). The organic layers were combined, dried 
over Na2SO4 and concentrated in vacuo. Purification by column chromatography on silica gel 
(eluting with 1 % ethyl acetate in hexane) gave the target (–)-elisabethadione as a yellow oil 
(22 mg, 70% yield).
 1
H NMR (400 MHz, CDCl3): δH 0.83 (d, J = 6.8 Hz, 3H, 4-H); 1.12 (d, J 
= 7.2 Hz, 3H, 1-H); 1.23-1.33 (m, 3H); 1.44-1.48 (m, 1H); 1.60 (s, 3H, 8/9-H); 1.68 (s, 3H, 
8/9-H); 1.75-1.86 (m, 3H); 1.93 (s, 3H, 10-H); 1.97-2.04 (m, 2H); 2.88 (m, 1H, 1/4-H); 2.94 
(m, 1H, 1/4-H); 5.12 (t, J = 6.4 Hz, 1H, 7-H); 6.97 (s, 1H, OH). 
13
C NMR (100 MHz, CDCl3): 
δC 8.2 (CH3), 17.6 (CH3), 17.7 (CH3), 18.1 (CH2), 20.8 (CH3), 25.7 (CH), 26.0 (CH2), 26.1 
(CH), 26.3 (CH2), 35.7 (CH), 36.0 (CH2), 36.9 (CH3), 116.8 (C), 124.5 (CH), 131.3 (C), 143.1 
(C), 148.2 (C), 150.6 (C), 182.9 (C), 187.9 (C); IR (neat) 3391.5, 2933.4, 1638.4, 1336.2, 
1234.6, 1155.1 cm
-1
; HRMS (ESI) 316.1986 (C20H28O3 [M]
+ 
requires  316.2033). []D
25
 = 
267 (c = 0.16, CHCl3; []D
25
 = +278, c = 0.58, CHCl3
145
). 
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4.6.  Synthesis of (–)-Erogorgiane 
(2-bromo-3-methylphenyl)Methanol (176) 
 
2-Bromo-3-methyl benzoic acid (3.55 g, 15.5 mmol, 1 eq.) was placed in a 500 mL 
RBF fitted with a stirring bar, evacuated and backfilled with N2. DCM (200 mL) was added 
into the vessel and the solution was cooled at 78 C. DIBAL-H, 1M in hexanes, (58.9 mL, 
58.9 mmol, 3.8 eq.) was added dropwise via syringe pump. The reaction was stirred for two 
further hours while allowed to warm at room temperature. The reaction was quenched with 
MeOH (10 mL) and HCl 5M (10 mL), washed with water and extracted with DCM (2x80 mL). 
The compound 176 was obtained as a white solid (2.65 g, 85% yield). 
1
H NMR (400 MHz, 
CDCl3): δH 2.78 (sbroad, 1H, OH); 2.46 (s, 3H, 2-H); 4.78 (s, 2H, 1-H); 7.21-7.34 (m, 3H, 3/4/5-
H). 
13
C NMR (100 MHz, CDCl3): δC 23.3 (CH3), 65.6 (CH2), 125.1 (C), 126.7 (CH), 127.1 
(CH), 129.9 (CH), 138.4 (C), 140.0 (C).IR: 3304, 2918, 1644, 1452, 1435, 1409, 1352, 
1376, 1242, 1167, 1069, 1056, 1027, 1003, 988, 900, 769 cm
-1
, HRMS (ESI) 310.8851 
(C8H9O
81
Br
109
Ag [M+Ag]
+
 requires 310.8858). 
2-Bromo-3-methylbenzaldehyde (177) 
 
MnO2 (11.4 g, 132 mmol, 10 eq.) was added to a solution of compound 176 (2.65 g, 
13.2 mmol, 1 eq.) in DCM (50 mL) and stirred at room temperature for three days. The 
reaction was filtered through a pad of Celite and concentrated in vacuo. Purification by column 
chromatography on silica gel (eluting with 85:15 petroleum ether/ethyl acetate) gave the title 
compound 177 as a white solid  (2.1 g, 80%); Mp = 77.9-85.2 C; 1H NMR (400 MHz, 
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CDCl3): δH 2.47 (s, 3H, 2-H); 7.31 (t, J = 7.6 Hz, 1H, 4-H); 7.46 (ddd, J = 7.6, 2, 0.8 Hz, 1H, 
5-H); 7.73 (dm, J = 7.6 Hz, 1H, 3-H); 10.44 (d, J = 0.8 Hz, 1H, 1-H). 
13
C NMR (100 MHz, 
CDCl3): δC22.8 (CH3), 127.3 (CH), 127.4 (CH), 129.6 (C), 133.9 (C), 136.2 (CH), 139.6 (C), 
192.7 (CH).IR:  3065, 2950, 2922, 2868, 2735, 1952, 1889, 1721, 1697, 1678, 1573, 1452, 
1416, 1374, 1265, 1241, 1168, 1105, 1031, 1006, 912, 781, 701 cm
-1
. 
(E)-Ethyl-3-(2-bromo-3-methylphenyl)-2-methylacrylate (178) 
  
(Carbethoxyethylidene)triphenylphosphorane (5.73 g, 15.8 mmol, 1.5 eq.) was added to a 
solution of benzaldehyde 177 (2.10 g, 10.55 mmol, 1 eq.) in water (10 mL) and the solution 
heated to 90 C for two days. The reaction was cooled and poured onto saturated NaHCO3 (50 
mL) and extracted with CH2Cl2 (2x70 mL). The organic layer was dried over Na2SO4 and 
concentrated in vacuo. Purification by column chromatography on silica gel (eluting with 10 % 
ethyl acetate/petroleum ether) gave the target compound 178 as colorless oil (2.29 g, 76 %); 
1
H 
NMR (400 MHz, CDCl3): δH 1.36 (t, J = 7.2 Hz, 3H, 3-H); 1.95 (d, J = 1.2 Hz, 3H, 4-H); 2.43 
(s, 3H, 5-H); 4.29 (q, J = 7.2 Hz, 2H, 2-H); 7.09 (dd, J = 6.8, 2.4 Hz, 1H, 8-H); 7.19-7.21 (m, 
2H, 7/6-H); 7.73 (d, J = 1.2 Hz, 1H, 1-H);13C NMR (100 MHz, CDCl3): δC 13.8 (CH3), 14.2 
(CH3), 23.5 (CH3), 60.8 (CH2), 126.4 (C), 126.5 (CH), 129.7 (C), 130.2 (CH), 136.8 (C), 138.7 
(C), 138.9 (CH), 168.1 (C);IR:  3427, 3068, 3048, 2980, 2958, 2927, 2905, 1711, 1640, 
1586, 1572, 1464, 1446, 1400, 1366, 1346, 1273, 1232, 1171, 1115, 1028, 935, 870, 800, 771, 
746, 729cm-1, HRMS (ESI) 305.0147 and 307.0126 (C13H15O2
79
BrNa and C13H15O2
81
BrNa 
[M+Na]
+
 requires 305.0148 and 307.0127). 
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(E)-3-(2-bromo-3-methylphenyl)-2-methylacrylaldehyde (179) 
 
Reduction-oxidation protocol: 
DIBAL-H 1M in hexane (28.3 mL, 28.3 mmol, 3.5 eq.) was added to a solution of 178 
(2.3 g, 8.1 mmol) in anhydrous CH2Cl2 (100 mL) with 4Å molecular sieves at 78 °C. The 
solution was allowed to warm to room temperature and stirred overnight. The reaction was 
quenched with MeOH (15 mL) followed by dropwise addition of 5M HCl (25 mL) and 
extracted with CH2Cl2 (2x75 mL). The organic layers were combined and dried over Na2SO4 
and concentrated in vacuo. The crude mixture was used in the next step without further 
purification.  
MnO2 (2.2 g, 25 mmol, 3 eq.) was added to a solution of the previous crude in CH2Cl2 
(100 mL) and stirred at room temperature for three days. The reaction was filtered through a 
pad of Celite and concentrated in vacuo. Purification by flash column chromatography on silica 
gel (eluting with 10 % ethyl acetate/petroleum ether) gave the title compound 179 as yellow oil 
(1.59 g, 82% over two steps). 
Direct aldol condendensation: 
To a solution of aldehyde 177 (100 mg, 0.5 mmol, 1 eq.) and propanal (54 L, 0.75 
mmol, 1.5 eq.) in MeOH (2 mL), a 2M solution of NaOH (0.25 mL, 0.5 mmol, 1 eq.) was 
added dropwise at room temperature. The reaction was allowed to stir at 50 C overnight 
before being quenched with NH4Cl. The mixture was washed with NH4Cl until neutral pH and 
extracted with DCM (3  20 mL). The combined organic layers were dried over Na2SO4 and 
concentrated in vacuo to yield the corresponding cinnamaldehyde 179 (72 mg, 60% yield). 
1
H 
NMR (400 MHz, CDCl3): δH 1.92 (s, 3H, 3-H); 2.47 (s, 3H, 4-H); 7.20-7.22 (m, 1H, 5/6/7-H); 
7.25-7.27 (m, 2H, 5/6/7-H); 7.50 (s, 1H, 1-H); 9.69 (s, 1H, 2-H)13C NMR (100 MHz, CDCl3): 
δC 10.7 (CH3), 23.6 (CH3), 126.6 (C), 126.7 (CH), 127.8 (CH), 131.2 (CH), 135.5 (C), 139.1 
(C), 139.5 (C), 149.1 (CH), 195.3 (CH);IR: 3049, 2954, 2922, 2819, 2710, 1686, 1629, 
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1572, 1445, 14411, 1385, 1355, 1264, 1186, 1027, 1005, 935, 866, 834, 789, 771, 723, 681 cm
-
1
;HRMS (ESI) 239.0054 and 241.0034 (C11H11
79
BrO and C11H11
81
BrO [M+H]
+
 requires 
239.0066 and 241.0046). 
()-(3S,4R,E)-1-(2-bromo-3-methylphenyl)-2,4-dimethlhexa-1,5-dien-3-ol (180) 
 
A 100mL round bottom flask fitted with a magnetic stirring bar was flame-dried, 
evacuated and backfilled with N2. The flask was charged with 30 mL of dry propionitrile and 
successively with a solution of bis-N-oxide ()-165 (80.4 mg, 0.1 mmol, 2 mol%), aldehyde 
179 (1.25 g, 5.2 mmol, 1 eq.) and  Hünig's base (1.8 mL, 10.3 mmol, 2 eq.) in 1 mL of dry 
propionitrile each. The solution was cooled at 60 C and a solution of Z-crotyltrichlorosilane 
164 (1.7 g, 8.9 mmol, 1.7 eq.) in 1 mL of dry propionitrile was added dropwise to the reaction 
mixture. The reaction was stirred at this temperature for two days.  After that time, the reaction 
mixture was quenched with a saturated solution of NaHCO3 (10 mL), washed with 20 mL of 
NaHCO3 and extracted with DCM (3 x 60 mL). Combined organic layers were dried over 
Na2SO4 and solvent was removed in vacuo. Flash chromatography on silica with a gradient 
eluent system (100% hexane to 95:5, hexane/ethyl acetate) afforded the target homoallylic 
alcohol ()-180 as a colourless oil (1.10 g, 72 % yield). 1H NMR (400 MHz, CDCl3): δH 1.13 
(d,J = 6.8 Hz, 3H, 6-H); 1.70 (s, 3H, 7-H); 1.73 (sbroad, 1H, OH); 2.43 (s, 3H, 8-H); 2.53 (q, J = 
6.8 Hz, 1H, 3-H); 4.08 (d, J = 6.4 Hz, 1H, 2-H); 5.06-5.15 (m, 2H, 5-H); 5.83-5.91 (m, 1H, 4-
H); 6.53 (s, 1H, 1-H); 7.04-7.06 (m, 1H, HAr); 7.11-7.17 (m, 2H, HAr); 
13
C NMR (100 MHz, 
CDCl3): δC 13.9 (CH3), 14.4 (CH3), 23.7 (CH3), 41.4 (CH), 80.0 (CH), 114.7 (CH2), 126.3 
(CH), 126.7 (C), 127.1 (CH), 128.2 (CH), 128.9 (CH), 138.3 (C), 138.3 (C), 139.5 (C), 140.9 
(CH); IR:  3412, 3069, 2975, 2923, 2870, 1640, 1586, 1463, 1449, 1401, 1379, 1228, 1107, 
1024, 913, 791, 767, 725 cm
-1
; HRMS (ESI) 400.9666 and 402.9651 (C15H19
79
BrO and 
C15H19
81
BrO [M+Ag]
+
 requires 400.9665 and 402.9644).; Chiral HPLC (Chiralpak IA-3, 
hexane/2-propanol = 98:2, 0.75 mL/min, UV detection at 225 nm) showed 98% ee (tR = 19.3 
min (major), tS = 20.8 min (minor)). []D
25
 = 27 (c = 6.5, CHCl3).  
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(3R,E)-3-(2-bromo-3-methylphenyl)-2,3-dimethylhept-5-enal (181) 
 
A 30 % suspension of KH in mineral oil (2.2 g, 55.5 mmol, 15 eq.) was washed with 
anhydrous DME (3 x 10 mL). Anhydrous DME (45 mL) was added to the KH. Alcohol 180 
(1.10 g, 3.7 mmol, 1 eq.) and 18-crown-6 (0.97 g, 3.7 mmol, 1 eq.) were successively added to 
the solution and the mixture was stirred for two days at room temperature. The solution was 
cooled to 78 °C and quenched with a 1M solution of 2,4,6-tri-tert-butylphenol in dry DME 
(7eq). The solution was poured into a saturated solution of NH4Cl (50 mL) and extracted with 
DCM (3 x 50 mL). The combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. Compound 181 (d.r. 2:1 at C-11) was obtained as a yellow oil and was used in the next 
step without purification. 
(2E,5R,7E)-ethyl 5-(2-bromo-3-methylphenyl)-4,5-dimethylnona-2,7-dienoate (183) 
 
LiCl (186.5 mg, 4.44 mmol, 1.2 eq.) was weighted in a 50 mL flame-dried round 
bottom flask. The flask was evacuated and backfilled with N2. Dried CH3CN (10 mL) was 
added followed by a solution of Hünig's base (0.8 mL, 4.44 mmol, 1.2 eq.) and triethyl 
phosphonoacetate (0.9 mL, 4.44 mmol, 1.2 eq.) in 2 mL of dry CH3CN each. After stirring the 
mixture for 5 minutes, the crude aldehyde 181 (3.7 mmol, 1 eq.) in 2 mL of anhydrous CH3CN 
was added dropwise. The reaction was stirred overnight at room temperature before quenching 
with a saturated solution of NH4Cl (20 mL). The mixture was extracted with DCM (3x50 mL), 
the organic phases dried over Na2SO4 and the solvents removed under reduced pressure. The 
crude mixture was purified by flash column chromatography on silica eluting with a gradient 
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system (100% petroleum ether to 5:1 petroleum ether/ethyl acetate) to yield the target 
compound 183 (d.r. 2:1) as a colorless oil (1.1 g, 81% yield over two steps). Major isomer 
(taken as a mixture): 
1
H NMR (400 MHz, CDCl3): δH 1.01 (d, J = 6.8Hz, 3H, 1-H); 1.27 (t, J = 
6.8 Hz, 3H, 7-H); 1.53 (d, 6.4Hz, 3H, 8-H); 2.37-3.33 (m, 2H, 3-H); 2.43 (s, 3H, 9-H); 2.68-
2.71 (m, 1H, 4/11-H); 3.49-3.53 (m, 1H, 4/11-H); 4.14-4.23 (m, 2H, 6-H); 5.11-5.41 (m, 2H, 
1/2-H); 5.74 (d, J = 15.6Hz, 1H, 5-H); 6.92-7.01 (m, 2H, Ar/4-H); 7.06-7.17 (m, 2H, Ar/4-H). 
Minor isomer (taken as a mixture): 
1
H NMR (400 MHz, CDCl3): δH 0.91 (d, J = 6.4Hz, 3H, 
1-H); 1.31 (t, J = 7.2 Hz, 3H, 7-H); 1.49 (d, J = 6.4Hz, 3H, 8-H); 2.37-3.33 (m, 2H, 3-H); 2.44 
(s, 3H, 9-H); 2.49-2.53 (m, 1H, 4/11-H); 3.38-3.41 (m, 1H, 4/11-H); 4.14-4.23 (m, 2H, 6-H); 
5.11-5.41 (m, 2H, 1/2-H); 5.82 (d, J = 14.8Hz, 1H, 5-H); 6.92-7.01 (m, 2H, Ar/4-H); 7.06-7.17 
(m, 2H, Ar/4-H). 
(E)-ethyl-4-((1R,4S)-8-bromo-1,4,7-trimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)pent-2-
enoate (184) 
 
Methanesulfonic acid (0.37 mL, 5.7 mmol, 3 eq.) was added to a solution of 183 (693 
mg, 1.9 mmol, 1 eq.) in CHCl3 (3 mL) and the reaction mixture was stirred at 40 °C for two 
days. The reaction was quenched with saturated NaHCO3 (5 mL) and extracted with CH2Cl2 (3 
x 20 mL).  The combined organic layers were dried over Na2SO4 and concentrated in vacuo. 
Purification by column chromatography on silica (eluting with 95:5 petroleum ether/ethyl 
acetate) gave the title compound 184 as a pale yellow oil (570 mg, 83% yield); Major isomer 
(taken as a mixture): 
1
H NMR (400 MHz, CDCl3): δH 0.89 (d, J = 6.8Hz, 3H, 8-H); 1.21-1.31 
(m, 6H, 7,1-H); 1.74-1.95 (m, 4H, 2,3-H); 2.38 (s, 3H, 9-H); 2.74-2.79 (m, 1H, 11-H); 3.04-
3.09 (m, 1H, 4-H); 3.49-3.53 (m, 1H, 1-H); 4.12-4.4.21 (m, 2H, 6-H); 5.74 (dd, J = 16, 1.6Hz, 
1H, 5-H); 7.06-7.12 (m, 3H, 4,Ar-H); 
13
C NMR (100 MHz, CDCl3): δC 14.2 (CH3), 14.2 
(CH3), 16.9 (CH3), 21.5 (CH2), 22.3 (CH), 24.2 (CH3), 29.2 (CH2), 32.2 (CH), 39.6 (CH), 41.7 
(CH), 60.1 (CH2), 120.0 (CH), 125.4 (CH), 128.2 (CH), 136.1 (C), 137.8 (C), 143.4 (C), 153.3 
(CH), 166.8 (C). Minor isomer (taken as a mixture): 
1
H NMR (400 MHz, CDCl3): δH 0.90 (d, 
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J = 6.8Hz, 3H, 8-H); 1.15 (d, J = 7.2Hz, 3H, 1-H); 1.21-1.31 (m, 3H, 7-H); 1.74-1.95 (m, 4H, 
2,3-H); 2.41 (s, 3H, 9-H); 2.74-2.79 (m, 1H, 11-H); 2.97-3.00 (m, 1H, 4-H); 3.40-3.44 (m,1H, 
1-H); 4.12-4.21 (m, 2H, 6-H); 5.64 (dd, J = 15.6, 1.6Hz, 1H, 5-H), 6.79 (dd, J = 15.6, 6.4Hz, 
1H, 4-H); 7.06-7.07 (m, 2H, Ar-H); 
13
C NMR (100 MHz, CDCl3): δC 14.2 (CH3), 14.3 (CH3), 
16.9 (CH3), 21.1 (CH2), 22.6 (CH), 24.2 (CH3), 28.5 (CH2), 31.8 (CH), 40.0 (CH), 42.7 (CH), 
60.0 (CH2), 120.0 (CH), 125.7 (CH), 128.4 (CH), 136.0 (C), 138.1 (C), 143.1 (C), 152.6 (CH), 
166.6 (C). 
Ethyl 4-((1R,4S)-8-bromo-1,4,7-trimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)pentanoate 
(185) 
 
A solution of compound 184 (557 mg, 1.52 mmol, 1 eq.) in MeOH (35 mL) was 
circulated for three hours through an H-Cube in-flow reactor (set at 2.0 mL/min, Full hydrogen 
mode, rt) equipped with a cartridge containing catalyst Pd/C 10%.  The resulting solution was 
concentrated in vacuo to give crude 185 as a colourless oil (407 mg, 72 %), which was 
subjected to the next step without further purification. 
4-((1R,4S)-8-bromo-1,4,7-trimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)pentan-1-ol (186) 
 
DIBAL, 1M in hexanes (2.2 mL, 2.2 mmol), was added to a solution of 185 (370 mg, 1 
mmol) in anhydrous CH2Cl2 (20 mL) at 78 °C. The solution was allowed to warm to room 
temperature and stirred overnight. The reaction was quenched with MeOH (10 mL), 5M HCl 
(15 mL) and extracted with CH2Cl2 (3x30 mL). The organic layer were combined, dried over 
Na2SO4 and concentrated in vacuo. The crude reaction mixture was filtered through a pad of 
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silica and after removal of solvent in vacuo gave 186 as colourless oil. The material was 
subjected to the next step without further purification. 
()-4-((1R,4S)-1,4,7-trimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)pentan-1-ol (187) 
 
A solution of compound 186 (336 mg, 1.03 mmol, 1 eq.) in MeOH (15 mL) was 
circulated for 5 hrs through an H-Cube flow reactor (2.0 mL/min, 20 bar, 40 C) equipped with 
a cartridge containing catalyst Pd/C 10%.  The reaction solution was concentrated in vacuo to 
give product 187 (d.r. 2:1) as a colourless oil (234 mg, 92 %). The diastereomers were 
separated by preparative HPLC (Dynmax-60Å, hexane/2-propanol = 98:2, 5 mL/min, UV 
detection at 220 nm). ()-Trans,syn-187a, major isomer: 1H NMR (400 MHz, CDCl3): δH 0.65 
(d, J = 5.2Hz, 3H, 4-H); 1.26 (d, J = 5.6Hz, 3H, 1-H); 1.31-1.38 (m, 3H); 1.61-1.70 (m, 3H); 
1.78-1.84 (m, 1H); 1.90-1.95 (m, 1H); 2.13-2.16 (m, 1H, 11-H); 2.30 (s, 3H, 9-H); 2.71-2.75 
(m, 1H, 4-H); 2.87-2.91 (m, 1H, 1-H); 3.70 (t, J = 5.2Hz, 2H, 7-H); 6.95 (d, J = 6.4Hz, 1H, 10-
H); 7.03 (s, 1H, 8-H); 7.14 (d, J = 6Hz, 1H, 11-H) ; 
13
C NMR (100 MHz, CDCl3): δC 14.5 
(CH3), 21.1 (CH3), 21.5 (CH2), 21.8 (CH3), 31.1 (CH2), 31.6 (CH2), 32.8 (CH), 37.1 (CH), 41.6 
(CH), 63.4 (CH2), 126.0 (CH), 126.4 (CH), 128.0 (CH), 134.7 (C), 139.6 (C), 140.3 (C); IR 
(neat) 3343, 2928, 2869, 1497, 1455, 1376, 1058, 812 cm
-1
; HRMS (ESI) 353.1037 
(C17H26O
107
Ag [M]
+
 required 353.1029). []D
25
 = 54.5 (c = 1.02, CHCl3; []D
25
 = 36.5, c = 
0.81, CHCl3
111
). ()-Trans,anti-187b, minor isomer: 1H NMR (400 MHz, CDCl3): δH 1.03 (d, 
J = 6.8Hz, 3H, 4-H); 1.28 (d, J = 6.8Hz, 3H, 1-H); 1.33-1.39 (m, 2H); 1.47 (sbroad, 1H, OH); 
1.55-1.60 (m, 3H); 1.89-1.94 (m, 2H); 2.08-2.13 (m, 1H, 11-H); 2.32 (s, 3H, 9-H); 2.75-2.81 
(m, 2H, 1,4-H); 3.48-3.56 (m, 2H, 7-H); 6.96 (d, J = 8Hz, 1H, 10-H); 7.04 (s, 1H, 8-H); 7.15 
(d, J = 8Hz, 1H, 11-H); 
13
C NMR (100 MHz, CDCl3): δC 140.3 (C), 139.6 (C), 134.6 (C), 
128.2 (CH), 126.8 (CH), 126.2 (CH), 63.1 (CH2), 43.7 (CH), 36.9 (CH), 32.7 (CH), 31.2 
(CH2), 31.1 (CH2), 27.3 (CH2), 22.2 (CH2), 22.1 (CH3), 21.1 (CH3), 18.2 (CH3); IR (neat) 
3343, 2928, 2869, 1497, 1455, 1376, 1058, 812 cm
-1
; HRMS (ESI) 353.1037 (C17H26O
107
Ag 
[M]
+
 required 353.1029). []D
25
 = 32.9 (c = 0.413, CHCl3). 
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()-4-((1R,4S)-1,4,7-trimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)pentanal (188a) 
 
Dess-Martin periodinane (1.5 eq.) was weighted in a 25 mL flame-dried round bottom 
flask. The vessel was evacuated and backfilled with N2 before being charged with alcohol 
trans,syn-187a (1 eq.) in 5 mL of DCM. The reaction was allowed to stir at room temperature 
for 2 hours. The solvent was partially removed in vacuum and the crude mixture was directly 
purified on a silica gel column chromatography (95:5, petroleum ether: ethyl acetate). 
Trans,syn-188a, pale yellow oil (85.6 mg, 84% yield). 
1
H NMR (400 MHz, CDCl3): δH 0.67 
(d, J = 6.8 Hz, 3H, 4-H); 1.27 (d, J = 6.8 Hz, 3H, 1-H); 1.28-1.37 (m, 1H); 1.57-1.83 (m, 4H); 
1.90-1.95 (m, 1H); 2.11-2.14 (m, 1H); 2.29 (s, 3H, 9-H); 2.49-2.55 (m, 2H); 2.70-2.76 (m, 1H); 
2.84-2.89 (m, 1H); 6.94-7.00 (m, 2H, 8,10-H); 7.14 (d, J = 8 Hz, 1H, 11-H); 9.83 (s, 1H, 7-H); 
13
C NMR (100 MHz, CDCl3): δC 14.4 (CH3), 21.2 (CH3/CH), 21.6 (CH3/CH), 21.9 (CH), 27.3 
(CH2), 31.6 (CH2), 32.8 (CH), 37.0 (CH), 41.8 (CH), 42.5 (CH2), 126.4 (CH), 126.7 (CH), 
128.1 (CH), 134.9 (C), 139.2 (C), 140.4 (C), 202.8 (CH); IR (neat) 2956, 2928, 2871, 2716, 
1725, 1612, 1497, 1456, 1411, 1377, 1321, 1043, 814 cm
-1
; []D
25
 = 25.3 (c = 0.3, CHCl3).  
(S)-4-((1S,4R)-4,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)pentanal (188b) 
 
Dess-Martin periodinane (1.5 eq.) was weighted in a 25 mL flame-dried round bottom 
flask. The vessel was evacuated and backfilled with N2 before being charged with alcohol 
trans,syn-187a (1 eq.) in 5 mL of DCM. The reaction was allowed to stir at room temperature 
for 2 hours. The solvent was partially removed in vacuum. Trans,syn-188b was obtained as a 
pale yellow oil which was not purified but subjected to the subsequent alkenylation reaction. 
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()-(1R,4S)-1,4,7-trimethyl-1-(6-methylhept-5-en-2-yl)-1,2,3,4-tetrahydronaphthalene. (–)-
Erogorgiaene (86a) 
 
n-BuLi, 1.6M solution in hexane (0.5 mL, 0.81 mmol, 3 eq.), was added dropwise to a 
solution of isopropyltriphenylphosphonium iodide (385.2 mg, 0.89 mmol) in anhydrous THF 
(3 mL) at 0 °C under N2. The mixture was stirred for one hour before aldehyde ()-trans,syn-
188a (65 mg, 1.3 mmol) in THF (15 mL) was added. The solution was allowed to stir at the 
same temperature for 30 minutes before warming to room temperature and heating at reflux for 
a further 2 hrs. After cooling, the reaction mixture was quenched with saturated NH4Cl (5 mL) 
and extracted with DCM (3x20 mL). The organic layers were combined, dried over Na2SO4 
and concentrated in vacuo. Purification by column chromatography on silica (10:1 petroleum 
ether/ethyl acetate) gave (–)-erogorgiaene 86a as a colourless oil (58 mg, 80 %); ()-
Erogorgiane 86a. 
1
H NMR (400 MHz, CDCl3): δH 0.66 (d, J = 6.8 Hz, 3H, 4-H); 1.29 (d, J = 
6.8 Hz, 3H, 1-H); 1.32-1.41 (m, 2H); 1.45-1.57 (m, 2H); 1.67 (s, 3H, 8/9-H); 1.75 (s, 3H, 8/9-
H); 1.80-1.87 (m, 1H); 1.91-1.97 (m, 1H); 2.04-2.19 (m, 3H); 2.33 (s, 3H, 11-H); 2.72-2.76 (m, 
1H, 1/4-H); 2.88-2.93 (m, 1H, 1/4-H); 5.20 (tm, J = 6.8 Hz, 1H, 7-H); 6.97 (d, J = 8 Hz, 1H, 
12-H); 7.05 (s, 1H, 10-H); 7.16 (d, J = 8 Hz, 1H, 13-H); 
13
C NMR (100 MHz, CDCl3): δC14.5 
(CH3), 17.7 (CH3), 21.1 (CH3), 21.5 (CH2), 21.8 (CH3), 25.7 (CH3), 26.3 (CH2), 31.8 (CH2), 
32.8 (CH), 35.2 (CH2), 36.9 (CH), 41.4 (CH), 124.9 (CH), 126.0 (CH), 126.4 (CH), 128.1 
(CH), 131.2 (C), 134.7 (C), 139.9 (C), 140.4 (C); IR (neat) 2959, 2924, 2853, 1613, 1497, 
1452, 1376, 1320, 1109, 1039, 983, 881, 811 cm
-1
; HRMS (ESI) 377.1390 and 379.1386 
(C20H30
107
Ag [M+Ag]
+
 requires 377.1393 and C20H30
109
Ag [M+Ag]
+
 requires 379.1390). []D
25
 
= 25.5 (c = 0.52, CHCl3; []D
25
 = 23.2, c = 0.75, CHCl3;
146
 []D
25
 = 69.1, c = 0.77, 
DCM;
147
 []D
25
 = 40.6, c = 0.14, CHCl3
148
; []D
25
 = 21.4; c = 0.14, CHCl3
111
). 
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()-(1R,4S)-1,6-dimethyl-4-((S)-6-methylhept-5-en-2-yl)-1,2,3,4-tetrahydronaphthalene (86b) 
 
()-86b C-11 epimer was obtained similarly to ()-86a as a pale yellow oil (15 mg, 
30% yield over two steps): 
1
H NMR (400 MHz, CDCl3): δH 1.00 (d, J = 6.8 Hz, 3H, 1-H); 
1.23-1.27 (m, 7H); 1.55 (s, 3H, 8/9-H); 1.66 (s, 3H, 8/9-H); 1.80-2.00 (m, 4H); 2.07-2.12 (m, 
2H); 2.30 (s, 3H); 2.73-2.77 (m, 2H, 1,4-H); 4.98 (t, J = 7.4 Hz, 1H, 7-H); 6.94 (m, 1H, 12-H); 
7.03 (s, 1H, 10-H); 7.13 (d, J = 8 Hz, 1H, 13-H); 
13
C NMR (100 MHz, CDCl3): δC 17.6 (CH3), 
18.1 (CH3), 21.1 (CH3), 22.2 (CH3), 22.4 (CH2), 25.7 (CH3), 26.3 (CH2), 31.4 (CH2), 31.5 
(CH2), 32.7 (CH), 36.2 (CH), 43.8 (CH), 125.0 (CH), 126.1 (CH), 126.7 (CH), 128.4 (CH), 
131.2 (C), 134.5 (C), 139.7 (C), 140.2 (C). IR (neat) 2959, 2924, 2853, 1613, 1497, 1452, 
1376, 1320, 1109, 1039, 983, 881, 811 cm
-1
; HRMS (ESI) 377.1390 and 379.1386 
(C20H30
107
Ag [M+Ag]
+
 requires 377.1393 and C20H30
109
Ag [M+Ag]
+
 requires 379.1390). []D
25
 
= 25.3 (c = 0.3, CHCl3; []D
25
 = 55.2, c = 0.83, DCM147) 
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4.7.  NMR spectra and HPLC traces 
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